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Summary 
 
Treatment of non-healing wounds represents hitherto a severe dilemma for the healthcare 
worldwide because of wound failure to recover. The physiological wound healing is in fact 
a critical process requiring lack of both bacterial contamination and persistent 
inflammatory events in the damaged site. Despite a broad range of both antimicrobial and 
anti-inflammatory agents is commercially available, a successful tackling of bacterial 
infections and chronic inflammation is particularly challenging due to the increase of 
microbial resistance and remarkable side effects caused by an abuse of drugs. To this end, 
the development of innovative biomaterials used in combination with alternative agents is 
very challenging. The goals for the present thesis were to fabricate and characterize in 
terms of physical, chemical and biological properties, nanoengineered biomaterials to be 
used in the treatment of severe wounds. The potential use of two polysaccharides, namely 
chitosan and hyaluronan, and of their derivatives has been investigated. 
In the Chapter I is described an innovative method for the production of tridimensional 
hydrogels based on chitosan and on the cross-linker tripolyphosphate (TPP). The 
possibility to obtain hydrogels with chitosans with different acetylation degree (Fa) and 
molecular weight (Mw) was tackled. Resulting hydrogels were studied in terms of 
mechanical properties. Finally, soft-pliable and biocompatible membranes were obtained 
by freeze-drying. 
Further analyses are accounted in the Chapter II aiming at deeply investigating on 
hydrogel-forming process. More in detail, the different affinity of cross-linkers TPP and 
pyrophosphate (PPi) towards chitosan was explored in diluted solutions. The mechanical 
behavior of resulting hydrogels was further investigated whereas the polymer distribution 
within matrices has been assessed by both qualitative and quantitative methods. 
In the Chapter III the preparation of soft pliable chitosan-based membranes prepared from 
hydrogels containing antimicrobial silver nanoparticles (AgNPs) stabilized by a lactose-
modified chitosan (chitlac) is tackled. A thorough investigation on bactericidal properties 
of the material revealed the synergistic activity of chitosan and AgNPs to reduce the 
growth of different bacteria strains and to break apart mature biofilms. Finally, 
biocompatibility assays on keratinocytes and fibroblasts did not prove any harmful effect 
on mammalian cells. 
 V 
The anti-inflammatory behavior of the short chain fatty acid butyrate is discussed in the 
first part of Chapter IV. Such feature was proved to be time- and dose-dependent. To 
extend on time and to modulate the biological activity of butyrate, chitosan/hyaluronan-
based nanoparticles (complexes) were developed. These carriers showed the ability to 
encapsulate butyrate as payload, an intrinsic scavenging activity, the ability to quickly 
interact with neutrophils, muco-adhesive properties and lack of cytotoxicity.  
In the Chapter V it has been reported the biological investigation of a complex between 
hyaluronan-lipoate and silver ions (named SHLS12). Biological studies showed the ability 
of SHLS12 to exert a straightforward bactericidal activity against different bacterial strains 
grown both in sessile and planktonic state. The lack of toxicity was proved towards 
mammalian cells. By considering its ability to preserve antibacterial properties when 
exposed to serum proteins, this complex may be considered as a promising biomaterial for 
the treatment of non-healing wounds. 
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Sommario 
 
Il trattamento delle ferite difficili rappresenta ad oggi un grave problema per la sanità a 
livello mondiale a causa della difficoltà di queste ferite a guarire. La fisiologica guarigione 
delle ferite è un processo altamente regolato che richiede assenza sia di contaminazione 
batterica che di una persistente risposta infiammatoria. Nonostante sia disponibile sul 
mercato un’ampia varietà di agenti antimicrobici e antiinfiammatori, il trattamento delle 
ferite difficili risulta estremamente difficoltoso a causa dell’aumentata resistenza batterica 
agli antibiotici e dei numerosi effetti indesiderati dovuti ad un abuso di questi farmaci. A 
questo scopo, lo sviluppo di biomateriali innovativi preparati in combinazione con agenti 
alternativi rappresenta un campo di ricerca in espansione. Gli obiettivi per questo lavoro di 
tesi sono stati di conseguenza quelli di sviluppare e caratterizzare a livello chimico-fisico-
biologico biomateriali nano-ingegnerizzati da usare nel trattamento delle ferite difficili. In 
particolare sono stati presi in considerazione due polisaccaridi, rispettivamente il chitosano 
e l’acido ialuronico, e loro derivati ingegnerizzati. 
Nel Capitolo I viene descritto un metodo innovativo per la preparazione di idrogeli a base 
di chitosano e del reticolante tripolifosfato (TPP). È stata considerata la possibilità di 
sviluppare idrogeli utilizzando chitosani con un diverso grado di acetilazione (Fa) e peso 
molecolare (Mw). Gli idrogeli risultanti sono stati studiati in termini di proprietà 
meccaniche. In ultimo, sono state sviluppate membrane flessibili e biocompatibili 
attraverso congelamento e liofilizzazione degli idrogeli. 
Ulteriori analisi per elucidare il processo di formazione degli idrogeli sono riportate nel 
Capitolo II. Nel dettaglio, è stata valutata la differente affinità nei confronti del chitosano 
dei reticolanti TPP e pirofosfato (PPi) in sistemi diluiti. In seguito è stato studiato il 
comportamento meccanico degli idrogeli risultanti mentre la distribuzione del polimero 
all’interno delle matrici è stata valutata tramite metodi sia qualitativi sia quantitativi. 
Nel Capitolo III viene riportata la preparazione di membrane flessibili a base di chitosano a 
partire da idrogeli che includono nanoparticelle di argento (AgNPs) stabilizzate da un 
derivato del chitosano (chitlac). Uno studio approfondito sulle proprietà antibatteriche del 
materiale ha rivelato un’attività sinergica tra il chitosano e le AgNPs nel ridurre la crescita 
batterica di diversi ceppi e nel disgregare biofilm maturi. In ultimo, saggi di citotossicità 
non hanno dimostrato alcun effetto negativo sulla vitalità delle cellule eucariotiche. 
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Nella prima parte del Capitolo IV è riportata l’attività antiinfiammatoria dell’acido grasso a 
corta catena butirrato. Questa proprietà si è dimostrata sia tempo che dose dipendente. Con 
l’obiettivo di prolungare e modulare il rilascio e quindi l’effetto biologico del butirrato, 
sono state sviluppate nanoparticelle (complessi) a base di chitosano e acido ialuronico. Tali 
carriers hanno mostrato l’abilità di incapsulare il butirrato, una intrinseca attività 
antiossidante, l’abilità di interagire velocemente con i neutrofili, proprietà mucoadesive ed 
assenza di citotossicità. 
Nel Capitolo V è riportato lo studio sulle proprietà biologiche di un complesso tra argento 
ionico e un derivato lipoato dell’acido ialuronico, definito SHLS12. Gli studi biologici 
hanno mostrato l’abilità di SHLS12 di esercitare un’importante attività battericida nei 
confronti di diversi ceppi batterici cresciuti sia in stato sessile che planctonico. L’assenza 
di citotossicità è stata dimostrata con cellule eucariotiche. Considerando la sua 
caratteristica di mantenere proprietà antibatteriche quando è in contatto con proteine del 
siero, questo complesso di argento può essere considerato come un biomateriale 
promettente per il trattamento delle ferite difficili. 
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1. INTRODUCTION 
 
1.1. Wound healing process. 
Wound healing is a critical physiological process requiring step-by-step dynamic phases 
and involving different cells and tissues. Upon tissue damage occurs, sequential time-
dependent events are triggered as well as (a) hemostasis, (b) inflammation, (c) proliferation 
and (d) wound remodeling (Figure 1).(1)  
 
 
 
Figure 1.  Stages of wound healing. Wound healing is classically divided into four stages: (A) 
hemostasis, (B) inflammation, (C) proliferation, and (D) remodeling. Each stage involves a 
plethora of both molecular and cellular events and is finely balanced by secreted factors that are 
recognized and released by the cells of the wounding response. A representative subset of major 
factors involved are pointed out. PDGF, platelet-derived growth factor; TGF, transforming growth 
factor; FGFs, fibroblast growth factors; IL-1, interleukin-1; TNF, tumor necrosis factor; KGF, 
keratinocyte growth factor; IGF, insulin-like growth factor; IFN, interferon; VEGF, vascular 
endothelial growth factor; HGF, hepatocyte growth factor; MMP, matrix metalloproteinase; TIMP, 
tissue inhibitor of metalloproteinase. From (1). Reprinted with permission from AAAS. 
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1.1.1. Hemostasis 
Hemostasis represents the early phase of wound healing occurring immediately after the 
lesion. The main purpose is to dampen bleedings in order to protect other organs. The 
second aim deals with the production of an extracellular matrix able to host different cell 
types which will take over in the later phases of healing.(2),(3),(4) The hemostasis and the 
amount of fibrin settled to the lesion site are strictly governed by different cells and 
processes as well as endothelial cells, thrombocytes, coagulation, and fibrinolysis so as to 
modulate the final healing of wound. Different insults may induce micro vascular injury 
and bleeding throughout the wound. Damaged vessels quickly constrict because of the 
contraction of vascular smooth muscle cells in the circular muscle layer. This event is 
sufficiently intense to prevent blood extravasation from a thin artery. In spite of this, 
hemostasis works efficiently only in transversally interrupted vessels where may contribute 
to completely impair bleeding. At variance, if vessels are cut longitudinally, the system 
may not work properly by increasing the breach.(2) In any case, vasoconstriction can 
block, or at least dampen, the extravasation provisionally. Indeed, the vascular smooth 
muscles are advantageous to allow vasoconstriction only for few minutes. Afterwards, 
hypoxia and acidosis elicit their relaxation thereby extravasation restarts. As a 
consequence, vasoconstriction is ineffective to stop bleeding when the insult is persistent 
or unsolved. 
Coagulation cascade is activated together with hemostatic events by both extrinsic and 
intrinsic pathways, causing the aggregation of blood platelet and the clot formation so as 
limiting the leakage of blood from vessels.(4),(3) More in detail, blood components and 
platelets interplay with the extracellular matrix at the wound level thereby inducing the 
release of clotting factors and the consequent formation of blood clot composed by 
fibronectin, fibrin, vitronectin, and thrombospondin.(5) Resulting clot is suitable not only 
for the hemostasis process but even for the migration of cells by behaving as support in the 
later inflammatory phase. The wound healing cascade is triggered by growth factors and 
cytokines present in the α-granules of platelet cytoplasm: these molecules are platelet 
derived growth factor (PDGF), transforming growth factor-β (TGF-β), epidermal growth 
factor and insulin-like growth factors.(5) Such molecules stimulate and attract different 
cells as neutrophils, macrophages, endothelial cells and fibroblasts. For instance PDGF 
boosts the chemotaxis of neutrophils, macrophages, smooth muscle cells and fibroblasts. 
Moreover, it even elicits the mitogenesis of the fibroblasts and smooth muscle cells. On the 
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other hand, TGF-β attracts macrophages and stimulates them to secrete additional 
cytokines including FGF (fibroblast growth factor), PDGF, TNF-α (tumor necrosis alpha) 
and IL-1 (interleukin-1). TGF-β further enhances fibroblast and smooth muscle cell 
chemotaxis and modulates collagen and collagenase expression. At the same time 
vasoactive amines, such as serotonin, are released from the dense bodies of platelet thus 
favoring vasodilation and increased vascular permeability. Finally, cell membrane-derived 
products as well as eicosanoids are leaked after the lesion contributing to subsequent 
inflammatory phase.(6) 
 
1.1.2. Inflammation 
The main aim of the inflammation is to guarantee an immune barrier against pathogens and 
it may be temporarily divided into the early and the late response.(7) 
Early inflammatory phase begins during the last stages of coagulation and it was found to 
afford different functions. This response elicits the complement cascade and favors the 
infiltration of neutrophils as shown in Figure 2 throughout the lesion by preventing or 
eradicating pathogen infections.(8)  
 
 
 
Figure 2. Migration of circulating neutrophils to sites of inflammation or infection. Reprinted by 
permission from Macmillan Publishers Ltd: Nature Reviews Rheumatology (9), copyright 2014. 
Nature Publishing Group is acknowledged. 10.1038/nrrheum.2014.80 
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Neutrophils are recruited to the wound site within 24-36 hours of injury by several 
chemoattractive agents as TGF-β, complement components as well as C3a and C5a, and 
formylmethionyl peptides produced by bacteria and platelet debris.(6) The pivotal role for 
such cells is to eliminate foreign material, bacteria and non-functional host cells and 
damaged matrix components.(7),(10) The weapons that neutrophils exploit to perform their 
role are the phagocytosis activity and the production of ROS. Upon wound occurs, 
neutrophils start to adhere to the endothelial cells in post-capillary vessels surrounding the 
lesion through a phase named margination. Later, cells roll along the endothelium moved 
by the blood stream. Both adhesion and rolling phenomena are due to selectin-dependent 
interactions between the cells and the endothelium.(7),(11) Chemical signal derived from 
endothelial cells immediately stimulate the adhesion of neutrophils mediated by integrins. 
At this point cells stop to roll and infiltrate throughout endothelium by a phenomenon 
termed diapedesis.(7) Once in the lesion environment, neutrophils may be further 
stimulated by bacterial signals as the tripeptide called f-Met-Leu-Phe.(12) Consequently 
neutrophils can either swallow pathogens or attack the same releasing proteolytic enzymes 
and oxygen-derived free radical species. At the end of their activity, neutrophils undergo 
apoptosis in order to not affect the complete recover of the wound and to dampen the 
strong pro-inflammatory condition at the lesion site. Apoptotic bodies are finally 
eliminated by macrophages.(6) Mast cells are also involved in wound healing. Mast cells 
leak granules containing enzymes, histamine and other active amines that contribute to 
determine the typical signs of inflammation rubor (redness), calor (heat), tumor (swelling) 
and dolor (pain). 
By 48 hours after injury, late inflammatory phase starts with the recruitment of monocytes 
that differentiate into macrophages upon fixed to the inflamed tissue. More in detail, 
monocytes undergo phenotypic changes until to transform macrophages. The latter are 
attracted by a plethora of molecules as clotting factors, complement components, PDGF, 
TGF-β, leukotriene B4, platelet factor IV and elastin/collagen debris. At variance with 
neutrophils, macrophages undergo a lower cellular turnover and their biological activity is 
still efficient for low value of pH.(13),(14) Once activated, macrophages release tissue 
growth factors as TGF-β and mediators as well as TGF-α, heparin binding epidermal 
growth factor, fibroblast growth factor (FGF) and collagenase boosting the stimulation of 
keratinocytes, fibroblasts and endothelial cells.(5) Macrophages are also responsible for 
eliminating nonfunctional host cells, bacteria filled neutrophils, damaged matrix, and any 
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residual bacteria at the wound level. If the activity of macrophages decreases at this stage 
of inflammation, the physiological wound healing might be compromise causing delayed 
fibroblast proliferation and maturation, lag angiogenesis implying on altered fibrosis.(15) 
At the end of late inflammatory phase, lymphocytes are recruited about 72 h after the 
damage by molecules as interleukin-1 (IL-1), complement components and 
immunoglobulin G (IgG).(16) IL-1 modulates even the activation of the collagenase, a 
pivotal step in the remodeling of collagen, and the regulation of synthesis/degradation of 
novel extracellular matrix.(17) 
 
1.1.3. Proliferation 
The proliferative phase represents perhaps the most complicated event in the recovery of 
wounds because of different events occurring in a very large timeframe. Generally, 
proliferative phase begins after 72 hours post injury and lasts for about two weeks later. 
The migration of fibroblasts and the temporary sediment of fibronectin and fibrin as 
extracellular matrix, together with the formation of the granulation tissue, represent the 
main processes happening in such phase. 
Concerning fibroblast activity, proliferation occurs at the beginning in the wound 
surrounding tissues during the first 72 hours after injury. Subsequently, TGF-β and PDGF 
released from inflammatory cells and platelets foster fibroblasts to migrate into the 
lesion.(18) Upon arrived, they start to proliferate and to produce matrix components as 
hyaluronan, fibronectin, proteoglycans and type 1 and 3 procollagen which are 
accumulated extracellularly.(14) Subsequently, extracellular components are continuously 
synthetized and accumulated allowing the migration of cells. In the same timeframe, 
fibroblasts modify their phenotype to myofibroblasts characterized by extend pseudopodia 
able to interact with the fibronectin and collagen of the extracellular matrix. Once cells 
reach a notable number, wound contraction takes place due to cell retraction upon 
extracellular matrix and the lesion tends gradually to narrow. Ended their work, 
myofibroblasts are eliminated by apoptosis.(5)  
Another pivotal step belonging to the proliferation phase regards the angiogenesis and the 
formation of granulation tissue. With respect to the former, angiogenesis is a physiological 
event involving angiogenic factors secreted from surrounding tissues during the hemostatic 
phase able either to stimulate endothelial cells (as FGF, vascular endothelial growth factor 
VEGF, PDGF, angiogenin, TGF-α and TGF-β) or inhibit them (angiostatin and steroids) in 
a refined balance.(19),(20) The biological activity played by angiogenic factors deals with 
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the activation of mitosis, movement and the stimulation of host cells to leak endothelial 
growth factors and may be recapped into four steps: production of proteases enzymes by 
endothelial cells thereby damaging the basal lamina of vessels and proceeding throughout 
the extracellular matrix, chemotaxis, proliferation, remodeling and proliferation.(5) At the 
beginning of wound healing, the lesion site is not provided by vascular supplies; as a 
consequence, the progression of novel capillaries proceeds by diffusion of unaltered 
vessels present at the edge of wound and, within few days, the formation of micro-
capillaries occurred.(16) Such activity is prompted by the ability of cells to follow a 
chemical gradient of chemotactic agents (endothelial cell growth factor, TGF-α, VEGF, 
angiopoietin-1, fibrin and lipid growth factors) that stimulate cells to migrate, growth and 
proliferate.(21) Endothelial cells quickly migrate after injury until reaching a slower 
migration rate afterwards. On the other hand, granulation tissue starts to be evident when 
macrophages, fibroblasts and vascularized stroma, together with collagen matrix, 
fibrinogen, fibronectin and hyaluronic acid substitute the fibrin clot above discussed. 
Granulation tissue converts into scar after collagen accumulation. The proliferation phase 
ends with the epithelialization involving epithelial cells. By starting from wound margins, 
a single layer of cells begins to proliferate and consequently to migrate towards the center 
of the lesion until they are sufficiently close to fully cover the underlying extracellular 
matrix. 
 
1.1.4. Remodelling 
The remodeling phase is considered the last event of the physiological wound healing and 
its main target concerns the formation of new epithelium and final scar formation. The 
remodeling of a lesion is strictly governed by fine mechanisms maintaining the correct 
equilibrium between degradation and synthesis of tissues. Some changes happen mainly at 
the extracellular matrix level, where the increasing of collagen bundles and the degradation 
of hyaluronic acid and fibronectin are the pivotal events(22) that imply on the rising of the 
wound tensile strength. In spite of this, the regain of original resistance is never reached 
and it is variable considering the localization of lesion and its time-recovery. The correct 
balance among synthesis and degradation lasts up to three weeks(23) and it is chiefly due 
to the metalloproteinase enzymes activity. They are produced by neutrophils, macrophages 
and fibroblasts at the wound level and are responsible of the collagen degradation. The 
biological activity of such enzymes is inhibited by inhibitor factors when new matrix 
deposition occurs.(24) New formed collagen bundles are initially disorganized but become 
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progressively more organized later. On the other hand, fibroblasts interact with 
extracellular matrix by favoring the wound margins closure. This process is tightly 
modulated by several factors as well as PDGF, TGF-β, FGF, etc.(23) As final steps of 
physiological wound healing, the density of fibroblasts and macrophages reduces,(24) the 
growth of new vessels stops, blood stream dampens and the metabolic activity at lesion site 
weakens. The final outcome is a mature scar with increased tensile strength. 
 
1.2. Acute and chronic wounds: an overview 
Based on their nature and time-healing process, wounds can be classified as either acute or 
chronic. The former are considered lesions that fully recover with an expected period 
spanning from eight to twelve weeks.(25) Acute lesions concern to different types of 
trauma at skin level including mechanical injuries as well as abrasions, wounds due to 
blades, shootings and surgical incisions. Furthermore, chemical injuries, burns and 
radiations may be classified as acute wounds as well. Generally, acute wounds heal by 
either primary or secondary intention. Healing by primary intention may be defined as the 
recovery of a clean wound without loss of tissue and lack of contamination by pathogens. 
At variance, healing for second intention is characterized by loss of a limited number of 
epithelial and connective cells. Such process requires a large amount of granulation tissue 
and an extended time healing. Conversely, chronic wounds, also known as non-healing 
wounds, are lesions that do not undergo the normal healing process with an expected 
partial recovery (and often relapse) beyond twelve weeks.(26) 
 
1.3. Non-healing wounds 
Non-healing wounds gather a number of pathologies in which topical lesions can be related 
to a defect or a break in the skin, resulting from physical or thermal damage and 
pathological conditions. Furthermore, several pathophysiological and metabolic factors 
might affect the physiological wound healing thereby resulting in a poor recovery. The 
most common factors that contribute to make the lesion worse include edema, ischemia, 
tissue hypoxia, infection, necrosis, growth factors imbalance, metabolic diseases and pre-
existing illness. In this context, all phases occurring during the wound healing (ranging 
from inflammatory phase to extracellular matrix deposition) are hindered. Alterations 
derived from one or more aforementioned pathologies affecting the wound repair by 
impairing the recovery and turning an acute lesion into a chronic one. This pathological 
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condition is worldwide diffused, with an incidence of the 0.78% of the population, mostly 
affected elders over the age of sixty.(27) As the life expectancy tends to increase, the 
number of chronic wounds are expected to rise by negatively implying on the costs for the 
healthcare.(28) For instance, the cost related to non-healing ulcers has been estimated at 25 
billion dollars annually in the United States.(29) Chronic wounds may be classified as 
pressure sores, diabetic ulcers, venous ulcers, burns and ulcers secondary to ischemia. 
Moreover, these lesions can even categorized considering either the number or the amount 
of area of skin strata involved.(30),(31) Non-healing wounds do not recover because of 
mainly three aspects: the excessive production of exudates, the presence of bacteria and the 
persistent inflammatory response. The excessive production of exudates leads to the 
progressively damage of healthy tissues surrounding the wound thus impairing the correct 
healing.(32) Specifically, chronic wounds exudates are characterized by the presence of 
proteinase enzymes which contribute to make the lesion worse following to their corrosive 
activity.(33) Nevertheless, the colonization of bacteria both in planktonic and sessile state 
together with the lengthen inflammation are the pivotal factors causing the worsening of 
chronic wounds.  
 
1.4. Bacterial infection 
Chronic wounds represent a fertile ground for bacteria attachment and consequent 
proliferation.(34),(35) Damaged skin exposes underlying tissues to microbial 
contamination and colonization. As a result, resident or opportunistic bacteria present at 
the wound level colonize injured sites and enhance their proliferation thereby forming 
complex surface-attached polymicrobial communities termed biofilm. In fact, chronic 
wounds represent a suitable site for biofilm formation: the necrotic tissue and debris favor 
bacteria attachment (e.g. Staphylococcus aureus and Pseudomonas aeruginosa). The 
presence of such polymicrobial community often produces severe infections involving both 
anaerobic and aerobic strains. James et al. demonstrated the presence of densely 
aggregated bacteria colonies surrounded by an extracellular matrix in human wounds: 
particularly, 60% of chronic wound specimens have proven hosting biofilm.(36)  
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Figure 3. Schematic representation of biofilm formation. (A) Necrotic tissues and debris form a 
good substrate for planktonic, free-swimming bacteria to adhere to. (B) The sessile bacteria will 
recruit additional bacteria from the direct environment and also proliferate on the surface. (C) The 
adhered bacteria change gene expression patterns and start producing the extracellular polymeric 
substance, the main component of the biofilm. (D) The biofilm slowly grows by forming 
microcolonies of mono-poly microbial bacteria. (E) Finally, pieces of the biofilm can break off and 
planktonic bacteria escape from the biofilm and can invade close tissues. Reprinted from (37) with 
permission. Dr. Knetsch is acknowledged.  
 
From a structural point of view, biofilms are composed by an extracellular polymeric 
substance (EPS) surrounding the bacterial cells making them one thousand times more 
resistant to antibiotics and drugs than planktonic ones.(38) The thickness of biofilms may 
span from microns to few millimeters. Mature biofilms are less susceptible than less 
organized ones to antibiotics treatment. Bacteria in sessile state (biofilm) differ from 
planktonic ones also in terms of gene expression and interaction with the injured site. 
Planktonic bacteria engage necrotic tissues and increase in number forming colonies 
(Figure 3). Afterwards they spread throughout the surface either as single layer or 
microcolonies detached from the main biofilm.(39),(40) Generally, biofilms are made up 
of a single bacterial strain or in some cases by different ones as anticipated above.(41) This 
condition affects negatively the physiological healing process by delaying it. Some 
phenomena can contribute to the worsening of chronic lesions as well as poor perfusion, 
presence of a foreign body, pressure, repetitive trauma, hyperglycemia and white blood 
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dysfunction. About the latter aspect, a compromised immune system clearly does not help 
biofilm elimination.(41),(42)  
 
1.5. Antibiotics and antiseptics 
Generally, treatment of non-healing wounds requires antibiotics administered either 
systemically or topically. The most common systemic antibiotics are betalactams, 
aminoglycosides, macrolides, quinolones, lincosamides, nitrimidazoles and sulfonamides 
whereas topical ones include mupirocin, fusidic agents, neomycin, polymyxin and 
bacitracin.(43) Antibiotics represent the paramount tool to treat non-healing wounds but 
the optimal choice of drugs and the duration of therapy is not often well defined.(44) 
Usually, antibiotics have to be used in case of increased bioburden, cellulitis, lymphangitis 
and lymphadenopathy, osteomyelitis, bacteraemia, systemic inflammatory response 
syndrome, life-threatening sepsis and multiple organ dysfunction syndrome, 
immunosuppression and diabetes.(45),(44) Three main recommendations may be taking 
into account when antibiotics are chosen in the therapy of chronic lesions: systemic 
antibiotics should be employed only for clinically infected wounds; antibiotics must to be 
chosen based on the current microbial epidemiology by avoiding the use of wide-spectrum 
ones; topical drugs should be employed only to dampen the critical colonization at the 
wound site. O’Meara et al. claimed that there is not any evidence to support the continuous 
use of systemic antibiotics in specific chronic wounds.(46) Different factors may influence 
the final outcome of antibiotic therapy: the concentration of pathogens at the lesion site as 
well as ischemia phenomena which hinder drug distribution favoring antimicrobial 
resistance against antibiotics. For instance, it was already demonstrated in several cases 
that antibiotics did not reach the minimum inhibitor concentration (MIC) to eradicate, or at 
least dampen, pathogens at wound level.(47) Furthermore, the presence of mature biofilms 
impairs the penetration of antibiotics towards underlying tissues. Methicillin-resistant 
Staphylococcus aureus (MRSA), vancomycin-resistant enterocci and pseudomonads are 
the typical strains residing in the chronic wounds.(44) Colsky et al. reported that up to 50% 
of chronic leg ulcers in hospitalized patients are infected with MRSA, whilst more than 
one-third of Pseudomona aeruginosa isolates are resistant to ciprofloxacin.(48) Given 
these premises, it is evident that pathogens present in the harsh environment of chronic 
wounds could not respond to antibiotic therapy thereby producing onset of resistance. The 
increasing of antibiotic resistance towards a wide range of bacteria strains represents 
 11 
hitherto a serious problem to be solved. Nevertheless, therapeutic indications about the 
correct treatment of chronic wounds are not completely figured out and the inappropriate 
use of systemic antibiotics (together with topical wide-spectrum ones) may lead to the 
antibiotic resistance onset. Vancomycin is the straightforward example to these 
considerations: albeit it is the drug of choice for MRSA and other device-related 
staphylococcal infections, the poor penetrance within staphylococcal biofilms limits its 
use.(49)  
Antiseptics are antimicrobial substances used for the treatment of non-healing wounds 
because of their ability to reduce the possibility of infection and sepsis. Antiseptic agents 
differ from antibiotics for three aspects: they can be used only topically, they have more 
than one of mechanism of action and their biological activity is quicker than antibiotics. 
Ideally, the typical antiseptic should possess some features as well as to guarantee a broad 
antimicrobial spectrum, to provide a constant supply to the wound site, to be not 
inactivated by proteins, to be biocompatible and to exhibit low allergenicity. Antiseptics do 
not cause bacterial resistance, albeit risks about the selection of resistant bacteria exist. In 
spite of this, no antiseptic-resistant human pathogens have registered hitherto. Conversely, 
antibiotics display selective bactericidal activity and their abuse evokes transmissible 
resistance. Mechanisms of action regarding about antiseptics biological activity are 
addressed to impair bacteria metabolism: disruption of efflux pumps, damage to cell walls 
and cytoplasmic processes and nuclear alterations.(50) Actually, a large number of 
antiseptics is available in biomedical field including phenolics, hydrogen peroxide, 
hexachlorophene, cetrimide, benzalkonium salts, potassium permanganate, dilute 
hypochlorite preparations, povidone iodine, chlorhexidine gluconate, triclosan and silver-
releasing agents.(45),(43),(51) For instance, povidone iodine is commonly employed as 
agent to limit bacterial infections prior to surgery. More in detail, it is a valid antiseptic 
endowing with a broad-spectrum activity which may be considerably diminished by 
interaction with proteins. Moreover, in vitro and in vivo studies reviewed by Kramer 
demonstrated conflicting results about bactericidal effects and the safety of povidone 
iodine.(52) Concerning such substances, silver represents a good example of antiseptic and 
it is one of the most studied agents to prevent, control and eradicate bacterial infections at 
the wound site. 
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1.6. Silver: benefits and hazards 
From centuries silver is well known to exert antibacterial properties towards a wide range 
of bacteria strains. It is already employed in medical dressings in its ion (Ag+) or reduced 
(Ag0 or AgNPs) nanoparticle-state to face bacterial infections.(53) AgNPs span from 1 to 
100 nm in size and their physical, chemical, biological features considerably vary based on 
dimensions because of different surface/volume ratio. Silver nanoparticles are currently 
used in biomedical field in diagnosis, drug delivery, coatings, medical textiles and wound 
dressings.(54),(55),(56),(57) With the advancement of nanotechnology, nanocrystalline 
forms of silver can be prepared with variable size and shape by means of reliable 
methods.(58) AgNPs are obtained by physical, chemical and biological methods. 
Evaporation/condensation and laser ablation are the principal physical techniques to form 
AgNPs. The former exploits a furnace tube under atmospheric pressure but high-energy 
usage and long-time working are the main drawbacks for such method. As a matter of fact, 
laser ablation works by ablating metals in solution without chemical reagents thus 
producing nano-silver colloids.(59) Chemical reduction of silver ions is probably the most 
common technique to obtain AgNPs. Three components are fundamental to such a 
purpose: silver salts (for instance silver nitrate), reductants (borohydride, citrate, 
ascorbate(60),(61),(62)) and capping agents. Capping or stabilize agents are surfactans or 
polymers containing functional groups as well as polyvinylpyrrolidone, poly(ethylene 
glycol), poly(methacrylic acid), poly(methyl methacrylate) and biopolymers (chitosan, 
alginate and chitlac) able to avoid aggregation phenomena. Biosynthesis of AgNPs (green 
synthesis) is recently gaining appeal due to the growing need of environmentally friendly 
synthesis methods using mild agents as peptides, carbohydrates, bacteria, fungi, yeast, 
algae and plants.(63),(64),(65) 
Silver-based derivatives are of interest in the biomedical field following to the increasing 
of bacterial resistance towards many antibiotics as discussed above. The work of Xiu et al. 
identified Ag+ as the molecular toxicant for bacteria with respect to AgNPs.(66) In this 
context, silver nanoparticles are supposed to be made by a reduced core surrounded by an 
ion corona. Physical contact of bacteria with such Ag+ ions, dissolved and released in the 
environment surrounding the nanoparticles, is at the root of their toxicity toward 
prokaryotic cells. The antimicrobial mechanisms of action of silver are numerous (Figure 
4). For instance, some studies demonstrated that silver proved its toxicity by interaction 
with bacterial membranes,(62),(67) likely in correspondence to specific molecular targets 
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as thiol groups (-SH) of proteins, causing membrane damage.(68) Feng et al. demonstrated 
the presence of many small electron-dense granules either surrounding the cell wall or 
depositing inside the cells, likely deriving from the silver-proteins combination.(69) This 
might impair electron transport throughout the membrane due to its altered permeability. 
Finally, silver is supposed to bind phosphorus atoms containing DNA and to attack the 
bacterial respiratory chain.(69),(70),(67) 
 
 
 
Figure 4. Antimicrobial mechanisms of action of silver. Reproduced from (71) with permission of 
The Royal Society of Chemistry. 
 
The potential toxicity upon mammalian cells represents the major concern for the scientific 
community in the use of silver in medical dressings. Firstly, it should be claimed that silver 
becomes cytotoxic beyond threshold concentrations when internalized within cells. This 
can occur when silver is present in the surrounding milieu of mammalian cells and 
consequently it is able to penetrate the cell membrane as well. A recent study proved that 
the exposure of eukaryotic cells to AgNPs led to oxidative stress by inducing the 
production of ROS, the up-regulation of HO-1 expression, apoptosis and autophagy.(72) 
Furthermore, the cytotoxicity of metal was found to be dose-dependent. ROS are able to 
interact with DNA thus causing the damage of double helix, the modification of 
nucleobases and the formation of coupling phenomena.(73) Silver even proved to enter 
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into the nuclei of cells (by diffusive phenomena or through nuclear pores) thereby inducing 
protein aggregation and block of transcription, replication and cellular proliferation.(74) 
Given these premises, it is noteworthy consider to entrap silver ions or AgNPs in 
tridimensional matrices thus avoiding, or at least limiting, from being available to the 
eukaryotic cell uptake but preserving its antibacterial properties at the same time. For 
instance, the ability of a 1-deoxylactit-1-yl chitosan, (shortly named chitlac) in 
combination with other polysaccharides is reported for the in situ preparation of stable 
suspensions of evenly sized AgNPs,(62) allowing to obtain an antimicrobial and 
biocompatible system for various biomedical applications.(75),(76),(77) 
 
1.7. Inflammation treatment 
As described above, persistent inflammatory response at lesion site represents one of the 
main critical aspects for the correct recovery of chronic wounds. For instance, the 
activation of neutrophils and other neutrophilic polymorphonuclear leukocytes (PMN) 
recruited to the inflamed site leads to the release of ROS and other pro-inflammatory 
mediators which, on one end, contribute to the PMN antimicrobial activity and, on the 
other, are involved in the pathogenesis of tissue damage. It is therefore plausible that, in 
the attempt to mask the negative side of inflammation, an increasing number of studies are 
continuously performed worldwide with the aim of finding drugs that can eliminate, or at 
least dampen, inflammation-derived tissue injury. 
The review paper of Karukonda et al.(78) discusses the principal anti-inflammatory drugs 
employed for the wound healing (Table 1). 
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Drug 
Mechanism of 
action 
Wound healing 
positive effects 
Wound healing negative effects 
Corticosteroids 
Inhibition of gene 
expression 
Dampening of 
immune-mediate 
damage 
Worsening of infections 
   
Decreased of inflammatory 
mediators, platelet adhesion and 
phagocytosis 
   
Decreased synthesis of collagen due 
to reduced protein synthesis 
   Decreased tissue remodelling 
Colchicine 
Inhibition of 
microtubule 
formation 
Improvement in the 
early inflammatory 
phase 
Decreased granulocytes migration 
and cytokine release 
   
Decreased fibroblast synthetic 
activity 
   Increased collagenolysis 
Dapsone 
Inhibition of PMN 
integrins 
Limitation of PMN-
mediated damage 
and inflammation 
Not active towards macrophages and 
lymphocytes 
Ibuprofen 
Inhibition of 
cyclooxygenase 
Limitation of 
inflammation 
Reduction of the tensile strength of 
wound 
Aspirin 
Inhibition of 
arachidonic and 
metabolites 
Limitation of 
inflammation 
Impairing of hemostatic phase by 
inhibiting platelet aggregation 
 
Table 1. Anti-inflammatory drugs employed in wound healing. Adapted from (78). 
 
Table 1 points out that common drugs can provide both benefits and drawbacks for the 
correct wound healing. This situation might dramatically worsen when chronic lesions are 
considered (compared to acute ones) and drugs are administered improperly. Besides to the 
mechanism of action, other points having to take into account as dosage and route of 
administration with respect to specific phases of wound healing. For instance, while oral 
doses of the corticosteroid prednisone (above 10 mg per day) negatively influence wound 
healing in the first three days, higher dosage (at or above 40 mg per day) is requested 
afterwards to favor collagen remodeling. However, administration of corticosteroid inhibits 
wound closure regardless of the inflammation phases.(78) As mentioned above, the route 
of administration is also important to the final outcome. As an example, topical 
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hydrocortisone shows poor benefits for wound healing, in any case lower if compared to 
other corticosteroids administered orally. 
To date, several studies claimed the possibility to employ “natural drugs” derived from 
both plants and animals to face chronic wounds. A recent review paper screened hundreds 
of studies where combined herbal preparations and their phytochemical constituents have 
been used for wound management.(79) For example, single herbal preparations of Achillea 
millefolium proved to decrease inflammation and showed angiogenic, debridement, 
granulation and antimicrobial functions. Gels of Aloe vera demonstrated wound healing 
potential by anti-inflammatory effects and increasing re-epithelialization and 
microcirculation. Moreover, the production of pro-inflammatory cytokines TNF-α, IL-6 
and leukocyte adhesion have been found to diminish in a rat model of burn wound treated 
with such gels. Combined herbal preparations as Ampucare (a topical oil-based preparation 
containing Azadirachta indica, Berberis aristata, Curcuma longa, Glycyrrhiza glabra, 
Jasminum officinale, Pongamia pinnata, Rubia cordifolia, Terminalia chebula, 
Trichosanthes dioica, Symplocos racemosa, Ichnocarpus frutescens, Capsicum abbreviata, 
Nymphaea lotus) showed burn healing effect with enhancement of antioxidant function, 
NO levels, as well as increase in protein level and vitamin C in rats.(79) 
Another review paper collected several works dealing with the possibility to use honey as 
anti-inflammatory agent.(80) Honey proved potent multiple anti-inflammatory effects. For 
instance, the reduction of inflammation was observed in the clinic following the 
application of honey as well as supported by histological evidences. Clinically, numerous 
observations reported that honey is able to reduce edema and exudates. The anti-
inflammatory effect of honey may be explained by several mechanisms of action as 
inhibition of the complement pathway, of ROS production, of leukocyte infiltration and of 
COX-2 and inducible NO synthase expression. Lastly, the inhibition of matrix 
metalloproteinase 9 (MMP-9) is considered a further anti-inflammatory mechanism of 
honey action. While honey components (including phenolic compounds and flavonoids) 
responsible for the anti-inflammatory activity in vitro have been partially identified, it is 
not completely obvious whether such components elicit anti-inflammatory activities in 
vivo.(80) Many other natural products as yoghurt, tea tree oil and potato peeling have been 
used to face chronic wounds but controlled studies are lacking. 
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1.8. Butyrate 
Among natural drugs, butyrate represents one the most studied as anti-inflammatory 
molecule. Butyrate belongs to the short chain fatty acids (SCFAs) family, together with 
propionate and acetate. Butyrate is physiologically present in the healthy intestine of 
human body and together with propionate and acetate is the major metabolic products of 
the anaerobic fermentation of indigestible dietary fibers carried out by microbiota 
colonizing the large intestine. More in detail, such molecule is produced by some 
Firmicutes using either the Butyryl-CoA:acetate CoA-transferase enzyme or, less 
commonly, the phosphotransbutyrylase and the butyrate kinase.(81) The former pathway is 
the one exploited by most of the healthy gut microbiota. The concentration of acetate, 
propionate and butyrate was found to be around 50-150 mM in the colon with a ratio of 
3:1:1. Immediately after its production, butyrate is quickly absorbed by epithelial cells at 
lumen level and used as an energy source. This implies that the concentration in the 
systemic circulation is very low. 
Besides being the preferred energy source for the cells that lines the colon, SCFAs have 
been shown to possess interestingly biological properties, including anti-inflammatory and 
anti-tumorigenic activities.(82),(83) The role of SCFAs exerted in modulating the 
inflammatory response is mainly related to their effects on endothelial cells and leukocyte 
pathophysiology. In this respect, most of the studies deal with the capability of butyrate to 
influence several functional responses of PMN that play a crucial role during the early 
inflammatory phase. It has been reported, for instance, that butyrate influences PMN 
adhesion, chemotaxis, degranulation, phagocytosis, microbial killing and release of pro-
inflammatory mediators.(84),(85),(86)(87) Concerning the production or ROS, the effect 
of SCFAs on PMN respiratory burst remains under debate. Indeed, either stimulatory(88) 
or inhibitory(89) activities have been reported where ROS release was assessed almost 
exclusively from PMN maintained in suspension, a situation that is closer to the condition 
of circulating leukocytes than of granulocytes in inflamed tissues. The anti-inflammatory 
properties of butyrate derives from the interaction via GPR41 and GPR43 receptors (G-
coupled protein)(82) expressed on PMN and on the cells of the mucosa. Moreover, 
butyrate plays also the role of histone deacetylase (HDAC) inhibitor in colonocytes and in 
cells of the immune system so promoting hyperacetylation.(90) 
In spite of this, the activity of butyrate results transient because of many factors and many 
authors have already investigated this aspect.(91),(92),(93) Given these premises, the need 
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to develop smart systems able to provide the right amount of butyrate over time to the cells 
should be a promising strategy to face chronic inflammation at wound site. 
 
1.9. Wound dressings 
Historically, the main role of wound dressings was to contribute palely in the healing 
cascade by assuming only protective functions. Nevertheless, so far it is common opinion 
to consider wound dressings as dynamic systems positively enhancing the recovery of 
lesions. Overall, wounds may be treated by either passive or active dressings.(94) The 
former are generally employed in the treatment of acute wounds, ensuring high absorption 
of exudates and adequate protection, whereas the latter are commonly used in chronic 
lesions considering their ability to adapt to wounds and to guarantee a moist environment 
so as to enhance the recovery.(95) An important parameter to take into account in the 
wound dressing production is the environment that characterizes chronic wounds: indeed, 
the moist milieu is a paramount factor favoring the proliferation and migration of 
fibroblasts and keratinocytes, the collagen synthesis thereby leading to reduced scar 
formation.(96) At the same time, moist dressings are considered to aid lesion healing faster 
compared to dried ones.(97) Other features that wound dressings have to ensure are to 
provide thermal insulation, gaseous exchange and to help drainage and debris removal; 
they should not be cytotoxic or elicit any allergic or immune response; they should possess 
antimicrobial properties thereby facing primary infections and protecting from secondary 
ones; finally, ideal wound dressings should be easily removed without damaging healthy 
tissues.(98) Generally, wound dressings may be categorized as hydrocolloids, hydrogels, 
foams and films/membranes. 
 
1.9.1. Hydrocolloids 
Hydrocolloids concern moist wound dressing made of a support material and a layer with 
colloidal particles containing biocompatible either protein (collagen, gelatin) or 
polysaccharide (cellulose) gels.(97) These dressings swell when in contact with exudates 
because of absorption of wound fluids so as to create a moist environment. Nevertheless, 
potential use of hydrocolloids in the treatment of non-healing wounds is contradictory: the 
excessive moist environment may generate hypoxic conditions thus favoring the autolysis 
of necrotic tissue and increasing the risk of infection by pathogens. 
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1.9.2. Hydrogels 
From a structural point of view, hydrogels are composed by a single or mixed hydrated 
polymers where at least the 20% of total weight is water.(99) When the total content of 
water reaches more than 95% of the total weight these constructs may be classified as 
superabsorbents. Hydrogels are simply fabricated by covalent or ionic gelation by means 
of small molecules named cross-linkers. Usually, covalent cross-linkers allow the 
formation of hydrogels with a permanent network structure, since irreversible chemical 
links are formed. This system enables absorption of water and/or bioactive compounds 
without disgregation and permits drug release by diffusion. On the other hand, ionic cross-
linkers are generally considered more biocompatible towards mammalians and they allow 
the fabrication of less stable networks formed by reversible links. For instance, ionically 
cross-linked chitosan hydrogels exhibit a higher swelling behavior to pH changes with 
respect to covalently ones.(100) To conclude, the type of gelation strongly influences the 
physical-chemical behavior of such systems. Similarly to hydrocolloids, hydrogels foster 
the autolytic debridement of necrotic tissues and are chiefly more efficient to dry wounds 
with few exudates. On the other hand, if applied in lesions with higher content of wound 
fluids, they may foster maceration phenomena. The main advantage in the use of hydrogels 
as wound dressing resides in their easy usage without impairing with the physiological 
healing.(45) 
 
1.9.3. Foams 
Such constructs were fabricated as alternatives to hydrocolloids for draining lesions with 
higher content of wound fluids. The ability of foams to absorb exudates depends on which 
polymer has been employed for the fabrication and by the thickness or resulting 
material.(45) Foams are easy to manipulate by adapting to different lesions, highly 
absorbent, protective and comfortable. 
 
1.9.4. Films/membranes 
These wound dressings range from micrometers to millimeters in thickness and are 
fabricated by different techniques by using one or more polymers. These constructs are 
usually durable, comfortable, easy to manipulate, adhesive, cheap, semi-permeable to 
oxygen and water vapor and often impermeable to liquid and to bacterial 
contamination.(45) On the other hand, the main drawback for such systems is that they 
should be employed only in the case of low amount of exudates lesions and in applications 
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that last up to five days in superficial wounds. However, films might be used in association 
with other dressings thereby improving their absorption properties. In any case, drugs, 
growth factors or silver may be embedded within active polymeric dressing in order to 
improve the healing process. 
 
1.10. Natural and synthetic polymers for wound healing 
Several polymers with peculiar chemical, physical and biological properties are currently 
used for the fabrication of wound dressings with different shape, morphology and 
dimensions.(101) Based on their origin, polymers may be easily classified as natural or 
synthetic. Engineered polymers as well as mixtures of two or more ones can even 
considered as further types. Table 2 summarizes the majority of polymers employed in the 
treatment of non-healing wounds as active constructs. 
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Polymer Type System Embedded substances 
Protein Collagen - gelatin Gelatin microsphere (102) bFGF 
  Collagen matrix (103) Glucose oxidase 
  Collagen-gelatin foam (104) bFGF 
 Fibrin Scaffold (105) AdeNOS 
  Gel (106) CD34+ cells 
 Silk fibroin Film (107) Aloe vera extract 
 Elastin Peptides gel (108) KGF 
Polysaccharide Chitosan 
Chitosan-crosslinked 
collagen (109) 
Recombinant human 
aFGF 
 
Hyaluronan and 
derivatives 
Benzyl esters films (110) 
Autologous human 
keratinocytes 
  High molecular weight (111) Iodine complex 
  Foam (112) Arginine and EGF 
  Gel (113) Amino acids 
 
Cellulose and 
derivatives 
Dressing (114) Silver nanoparticles 
  
Carboxymethyl cellulose 
hydrogel (115) 
Chestnut honey 
 Alginate Hydrogel (116) Phenytoin 
Synthetic PVA 
Aminophenyl boronic acid 
with PVA (117) 
Ciprofloxacin 
 PEG PEG-PCL nanofibers (118) EGF / bFGF 
 PVP PVMMA and PVP (119) NO 
 Poly(α-esters) PLGA microspheres (120) rhEGF 
  PCL nanofibers (121) Curcumin 
  PLA fibers (122) bFGF 
 
Table 2. Polymers employed in the treatment of non-healing wounds as active materials. Adapted 
from (123). 
 
Among them, natural polymers are used in regenerative medicine field, and consequently 
in skin regeneration, because of their lack of toxicity, biodegradability and the capacity to 
resemble the extracellular matrix.(124) Natural polymers can even easily engineered or 
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surface modified in order to improve their physical, chemical and biological features. The 
use of such materials is favored with respect to synthetic ones, because of the lack of cell 
recognition signals. However, some concerns may be cited for natural polymer as their low 
mechanical properties and the inability to finely control the degradability in vivo. To date, 
natural polymers can be obtained by fermentation of microorganisms or produced in vitro 
by enzymatic processes. In spite of this, the largest amount is still extracted from plants, 
animals or algae. Below are described natural polymers employed during the experimental 
activity carried out during the PhD experimental activity. 
 
1.10.1. Chitosan 
Chitosans are considered as a family of polysaccharides made of linear binary copolymers 
of β-(1→4)-linked D-glucosamine (D unit) and N-acetyl-D-glucosamine (A unit) as 
pointed out in Figure 5.  
 
 
 
Figure 5. Structure of chitosan. 
 
From a chemical point of view, chitosans show a different distribution of A and D units, 
where the latter are generally higher in number and the former are random distributed in 
the polymer backbone. Chitosans stem from chitin, one of the most abundant 
polysaccharides on the earth, from the exoskeletons of arthropods, or from certain fungi 
and it is possible to prepare chitosans with different fractions of A units (Fa) by means of 
either deacetylation of chitin (under acidic or alkaline conditions) or reacetylation of highly 
deacetylated chitosans.(125) While acidic conditions cause drastic degradation rates of 
polysaccharide, alkaline ones are well tolerated by acetomido groups of chitin. Indeed, 
only limited degradation occurs during drastic alkaline conditions.(125) As soon as 
deacetylation (or reacetylation) reaction ends, Fa can be easily determined by means of 
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different techniques as IR, UV, gel permeation chromatography, colloid titration, elemental 
analysis, dye adsorption and acid-base titration,(126) although 1H-NMR may be assumed 
the “golden standard” method for such purpose.(127) Chitosans are also considered the 
water-soluble form of chitin containing from ~ 100 to ~ 40% of D units: a typical 
assumption to discriminate them is their solubility in 0.1 M acetic acid where chitosans are 
soluble whilst chitin is not.(126) Chitosans behave as amphiphilic polymers in solutions 
because of the hydrophobic nature of N-acetylated aminogroups and the hydrophilic 
character of D-units aminogroups to take up a proton and become positively charged.  
Chitosans, as well as other polysaccharides, are polydispersed with respect to molecular 
weight. The molecular mass is therefore an average of the whole distribution of molecular 
masses. The most commonly used are the number Mn, which weights the polymer 
molecules according to the number of molecules having a specific molecular weight, and 
the weight-average (Mw), which weights the polymer molecules according to the weight of 
molecules having a specific molecular weight. They are defined as: 
 𝑀! =    𝑛!! 𝑀!𝑛!!    
 𝑀! =    𝑛!𝑀!!! 𝑛!! 𝑀!  
 
where ni is the number of molecules and Mi is the molecular weight. A useful parameter is 
the polydispersity index (PI), defined as the ratio between 𝑀! and 𝑀! that indicates how 
the polymer distribution is polydispersed with respect to molecular weight. A PI = 1 refers 
to a monodispersed sample whereas a PI less than 2 refers to a heterogeneous population of 
molecular weights. PI > 2 indicated a very broad distribution, suggesting either a mixing of 
polymer with different molecular weights or a non-random degradation occurred during 
the production process.(125) 
Commercial chitosans generally show Fa values spanning from 0 and ~ 0.2 and are 
characterized to be soluble only in aqueous solutions in acidic conditions whereas are 
considered insoluble for neutral or basic pH values.(128) All chitosans are in fact soluble 
at pH values below 6 and the solubility tends to decrease by increasing pH. Beyond such 
pH value commercial chitosans begin to precipitate. Other effects may contribute to the 
solubility of chitosans as well as the ionic strength (due to salting-out effects), the 
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molecular weight and the presence of ions (i.e. copper) in the solvent. However, soluble 
chitosans for neutral pH values can be fabricated by modulating the Fa. For instance, 
Sannan et al. obtained fully soluble polymers with Fa values ranging from 0.4 to 0.6.(129) 
Similarly, Vårum et al. demonstrated that the solubility of hydrochloride chitosans 
increases with increasing Fa.(128) About charge density, it depends by the degree of 
protonization (determined in turn by chemical composition, i.e Fa) and should be vary by 
tuning the molecular weight of polymers, the pH and the ionic strength.(125) Overall, 
different chitosans have shown similar values of the dissociation constant (pKa) ranging 
from 6.2 to 7 depending even on experimental conditions used.(130),(131),(132),(133) 
Many chitosan-based matrices reported in the literature and proposed for biomedical 
applications, are fabricated by three-dimensional hydrogels starting from chitosan solutions 
where the use of specific cross-linkers to form covalent or ionic bonds is a mandatory 
step.(134),(135),(136),(137) In addition, chitosan may form hydrogels without any cross-
linker only by changing the pH or using hydroalcoholic media.(138),(139) Chitosan 
hydrogels can be further processed by employing several technologies (i.e. freeze-drying 
and air drying) in order to obtain matrices as well as scaffolds and membranes.(140) The 
properties of cross-linked hydrogels depend mainly on their cross-linking density, that is, 
the ratio of moles of cross-linker to moles of polymer repeating units. Moreover, a critical 
number of cross-links per chain are required to allow the formation of a uniform polymeric 
network throughout the hydrogel defined as a “wall-to-wall” system. The most common 
cross-linkers used to promote a covalent reticulation of chitosan are dialdehydes such as 
glyoxal and glutaraldehyde.(141),(142) The use of genipin represents an alternative 
solution.(143) Nevertheless, most of the cross-linkers used to perform covalent cross-
linking are toxic and then incompatible with the biological environment. In order to 
overcome this drawback, ionic cross-linkers can be exploited because of their higher 
biocompatibility and milder conditions of use. The typical ionic cross-linker for chitosans 
is tripolyphosphate (TPP), which is an ionic cross-linker already used to reticulate chitosan 
to obtain fibers, nanoparticles, and micro/nano-gels.(144),(145) 
About wound healing properties, chitosan was found favoring wound recovery by 
stimulating the proliferation of cells and deposition of organized connective tissue. This 
behavior was ascribed to the ability of chitosan to elicit macrophages to release TGF-β and 
PDGF cytokines.(146) Furthermore, another study claimed that chitosan may boost the 
biological activity of growth factors present in serum by interacting with them.(147) Last 
but not the least, chitosan is well known to possess antibacterial properties (mainly 
 25 
bacteriostatic activity), a pivotal feature for an ideal wound dressing, because of its 
electrostatic, hydrophobic and chelating effects.(148)  
Different formulations based on chitosan were obtained in the past for the treatment of 
non-healing wounds: mesh membranes,(149) films endowed with nanosilver,(150) 
films/gels containing fucoidan as a wound dressing for dermal burn healing,(151) 
membranes containing Aloe vera,(152) ciprofloxacin-loaded chitosan-gelatin composite 
films,(153) chitosan-fibrin-alginate composites(154) and microporous chitosan hydrogel-
nanofibrin composite bandages.(155) 
 
1.10.2. Hyaluronic acid 
Hyaluronic acid, or hyaluronan in its dissociated form, is a linear polysaccharide composed 
of alternating (1→4)-β linked D-glucuronic acid and (1→3)-β linked N-acetyl-D-
glucosamine dimers (Figure 6) and belongs to a group of macromolecules known as 
glycosaminoglycans (GAG). 
 
 
 
Figure 6. Structure of hyaluronic acid. 
 
It is the most structurally simple one and it is not covalently associated to proteins, not 
synthesized in the Golgi apparatus and not sulphonated.(156) Hyaluronic acid is 
physiologically present in human body, for instance in the synovial fluid where it is at both 
high concentration and molecular weight in order to provide lubrication for the joints, by 
reducing the friction, and to serve as a shock absorber. It is a fundamental component of 
the extracellular matrix but it can be also found in the capsules of some bacteria. Such 
polysaccharide plays even a pivotal role in embryogenesis, signal transduction and cell 
motility.(156) Hyaluronic acid is an active biopolymer interacting with cells via CD44, 
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RHAMM and LYVE-1 receptors.(157) Generally, this polysaccharide shows high 
molecular weights but in some cases, as well as inflammatory pathologies, it can be 
degraded by the activity of radicals thereby forming low molecular weight fragments, 
which can accumulate during tissue injury. Due to its high biocompatibility, this 
polysaccharide is often employed in the biomedical field and it has used in several clinical 
applications as viscosurgery, viscoaugmentation, viscoseparation, viscosupplementation 
and viscoprotetion.(158) 
Hyaluronic acid has been extensively studied for the treatment of non-healing wounds. For 
instance, silver sulfadiazine-impregnated polyurethane foams were developed and used as 
wound dressing: the lesion size was found to decrease around 77% without any 
inflammatory response in a rat skin experimental model after one week of foam 
application.(159) Biomimetic hydrogels for wound healing applications containing 
hyaluronic acid were functionalized with thiol cross-linking sites,(160) or cross-linked 
with DNA.(161)  
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2. AIMS 
 
The main objectives for this thesis deal with the fabrication and characterization of 
innovative polysaccharide-based biomaterials in the form of membranes, gels and 
nanostructures, to be used as potential tools for the treatment of non-healing wounds.  
 
The specific aims were: 
 
• Establish a method to develop tridimensional matrices in the form of hydrogels and 
dried membranes using the biopolymer chitosan and tripolyphosphate (TPP) as 
ionic cross-linker. 
• Provide further insights with respect to literature on the ionotropic gelation of 
chitosan with either TPP or pyrophosphate (PPi) as cross-linkers in dilute solutions 
and in tridimensional hydrogels. 
• Enhance the antimicrobial properties of the chitosan membranes by using colloidal 
suspensions of chitlac-AgNPs without affecting the viability of mammalian cells. 
• Study the anti-inflammatory properties of the short chain fatty acid butyrate as 
potential molecule to load within chitosan membranes. 
• Fabricate and characterize chitosan/hyaluronan nanoparticles (complexes) able to 
host butyrate and to control its leakage. 
• Evaluate biological properties of a silver hyaluronan-lipoate derivative in gel state. 
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3. EXPERIMENTAL SECTION 
 
CHAPTER I 
 
Fabrication of chitosan-TPP hydrogels and membranes 
 
3.1.1. Aim of work 
In this section is presented the work aiming at (i) developing a slow diffusion-based 
technique to prepare homogeneous bulk chitosan-TPP hydrogels, (ii) investigating their 
physical-chemical and mechanical properties, (iii) preparing prototypes of membranes for 
biomedical applications by a freeze-drying technology and (iv) evaluating the 
biocompatibility of the resulting membranes on eukaryotic cells. 
 
3.1.2. Materials and methods 
3.1.2.1. Materials. Highly deacetylated chitosan (fraction of N-acetyl-glucosamine units - 
Fa - of 0.16 as determined by means of 1H-NMR), was purchased from Sigma-Aldrich 
(Chemical Co. USA) and purified by precipitation with isopropanol, followed by a dialysis 
against deionized water.(162) The relative molar mass (“molecular weight”, Mw) of 
chitosan determined by intrinsic viscosity measurements was found to be around 690 
kDa.(162) Other chitosans used in this study were kindly gifted by Prof. Kjell Morten 
Vårum (NTNU, Trondheim, Norway) and their features are shown in Table 4. 
Pentasodium tripolyphosphate (TPP) (MW 367.86 g mol-1; technical grade 85% wt), 
sodium chloride (NaCl), glycerol (ReagentPlus® ≥ 99.0%) and Phosphate Buffered Saline 
PBS (0.01 M phosphate buffer, 0.0027 M KCl and 0.137 M NaCl) were purchased from 
Sigma-Aldrich (Chemical Co. USA). Ammonium vanadate and ammonium molybdate 
were purchased from Honeywell Specialty Chemicals Seelze GmbH (Germany) and Carlo 
Erba (Italy), respectively. LDH (lactate dehydrogenase)-based TOX-7 kit was purchased 
from Sigma Aldrich (Chemical Co. USA). All other chemicals and reagents were of the 
highest purity grade commercially available. 
 
3.1.2.2. Chitosan-TPP hydrogel preparation. Chitosan-TPP hydrogels were fabricated 
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by exploiting an ion diffusion technique (Figure 7). Chitosan solution (3.5% w/v) was 
prepared as a stock solution by dissolving chitosan (0.35 g) in 10 mL of 0.2 M acetic acid 
solution and diluted to reach the desired concentration. Glycerol (5% v/v) was used as 
plasticizer. Chitosan solutions were casted in a mold (diameter = 22 mm, height = 2.5 mm) 
closed by two dialysis membranes (average flat width 33 mm, Sigma Aldrich, Chemical 
Co.) and fixed by double circular stainless iron rings. The system was hermetically sealed 
and immersed into a TPP-NaCl-glycerol solution (gelling bath). The concentrations of both 
TPP and NaCl in the gelling bath have been varied over the range 1-3% w/v and 0-500 
mM, respectively, in order to obtain a broad range of formulations. Conversely, glycerol 
was kept constant both for the inner chitosan solution and the outer TPP-NaCl solution for 
all experiments. Ion diffusion proceeded for 24 h under moderate stirring at room 
temperature. 
 
3.1.2.3. Membrane preparation. Resulting hydrogels were washed twice at the end of 
dialysis (1 h for each washing) with 150 mM NaCl solution first and finally with deionized 
water in order to remove all residual traces of unbound tripolyphosphate. Hydrogels were 
thereafter cooled by immersion in a liquid cryostat (circulating bath 28L, VWR, Radnor, 
PA, USA). Ethylene Glycol in water (3:1) was used as refrigerant fluid. Temperature was 
decreased from 20 to -20 °C by 5 °C steps with 20 minutes intervals. Samples were then 
freeze-dried for 24 h. 
  
3.1.2.4. Morphological analyses. Morphological analyses of hydrogels and membranes 
were performed by Scanning Electron Microscopy (Quanta250 SEM, FEI, Oregon, USA). 
In environmental conditions, hydrated specimens were mounted on aluminium stubs 
covered with double-sided conductive carbon adhesive tape. In the case of cross-section 
evaluation, samples were cut in parallel to the cylinder axis and then prepared as described 
above. The samples were then analysed in secondary electron detection mode. The 
working distance was adjusted in order to obtain the suitable magnification. Freeze-dried 
membranes were sectioned and directly visualized after sputter-coating with an ultrathin 
layer of gold and analysed as to both material surface and cross sections. The accelerating 
voltage was varied from 20 to 30 kV. 
 
3.1.2.5. Mechanical spectroscopy. Rheological characterization of cylindrical chitosan 
hydrogels was performed by means of a controlled stress rheometer Haake Rheo-Stress 
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RS150 operating at 25 °C using, as measuring device, a shagreened plate apparatus 
(HPP20 profiliert: diameter = 20 mm). To avoid water evaporation from the hydrogel, the 
measurements were led in a water-saturated environment formed by using a glass bell 
(solvent trap) containing a wet cloth. In addition, to prevent both wall-slippage(163) and 
excessive gel squeezing (which could reflect in the alteration of polymeric network 
properties), the gap between plates was adjusted, for each sample, by executing a series of 
short stress sweep tests (f = 1 Hz; stress range 1 - 5 Pa; maximum deformation < 0.1%) 
characterized by a reducing gap.(164) The selected gap was that maximizing the value of 
the elastic modulus G' (used gaps ranged between 2.5 and 2.0 mm). For each hydrogel, the 
linear viscoelastic range was determined by means of a stress sweep test consisting in 
measuring elastic (G') and viscous (G'') moduli variation with increasing shear stress (1 Pa 
< τ < 103 Pa) at a frequency ν = 1 Hz (hence with ω = 2πν = 6.28 rad s-1). Mechanical 
spectrum of the hydrogel was determined by measuring the dependence of the elastic (G') 
and viscous (G'') moduli from the pulsation ω at constant shear stress τ = 3 Pa (well within 
the linear viscoelastic range which, for all samples, spans up to at least 30 Pa).  
 
3.1.2.6. Uniaxial compression. Compressive properties of hydrogels were evaluated with 
a universal testing machine (Mecmesin Multitest 2.5-i) equipped with a 100 N load cell in 
controlled conditions (T = 25 °C, relative humidity = 50%). A compression speed of 6 mm 
min-1 was used. Toughness was calculated by measuring the area under the stress-strain 
curve at 70% of strain. All measurements were performed in triplicate. An unpaired 
Student's t-test was used to determine statistically significant differences for the toughness 
calculation. 
 
3.1.2.7. Attenuated total reflectance fourier transform infrared spectroscopy (FTIR-
ATR). Fourier transform infrared spectra of chitosan, membranes and TPP powder were 
obtained using Spectrometer Nicolet 6700 (Thermo Electron Corporation, Madison WI, 
USA) with DTGS KBr detector. The following setup was used throughout the 
measurements: number of sample scans 16, resolution 6 cm-1 from 500 to 2 000 cm-1. 
  
3.1.2.8. 31P-Nuclear Magnetic Resonance (31P-NMR). All 31P-NMR spectra were 
recorded, at 25 °C, on a JEOL Eclipse 400 (9.4 T) NMR spectrometer operating at 399.78 
MHz for 1H and 161.83 MHz for 31P. 512 scans were accumulated with a spectral width of 
5.66 kHz over 8192 complex data points. The employed pulse width was 45° and the total 
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recycle time 2.5 s. The data were multiplied by a decaying exponential function 
(broadening factor 0.5 Hz) and zero filled twice prior to Fourier transform (FT). A coaxial 
insert filled with a solution of Triphenylphosphine (PPh3) in CDCl3 containing 
Tetramethylsilane (TMS), was employed for lock and reference purposes. The 31P 
chemical shifts are referred to H3PO4 85%, considering it resonating at 40.5 (Ξ) at a field at 
which TMS protons resonate at exactly 100 MHz.(165),(166) Chitosan (3.6 g L-1) and TPP 
(0.3% w/v) solutions in 0.2 M acetic acid-150 mM NaCl were used to record NMR spectra. 
Moreover, NMR analyses were performed to assess the amount of TPP and other 
phosphates diffusing into chitosan solution during the dialysis. The gelling bath used in 
hydrogel preparation was collected at different time intervals (t = 0, 2, 4, 6, 8, 24 h) and 
subsequently analyzed. The decrease of the signals corresponding to phosphates was 
determined by normalizing the integrals with respect to the reference PPh3.  
 
3.1.2.9. Phosphate quantification. The amount of TPP present in the hydrogels was 
quantified by means of a protocol described elsewhere with slight modification.(144) 
Briefly, standard (TPP) or hydrogels were dissolved in hydrochloric acid 37% (Sigma 
Aldrich, Chemical Co. USA) at room temperature. 0.1 mL of the latter solution was added 
to 0.9 mL of deionized water. Finally, 0.2 mL of a solution containing ammonium 
molybdate (2.5% w/v) and ammonium vanadate (0.125% w/v) were added and mixed by 
shaking. After five minutes, the absorbance of the yellowish solution was measured at 420 
nm using Infinite M200 PRO NanoQuant, Tecan spectrophotometer. A blank solution was 
prepared with 1 mL of deionized water and 0.2 mL of the vanadium-molybdenum solution. 
A standard calibration curve for TPP was obtained with R2 > 0.99. All measurements were 
performed in triplicate.  
 
3.1.2.10. Swelling studies. Swelling studies of hydrogels were carried out in PBS at room 
temperature. Samples disks (diameter = 22 mm, surface/volume ratio 4 cm-1) were placed 
in 10 mL of PBS under moderate stirring. After blotting the excess of water using filter 
paper, the hydrogels were weighed at different time intervals (t = 0, 1, 2, 3, 4, 5, 6, 7 and 
24 h). The swelling ratio was calculated as the percentage of water loss with respect to the 
initial weight in agreement with the formula 
 𝐻𝑦𝑑𝑟𝑜𝑔𝑒𝑙  𝑑𝑒𝑠𝑤𝑒𝑙𝑙𝑖𝑛𝑔   % =     𝑊! −𝑊!𝑊!   ×  100 
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where Wt is the weight of samples at different time intervals and W0 the dry weight of 
hydrogels at t = 0. All measurements were performed in triplicate. 
 
3.1.2.11. Cell culture. Mouse fibroblast-like (NIH-3T3) cell line (ATCC® CRL-1658TM) 
was used for the in vitro experiments. Cells were cultured in Dulbecco’s Modified Eagle’s 
Medium high glucose (EuroClone, Italy), 10% heat-inactivated fetal bovine serum (Sigma 
Aldrich, Chemical Co. USA), 100 U mL-1 penicillin, 100 µg mL-1 streptomycin and 2 mM 
L-glutamine in a humidified atmosphere of 5% CO2 at 37 °C.  
 
3.1.2.12. Lactate dehydrogenase (LDH) assay. In vitro cytotoxicity of membranes was 
evaluated by using the lactate dehydrogenase assay on NIH-3T3 cells. UV-sterilized 
freeze-dried samples (30 minutes of irradiation for each side of sample) of approximately 6 
mm in length and 2 mm in width were placed in Dulbecco’s modified Eagle’s medium, 
inactivated fetal bovine serum 10%, penicillin 100 U mL-1, streptomycin 100 µg mL-1 and 
L-glutamine 2 mM for 72 h at 37 °C and 5% pCO2 (extraction medium). After 72 h of 
incubation, the cytotoxicity test was performed by direct contact of the cells with the 
swollen membranes and by using the extraction medium. In the case of the direct contact 
test, 25 000 cells were plated on 24-well plates and, after complete adhesion, culture 
medium was changed with 300 µL of fresh medium. Tested materials were directly 
deposited on the cell layer. After 24 and 72 h, medium was collected and the LDH assay 
was performed according to the manufacture’s protocol. In the extraction test, extraction 
medium was added on cells seeded on 24-well plates (25 000 cells/well). The LDH assays 
were performed after 24 and 72 h as described above. As a positive control material, 
poly(urethane) films (PU) containing 0.25% zinc dibuthyldithiocarbamate (ZDBC) (6 mm 
disks) were used. As negative control material, plastic poly(styrene) sheets (PS) (6 mm 
disks) were used. Triton X-100 0.1% v/v was used as a positive control for extraction test. 
Each material test was performed in triplicate. Evaluation of cytotoxicity was calculated 
according to the formula  
 𝐿𝐷𝐻  𝑟𝑒𝑙𝑒𝑎𝑠𝑒𝑑   % = 𝐴 − 𝐵𝐶 − 𝐵   ×  100 
 
with A: LDH activity in the culture medium of membrane-treated or extraction medium-
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treated cells; B: LDH activity of culture medium from untreated cells and C: LDH activity 
after total cell lysis at 24 and 72 h. 
 
3.1.3. Results and discussion 
The present section describes the preparation of chitosan-based hydrogels and dried 
membranes using TPP as cross-linker. Typically, when TPP is added to diluted chitosan 
solutions, the anions quickly cross-link cationic chitosan chains leading to the formation of 
nanoparticles or aggregates.(167) In accordance with literature, we observed that when 
chitosan concentration was increased up to 3% and TPP added in solution, a very fast 
reticulation took place causing the formation of polydisperse micro-aggregates. This leads 
to a highly inhomogeneous system with an unreacted liquid core and a highly cross-linked 
surface. Using this experimental approach, it was not possible to obtain homogeneous 
macroscopic hydrogels with well define shape and regular structure. Therefore, it was 
necessary to control the reaction rate and the cross-linking density to tune the properties of 
the polymeric network. To this end, an ion diffusion-based approach that enables TPP to 
diffuse slowly and gradually into the confined polymer solution from an external cross-
linking bulk, aiming at a uniform reticulation throughout the chitosan matrix, was devised. 
The experimental setup is depicted in Figure 7.  
 
 
 
Figure 7. Experimental set up to develop chitosan-TPP hydrogels by exploiting dialysis technique. 
Enclosed viscous chitosan solution is placed into an outer TPP solution under stirring condition. 
During the dialysis TPP ions diffuse through semipermeable membranes and after 24 h the viscous 
solution has turned into a homogeneous hydrogel by ionotropic gelation. Adapted with permission 
from (168). Copyright 2014, American Chemical Society. 
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First attempts with a chitosan (Fa 0.16, Mw 690 kDa) concentration of 1.5% w/v led to the 
formation of systems characterized by highly reticulated surfaces and liquid cores. This 
can be traced back to the fact that when the dialysis starts, TPP ions bind to chitosan 
charge groups at the boundary of the polymer-gelling bath, and polymer chain diffusion 
takes place towards the gelling zone causing the formation of a concentration gradient. 
Hence, chitosan progressively accumulates within the gelling zone, resulting into an 
inhomogeneous hydrogel with the highest concentration of polymer at the TPP-hydrogel 
interface. At higher chitosan concentrations, homogeneous hydrogels were obtained for 
different TPP concentrations explored. This phenomenon can be explained by taking into 
account the very high viscosity of the chitosan solution that hampered the diffusion of the 
polymer towards the gelling zone preventing the formation of the gradient. These 
experimental evidences are in line with what is known for alginate-Ca+2 systems.(169) The 
addition of non-gelling ions (i.e. Na+) in the gelling bath is expected to slow down the 
gelation process by screening the strong electrostatic interactions between polymer and 
cross-linker. Huang et al. demonstrated that small amounts of NaCl affect the binding 
mechanism of chitosan and TPP by decreasing the fast kinetics of their self-assembly and 
by weakening the binding of TPP to the polysaccharide.(170) Along this line, NaCl was 
added at two different concentrations (150 and 500 mM) into the gelling bath containing 
TPP. The presence of NaCl enabled to improve the homogeneity of the hydrogel for both 
NaCl concentrations. The outcome in the case of NaCl 150 mM was the hydrogel shown in 
Figure 8, which appears as a homogenous wall-to-wall system, albeit not transparent. 
Environmental scanning electron microscopy (E-SEM) in the wet state revealed the 
presence of a uniform polymeric structure both on the hydrogel surface and in the inner 
core (Figure 8, B-C).  
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Figure 8. Chitosan-TPP hydrogels: (A) top view, (B) E-SEM micrograph of the hydrogel surface, 
(C) E-SEM micrograph of the hydrogel cross-section. Chitosan-TPP membrane derived from the 
hydrogel depicted in (A): (D) top view, (E) SEM micrograph of the membrane surface, (F) SEM 
micrograph of the membrane cross-section. Reprinted with permission from (168). Copyright 2014, 
American Chemical Society. 
 
No evidences of irregular gelling zones were found even at high magnifications. Table 3 
summarizes the overall conditions used to fabricate the hydrogels. A temperature-
controlled freeze-drying procedure was applied to them to obtain soft pliable membranes 
as depicted in Figure 8. SEM images of the membrane (Figure 8, E-F) revealed a 
homogeneous polymeric mesh with a compact structure, which demonstrates the uniform 
reticulation occurred within the hydrogel phase. 
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 NaCl 0 mM NaCl 150 mM NaCl 500 mM 
 TPP 
1% 
TPP 
1.5% 
TPP 
3% 
TPP 
1% 
TPP 
1.5% 
TPP 
3% 
TPP 
1% 
TPP 
1.5% 
TPP 
3% 
Chitosan 1.5% ✖ ✖ ✖ ▲ ▲ ▲ ▲ ▲ ▲ 
Chitosan 2.5% ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ 
Chitosan 3% ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ 
 
Table 3. Experimental parameters investigated to fabricate chitosan-TPP hydrogels. ✖: Non-
continuous networks (inhomogeneous); ▲: Continuous networks (homogeneous). Both chitosan 
and tripolyphosphate are expressed as % w/v. Chitosan with Fa 0.16 and Mw 690 kDa. Adapted 
with permission from (168). Copyright 2014, American Chemical Society. 
 
The possibility to fabricate hydrogels with chitosans with different Fa and Mw was 
considered afterwards and the outcomes are pointed out in Table 4. 
 
Chitosan (Fa) 𝜂  mL g-1 Mw (kDa) Hydrogel formation 
 110 30 No 
0.16 660 210 Yes 
 1026 340 Yes 
 340 100 No 
0.46 650 205 No 
 920 300 No 
 300 88 No 
0.63 550 170 No 
 950 310 No 
 
Table 4. Experimental parameters investigated to fabricate chitosan-TPP hydrogels by means of 
hydrochloride chitosans with different acetylation degree (Fa) and molecular weight (Mw). Fa was 
determined by 1H-NMR whereas Mw was determined by using intrinsic viscosity 𝜂  in agreement 
to the Mark-Houwink equation reported in Berth et al.(171) Chitosan, TPP and NaCl 
concentrations were 2.5% w/v, 1.5% w/v and 150 mM, respectively. 
 
The formation of a continuous network (cylindrical hydrogel) was observed only for 
chitosan samples with Fa of 0.16 and Mw of 210 and 340 kDa. Chitosans with different 
acetylation degree were not able to favor the complete ionotropic gelation when dialyzed 
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against TPP. More in detail, chitosan solutions became opaque after 24 h of dialysis, thus 
indicating the formation of microgels (coacervates), without turning into a macroscopic 
hydrogel. These results indicate that the positive charges of chitosan play a pivotal role for 
the formation of the hydrogel: the higher is the Fa, the lower is the ability of chitosan to 
interact with TPP. However, chitosan with Fa of 0.16 and Mw of 30 kDa did not foster a 
complete gelation. In this case the role of molecular weight should be considered. Indeed, a 
macroscopic network was obtained with the same experimental conditions by increasing 
the Mw. In conclusion, macroscopic hydrogels are supposed being obtained only with 
chitosans with low Fa and medium/high Mw (≥ 210 kDa). 
Mechanical characterization of hydrogels was carried out only on homogenous systems 
screened according to Table 3. Hydrogels are systems exhibiting viscoelastic behavior 
when undergoing deformation depending on the frequency of the deformation. In order to 
investigate mechanical properties of hydrogels, rheological and uniaxial compression 
studies were performed. In detail, rheological analyses were carried out by measuring the 
mechanical spectrum of hydrogels in oscillatory shear conditions. In all cases considered, 
the storage (G') modulus was about ten times higher than the loss modulus (G'') and 
basically independent on the stress frequency, thus describing the systems under 
consideration as a strong gel. Mechanical spectrum of the samples was interpreted in terms 
of the generalized Maxwell model.(172) The storage and loss modulus can be modeled as 
function of oscillation frequency according to the following equations 
  
𝐺! =   𝐺! +    𝐺!!!!!    (𝜆!   𝜔)!1+ (𝜆!   𝜔)!    ;   𝐺! =   𝜂!𝜆!       (1) 𝐺!! =    𝐺!!!!!    𝜆!   𝜔1+   (𝜆!   𝜔)!    ;   𝐺! =   𝜂!𝜆!       (2) 
 
where n is the number of Maxwell elements considered, Gi, ηi, and λi represent the spring 
constant, the dashpot viscosity, and the relaxation time of the ith Maxwell element, 
respectively. Ge is the spring constant of the last Maxwell element which is supposed to be 
purely elastic.(163) The influence of chitosan concentration on shear stress response was 
investigated first.  
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Figure 9. (A) G' (full symbols) and G'' (open symbols) for chitosan-TPP hydrogels at a total 
polymer concentration of 3% (black squares), 2.5% (red triangles) and 1.5% (blue circles). (B) 
Dependence of the shear modulus - red solid line - (± SD) and Ge - black solid line - (± SD) versus 
Cp. (C) G' (full symbols) and G'' (open symbols) for hydrogels versus NaCl concentration of 0 mM 
(black squares), 150 mM (red triangles) and 500 mM (blue circles). (D) Dependence of the shear 
modulus - red solid line - (± SD) and Ge - black solid line - (± SD) versus NaCl concentration. 
Reprinted with permission from (168). Copyright 2014, American Chemical Society. 
 
Figure 9A compares the relaxation spectra of chitosan hydrogels with different chitosan 
concentration, TPP and NaCl concentrations of 1.5% and 500 mM, respectively. Lines 
represent the fitting of the experimental data according to equations (1) and (2). 
Experimental data were efficiently fitted by the generalized Maxwell model. Samples with 
a polymer concentration of 1.5% were fitted adequately by means of three Maxwell 
elements whereas hydrogels with concentrations of 2.5 and 3% required four spring-
dashpot elements. The use of the generalized Maxwell model to describe chitosan systems 
enables the shear modulus, G, to be calculated as  
 
𝐺 =   𝐺! +    𝐺!       (3)!!!!  
 
 39 
By fitting data shown in Figure 9A according to equation (3), this modulus was found to 
scale (R2 > 0.99) with the total polymer concentration (Cp) according to the following 
power law G ∝ 296.6 Cp3.1 (Figure 9B). Herein, red solid line represents the best fit of the 
experimental results. These findings are in agreement with those of Kong et al., who 
described a non-linear dependence of shear modulus versus polymer concentration for high 
molecular weight alginate hydrogels in the range 2 to 4.5% w/v.(173) As expected, these 
results indicate that mechanical performance of hydrogels versus shear stress is influenced 
by the increase of polymer concentration. A similar trend was identified for the purely 
elastic spring Ge who was found to scale in an analogue manner (Ge ∝ 206.5 Cp2.8, R2 > 
0.99). The effect of NaCl on mechanical behavior of hydrogels was then investigated. 
Figure 9C shows the mechanical spectra of chitosan hydrogels at different NaCl 
concentrations and constant chitosan and TPP concentrations (3 and 1.5%, respectively). 
Lines represent the fitting of the experimental data according to equations (1) and (2). In 
this case, shear modulus was not influenced significantly when NaCl (150 mM) was added 
to the system with respect to the salt free hydrogel (Figure 9D). However, shear modulus 
decreased when the sodium chloride concentration was increased further to 500 mM. A 
similar behavior was demonstrated for the Ge parameter that was found to progressively 
diminish by augmenting NaCl concentration. This result is in a very good agreement with 
those of Huang et al. who demonstrated that at high concentration of NaCl (500 mM) the 
chitosan-TPP binding is weakened.(170) This suggests that NaCl evokes screening effects. 
Similar experimental results were observed upon varying TPP concentration at constant 
polymer and NaCl concentrations (3% and 150 mM, respectively). By increasing cross-
linking ion concentration (1, 1.5 and 3%) shear modulus was found to be 12.0 ± 0.5, 17.0 ± 
0.5 and 9.3 ± 0.3 kPa, respectively. At the lowest concentration of tripolyphosphate (i.e. 
1%), hydrogels showed the shear modulus higher than hydrogels with 3% of TPP. This 
might be due to the very fast binding of the anion by the polysaccharide in the latter case 
that, despite the macroscopic continuous network formed (Table 3), induces anisotropy in 
polysaccharide distribution with the formation of a more liquid-like core. On the other 
hand, the best mechanical response was observed in hydrogels with 1.5% of TPP. 
Rheological data clearly suggested that the best mechanical behavior was observed only 
for a very narrow range of chemical concentrations explored, compared with those 
indicated in Table 3. To summarize, from rheological analyses we identified two optimum 
conditions for hydrogel formation: chitosan 3%, TPP 1.5%, NaCl 150 mM, glycerol 5% 
(a) and chitosan 3%, TPP 1.5%, glycerol 5% (b). Since rheological tests did not point out 
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significant differences between formulation a and b, the mechanical behavior of both 
formulations was evaluated considering a different stress condition, i.e. uniaxial 
compression. These measurements were performed by applying a very slow compression 
stress to the material, which induces an elastic deformation of the polymeric network. The 
toughness at 70% of total strain was used as a parameter to compare the two formulations 
(Figure 10).  
 
 
 
Figure 10. Representative stress-strain curves of the hydrogels under uniaxial compression. Black 
line: a (with supporting salt NaCl); red line: b (without supporting salt NaCl). Dashed green line 
represents the 70% of total strain. Reprinted with permission from (168). Copyright 2014, 
American Chemical Society. 
 
By integrating the areas under stress-strain curves, the toughness values were 20.5 ± 5.0 
and 9.6 ± 1.5 kJ m-3 for a and b, respectively. These data point out that, in the presence of 
supporting salt (a) the hydrogels are able to accumulate significantly (p < 0.05, n = 3) more 
energy than hydrogels without NaCl (b). These results clearly indicated that the former 
showed a better mechanical performance in compression compared to the latter. The 
interpretation of these results is somewhat unclear but it can be speculated that, although a 
continuous network is formed in both cases (Table 3), an anisotropic distribution of the 
polysaccharide component takes place which results in a stiffer structure. Given these 
results, formulation a was selected as the best candidate for further characterization studies 
and to optimize the preparation of dried membranes.  
In order to investigate the interaction between chitosan and TPP, FTIR-ATR analyses were 
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performed. Figure 11 shows the spectra of freeze-dried chitosan, membrane and TPP 
powder.  
 
 
 
Figure 11. FTIR-ATR spectra of freeze-dried chitosan (black line), a membrane (blue line) and 
TPP powder (red line). Reprinted with permission from (168). Copyright 2014, American 
Chemical Society. 
 
Chitosan-TPP membrane was developed starting from the best candidate hydrogel a. FTIR 
spectrum of freeze-dried chitosan (black line) showed two characteristic peaks at about 
1645 and 1550 cm-1 which were attributed to C=O stretching in amide group (amide I 
vibration) and N-H bending in amide group (amide II vibration), respectively. The peak at 
1375 cm-1 was attributed to the distorting vibration of C–CH3 bond.(174) Absorption bands 
at 1150 (anti-symmetric stretching of the C-O-C bridge), 1070 and 1025 cm-1 (skeletal 
vibrations involving the CO stretching) are characteristic peaks of the chitosan 
structure.(175) TPP spectrum shows peaks at 1210 (P=O stretching), 1140 (symmetric and 
anti-symmetric stretching vibrations in PO2 group) and 1093 cm-1 (symmetric and anti-
symmetric stretching vibrations in PO3 group).(176) Spectrum referring to membrane 
showed the appearance of the novel band at 1220 cm-1, corresponding to anti-symmetric 
stretching vibrations of PO2 groups and the significant shift of the peak at 1073 in dried 
chitosan to 1025 cm-1 in membrane. These peaks confirm the formation of ionic cross-links 
between NH3+ groups of chitosan and tripolyphosphate anions in agreement with the 
literature. Chitosan-TPP interactions were also investigated in diluted 0.2 M acetic acid-
150 mM NaCl solutions by exploiting 31P-NMR. The latter analyses (Figure 12) showed 
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the presence of characteristic peaks in TPP spectrum referring to orthophosphate (0.266 
ppm), pyrophosphate (-10.398 ppm) and triphosphate (-10.284 ppm: α terminal 
phosphorus; -22.679 ppm: β middle phosphorus atoms. JP, P = 19.5 Hz) species according 
to the literature.(177),(178)  
 
 
 
Figure 12. 31P-NMR spectrum of TPP (0.3% w/v) solution (red spectrum). The peak at -5.288 ppm 
refers to PPh3. Inset: magnification of the signal referring to PPi and α terminal phosphorus of TPP. 
Black spectrum: 31P-NMR of diluted solution composed by TPP (0.3% w/v), NaCl (150 mM) and 
chitosan (3.6 g L-1). Reprinted with permission from (168). Copyright 2014, American Chemical 
Society. 
 
By integrating the area under peaks, it was revealed that the percentage of orthophosphate 
and pyrophosphate was 1 and 17% w/w, respectively, and that of TPP was 82% w/w. This 
is in line with the 85% w/w purity of tripolyphosphate reported by the producer. The pKa 
values reported in the literature are: orthophosphoric acid pKa1 2.17, pKa2 7.31, pKa3 
12.36; pyrophosphoric acid pKa1 very small, pKa2 2.64, pKa3 6.76, pKa4 9.42; 
tripolyphosphoric acid pKa1 and pKa2 very small, pKa3 2.30, pKa4 6.50, pKa5 9.24.(179) 
Thus, in the present medium (containing 0.2 M acetic acid) the most abundant species 
should bear one negative charge in the case of orthophosphate, two charges in the case of 
the pyrophosphate, and three charges in the case of tripolyphosphate, one on each 
monophosphate unit in the latter two cases. When chitosan was added to the cross-linking 
ion solution, the signals of TPP and pyrophosphate disappear, being broadened beyond 
detection limit by the strong interaction with the polymeric chain, extremely slowly 
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reorienting. Also the orthophosphate signal seems to disappear likely indicating that it 
binds to chitosan, although the very low signal prevents a clear interpretation.  
To assess the amount of tripolyphosphate embedded within the best candidate hydrogel, a 
spectrophotometric method was exploited based on an acid hydrolysis of TPP by means of 
hydrochloric acid followed by a colorimetric reaction with a mixture of vanadium-
molybdenum salts. The reaction rate of TPP hydrolysis is equal for all samples analysed, 
provided pH and time treatment are equal. Thus, the comparison of the absorbance of the 
sample and those of solutions containing known amounts of tripolyphosphate provides a 
direct evaluation on the TPP concentration. Considering that the concentration of TPP in 
the gelling bath is equal to 1.5% w/v, the TPP concentration entered in the hydrogel was 
equal to 0.2% w/v, calculated on the basis of the amount of TPP measured in hydrogel by 
the spectrophotometric method. Thus, only a limited amount of TPP (estimated to be about 
13%) was uptaken. To better understand how the concentration of TPP and other 
phosphates present in the gelling bath decreased upon time, 31P-NMR spectra were 
performed on the gelling solution. The chemical shifts of the 31P-signals did not change 
with time, at variance with their integrated intensities that allowed calculating the 
concentration that results 1.3% w/v (about 13.3%) after 24 h in agreement with the 
spectrophotometric method. In addition, NMR spectroscopy enables to distinguish the 
signals of the phosphate species. The P, PPi and TPP concentrations slowly decreased over 
time as depicted in Figure 13, in accordance with an anion uptake by the chitosan solution.  
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Figure 13. Concentration decrease of P (black line), PPi (red line) and TPP (blue line) species 
(mM) with time (h) in the gelling solution as calculated from the integrals of 31P-NMR spectra. 
Reprinted with permission from (168). Copyright 2014, American Chemical Society. 
 
The orthophosphate concentration was very small and did not significantly vary, whereas 
the TPP and PPi concentrations (mM) decreased appreciably in 24 hours (from 32.80 at t = 
0 h to 29.20 at t = 24 h and from 9.28 at t = 0 h to 6.79 at t = 24 h, respectively). PPi 
present as minor component in the commercial TPP sample used did not hamper the 
hydrogel formation. Indeed, it was reported that it is able to ionically cross-link 
polyelectrolytes, chitosan included.(180),(181) The molar ratio of the latter two species 
(TPP/PPi) increased from 3.53 (t = 0 h) to 4.30 (t = 24 h). The decrease of TPP and PPi 
concentrations due to diffusion into chitosan solution during the dialysis was 3.6 and 2.4 
mM, respectively. Therefore, the contribution of PPi to the gelation process cannot to be 
ruled out. Indeed, the spectrum of chitosan-TPP mixture depicted in Figure 12 showed the 
disappearance of peaks at -10.398, -10.284 and -22.679 ppm, respectively, indicating that 
both TPP and PPi are implicated in binding with the polymer. 
The swelling capacity of ionically cross-linked hydrogels plays an important role to 
evaluate their potential use as biomaterials for biomedical applications. Swelling is mainly 
influenced by ionic interactions between chitosan chains, depending in turn on the cross-
linking density.(182),(183) With the aim of investigating the swelling behavior of a 
hydrogels in physiological pH conditions, the water loss kinetics of samples was followed 
in PBS buffer at room temperature for 24 h and the results are reported in Figure 14. 
Samples were characterized by a fast de-swelling that took place during the first 7 hours. 
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Further, the loss of solvent was basically stable up to 24 h (from -19.32 ± 4.97 to -20.28 ± 
5.89%). To explain the loss of solvent experienced by the hydrogels, it should be noted that 
during the hydrogel formation the dialysis took place at a pH of ~ 4.3 for a. In this case, 
chitosan amino groups are almost completely protonated. When hydrogels are placed in 
PBS with pH of ~ 7.4, chitosan amino groups are mostly in the form of -NH2, which makes 
it insoluble and leads to a shrinkage of the network with a loss of solvent. The same effect 
was observed by Lopez-Leon and co-workers who demonstrated that the diameter of 
chitosan-TPP nanoparticles diminished appreciably when pH was varied from 4 to 7.(184)  
 
 
 
Figure 14. Hydrogel de-swelling (%) versus time (h) of a hydrogels. The data are expressed as 
mean (± SD) of three samples. Reprinted with permission from (168). Copyright 2014, American 
Chemical Society. 
 
The cytotoxicity characterization has been carried out on the prototype membranes 
obtained by freeze-drying. LDH assay was performed on mouse fibroblasts using the 
freeze-dried sample a. As reported in Figure 15, membranes did not exert any cytotoxic 
effect both when the material was placed directly in contact with cells and when the extract 
medium was added on the cell layer. Indeed, there was no significant difference in the 
release of lactate dehydrogenase between sample-treated cells and negative control groups 
(indicated as Ps and Ad, respectively) after 24 and 72 h.  
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Figure 15. Effect of the freeze-dried sample a on NIH-3T3 cell line. The cytotoxicity test was 
performed both with the extract from the sample (CH-TPP-E) and with the sample in direct contact 
with cell layer (CH-TPP-C). Control cells cultured in adhesion in complete DMEM medium (Ad). 
Polyurethane sheets (Pu) were used as contact positive control, plastic poly(styrene) sheets (Ps) 
were used as contact negative control and Triton X-100 was used as extract positive control. 
Adapted with permission from (168). Copyright 2014, American Chemical Society. 
 
3.1.4. Main conclusions 
• Tridimensional hydrogels and dried membranes based on chitosan and TPP have 
been developed by exploiting a slow ion diffusion technique;  
• Only a limited group of chitosans allowed the formation of matrices;  
• Not only TPP but also PPi contribute to the gelation of chitosan; 
• Dried membranes derived from best candidate hydrogel proved lack of 
cytotoxicity. 
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CHAPTER II 
 
Investigation on the ionotropic gelation of chitosan in dilute solutions and 
tridimensional hydrogels 
 
3.2.1. Aim of work 
This section tackles the investigation upon the onset of TPP-PPi binding to chitosan in 
diluted solutions by using complementary techniques with respect to the common ones 
reported in literature and finally the study of the different contribution of both the polyions 
to the formation of hydrogels chitosan-based obtained by a slow ion diffusion technique 
reported in the previous chapter. In this section, the ability of the non-traditional cross-
linker PPi giving rise to the formation of wall-to-wall networks is demonstrated. 
 
3.2.2. Materials and methods 
3.2.2.1. Materials. Medium molecular weight chitosan (Fa: 0.23 determined by 1H-NMR; 
viscosity 200 - 800 cP declared by producer), was purchased from Sigma-Aldrich and 
purified by precipitation with isopropanol, followed by a dialysis against deionized water. 
Sodium tripolyphosphate pentabasic - Na5P3O10 - (TPP ≥ 98.0%), sodium pyrophosphate 
tetrabasic - Na4P2O7 - (PPi ≥ 95%), NaCl and glycerol (ReagentPlus® ≥ 99.0%) were all 
purchased from Sigma-Aldrich. 
 
3.2.2.2 Light Scattering (Turbidimetry). A Perkin-Elmer LS50B spectrofluorimeter was 
used to record the intensity of the light scattered (90°) by diluted chitosan solutions (0.05% 
w/v and 2 mL as final volume), upon irradiation with a 550 nm incident light (T = 25 °C). 
Chitosan was solubilized in acidified deionized water (pH = 2.6) and resulting solutions 
were titrated using either TPP or PPi solutions (6 µL injections) to gradually increase the 
molar ratio (r) between the cross-linker and the monomeric unit of chitosan (r = 
[crosslinker] / [monomeric unit]ru). Each injection increased r by 0.02 units. Before 
analysis, solutions were allowed to equilibrate for one minute. Considering the 
contribution of N-acetylglucosamine unite, the molecular mass of chitosan monomeric unit 
resulted 171 g mol-1. 
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3.2.2.3 Circular dichroism (CD).  CD spectra of dilute chitosan solutions (0.05% w/v) 
were recorded in acidified deionized water (pH = 2.6) with a Jasco J-700 
spectropolarimeter. The chitosan solution was titrated using either TPP or PPi solutions (3 
µL injections) to gradually increase r. Each injection increased r by 0.02 units. For all 
measurements, the volume of each injection was considered negligible with respect to that 
of chitosan solution (1 mL): in fact, the volume increase (i.e. chitosan dilution) was about 
13% at r = 1, while r never exceeded 0.24, corresponding to a dilution of less than 4%. 
Before analysis, solutions were allowed to equilibrate for one minute. Ellipticity of titrated 
solutions (𝜃!)  was normalized by that of chitosan (θ), with no correction for dilution. Data 
are expressed as values of reduced specific ellipticity in agreement to the equation 
 ∆𝜃 = −(𝜃!  –   𝜃)/|𝜃| 
 
A quartz cell of 1 cm optical path length was used, always using the following setup: 
bandwidth 1 nm, time constant 2 s, scan rate 20 nm min-1. Three spectra were averaged for 
each measurement. 
3.2.2.4 Nuclear magnetic resonance (1H-NMR). 1H-NMR analyses were performed on 
chitosan solutions (0.2% w/v in 0.2 M acetic acid as a solvent, pH = 2.6), with addition of 
TPP or PPi with final value r = 0.16. The 1H-NMR spectra were recorded at 25 °C, on a 
Varian VNMRS (11.74 T) NMR spectrometer operating at 499.65 MHz for proton. Water 
suppression was accomplished by means of WET.(185) A total of 512 scans were 
accumulated with a spectral width of 6 kHz over 16384 complex data points. The data 
were multiplied by a decaying exponential function (broadening factor 0.5 Hz) and zero 
filled twice prior to Fourier transform. The chemical shifts are referred to the chemical 
shift of the proton of HOD at 4.645 ppm. 
3.2.2.5 Chitosan hydrogels preparation. Wall-to-wall hydrogels were obtained by the 
slow diffusion technique presented in the previous chapter. Chitosan (3% w/v) was 
hermetically sealed and immersed into a gelling solution (final volume 50 mL) containing 
anions (TPP or PPi) - NaCl (150 mM) - glycerol (5% v/v). TPP and PPi concentrations 
were varied so that r spanned in the range from 0.3 to 7. Ion diffusion proceeded for 24 h 
 49 
under moderate stirring at room temperature allowing hydrogel formation. 
3.2.2.6 Mechanical spectroscopy. Rheological characterization of TPP/PPi chitosan 
hydrogels was performed by means of a controlled stress rheometer Haake Rheo-Stress 
RS150 operating at 25 °C using a shagreened plate apparatus (HPP20 profiliert: diameter = 
20 mm) as the measuring device. To avoid water evaporation from the hydrogel, 
measurements were performed in a water-saturated environment formed by using a glass 
bell (solvent trap) containing a wet cloth. In addition, to prevent both wall-slippage(163) 
and excessive gel squeezing, the gap between plates was adjusted, for each sample, by 
executing a series of short stress sweep tests (𝜈 = 1 Hz; stress range 1 - 5 Pa) characterized 
by a reducing gap.(164) The selected gap was that maximizing the value of the elastic 
modulus G' (used gaps ranged between 2.5 and 2.0 mm). For each hydrogel, the linear 
viscoelastic range was determined by means of a stress sweep test consisting in measuring 
elastic (G') and viscous (G'') moduli variation with increasing shear stress (1 Pa < τ < 5 Pa) 
at a frequency 𝜈 = 1 Hz (hence with ω = 2π𝜈 = 6.28 rad s-1). The mechanical spectrum of 
hydrogels was determined by measuring the dependence of the elastic (G') and viscous 
(G'') moduli from the pulsation ω at constant shear stress τ = 5 Pa (well within the linear 
viscoelastic range which, for all samples, spans up to at least 30 Pa).  
3.2.2.7 Evaluation of homogeneity. The homogeneity of the TPP and PPi hydrogels was 
assessed by means of the method reported elsewhere.(186) Briefly, cylindrical hydrogels 
were cut perpendicular to the cylinder axis into five slices with roughly the same thickness 
(5 mm). Only for these studies, the controlled gelation of chitosan was reached by 
exploiting a dialysis tube (diameter 25 mm) flooded into the same gelling solution mixture 
described in paragraph 2.5. After measuring their wet weights by an analytical balance, the 
slices were dried at 40 °C for 24 h. Samples were weighed again after drying, and their 
dry/wet weight ratios (Dw / Ww) were calculated. 
3.2.2.8 Image analyses. Image analyses were carried out on TPP and PPi hydrogels cross-
sections. Hydrogel slices of approximately 1 mm of thickness were dried in ethanol 70% 
v/v and overnight contrasted using UO2(CH3COO)2 0.2% w/v. Subsequently slices were 
totally dried in ethanol 100% v/v and finally embedded in Epoxy resin after completely 
removing the alcohol. Ultrathin sections were cut by means of a microtome (equipped with 
a diamond blade) and gently deposited onto Nickel grids. Visual analysis and image record 
were performed using a PHILIPS EM Transmission Electron Microscope.  
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3.2.3. Results and discussion 
TPP is by far the most employed cross-linker to ionically reticulate chitosan due to its high 
net negative charge (ranging from one to five based on pH) per monomeric unite. For 
instance, TPP was successfully exploited to obtain chitosan nanoparticles and nano/micro-
gels.(187),(145),(170) In spite of this, the colloidal stability of these systems is deeply 
affected by many parameters as well as polymer and cross-linker concentrations, pH, ionic 
strength, temperature and so on.(188) In recent years, the group of Lapitsky shed light on 
molecular interactions and formation process regarding the chitosan-TPP 
system.(170),(189) Moreover, they also proved that not only TPP but also PPi was able to 
boost the ionotropic gelation of chitosan until to obtain stable suspensions of 
nanoparticles.(180),(181) Nevertheless, both nanoparticles and nano/micro-gels based on 
the common gelation of chitosan (by means of either TPP or PPi) represent 
inhomogeneous systems with uneven structure which can not be applied for the fabrication 
of tridimensional matrices, as well as hydrogels, characterized by specific shapes. 
To study the interactions between chitosan and the cross-linker in dilute solutions, light 
scattering (turbidimetry), circular dichroism and 1H-NMR techniques were considered. 
About turbidimetry analyses, the relative intensity (90°) of chitosan solutions in water 
upon addition of TPP and of PPi was measured and reported in Figure 16 as a function of 
the molar ratio, r, between the cross-linker and monomeric unit of chitosan. In agreement 
with published data obtained by dynamic light scattering,(180) the addition of TPP is 
immediately accompanied by an increase of the scattering (up to the maximum measurable 
value), whereas in the case of PPi only a moderate, albeit non negligible, increase is 
observed up to about r = 0.4, followed by an abrupt increase of the observed scattering up 
to the (experimental limiting) value of about r = 0.5. For both TPP and PPi, at the highest 
accessible r value the solution becomes clearly turbid.  
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Figure 16. 90° scattered light for chitosan solutions titrated either with TPP (black dots) or PPi 
(red dots). The total polymer concentration was 0.05% w/v in all of the cases analyzed. Data are 
expressed as the ratio between the intensity of titrated solutions (In) and the intensity of that of 
chitosan alone (I0) vs. the molar ratio between cross-linker and monomeric unit of chitosan (r). 
Values are reported as mean (±SD, n = 8). Dotted curves are drawn to guide the eye. 
 
Circular dichroism is a versatile technique already employed in the study of 
polysaccharides and their mixtures.(190),(191) Since chitosan is a chiral molecule 
presenting the N-acetylglucosamine chromophore group which absorbs radiation in the 
range of 200 - 250 nm, it is possible to record its CD spectrum. Figure 17A reports the CD 
spectrum of a 0.05% w/v chitosan solution showing the presence of a negative minimum at 
~ 210 nm referring to the UV-absorption (stemming from the n → π* transition) of the N-
acetilglucosamine unit.(192) Titration of the chitosan solution by means of either TPP or 
PPi solutions was performed by gradually increasing the molar ratio r between cross-linker 
and the repeating unit of chitosan. Figure 17B shows the variation of chitosan ellipticity 
following titration with both cross-linkers. The experimental CD data have been reported 
as the ratio of the (relative) difference of ellipticity between the solution - at a cross-linker-
to-polymer ratio of r - and the cross-linker-free polymer solution, over the (absolute value 
of) the ellipticity of the polymer, ∆𝜃. 
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Figure 17. (A) CD curve of the chitosan solution (0.05% w/v) in acidified deionized water (pH = 
2.6). (B) Variation of reduced ellipticity by consecutively titrating previous polymer solution by 
means of either TPP (black dots) or PPi (red dots); blue dots represent the variation of reduced 
ellipticity due to the ionic strength determined by the PPi anions; dotted curves are drawn to guide 
the eye. (C) Variation of reduced ellipticity for chitosan solutions with constant polymer 
concentration (0.05% w/v and different ionic strength, I, due to the presence of NaClO4, pH = 2.6; 
dotted line represents the best linear fitting among experimental points (∆𝜃  𝛼  7 ∙ 10!!  𝐼).  
 
In the case of TPP, all observed variations are negative, and the shape of the CD curve 
versus. r closely parallels that of the scattering intensity (cfr. Figure 16), suggesting that 
the two processes are simultaneous. To ensure that the small, albeit well detectable, 
relative CD change (at most 8% of the original value) does not stem from artifacts deriving 
from the formation of chiral aggregates,(193) the position of the cuvette along the optical 
path was varied with respect to the detector. Even at the highest r value investigated no 
change in the measured ellipticity was observed, thus confirming the molecular origin of 
the observed change. To ascertain whether the observed ∆𝜃  stems from a specific 
TPP/chitosan interaction or from a non-specific electrostatic effect caused by the notable 
change in the solution ionic strength (I) brought about by the multivalent anion, ∆𝜃 was 
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measured for chitosan solutions (at constant polymer concentration = 0.05% w/v) 
increasing I from zero to 150 mM by NaClO4. The results are reported in Figure 17C: they 
indicate that a positive ∆𝜃	  is brought about by an increase of I. However, the calculated 
effect due to change of ionic strength in the r domain of the significant variations induced 
by TPP is totally negligible, thus pointing to a specific effect of the multivalent species on 
the chitosan chain. On the other hand, when using PPi as anion for the titration of chitosan 
solution, the relative increase of the CD change was much lower than in the case of TPP, 
but opposite in sign (at least for r > 0.15), where the ∆𝜃 became slightly larger than 
experimental uncertainty (Figure 17B). Also in this case, the observed ∆𝜃 effect in the 
higher range of r is by far larger than that induced by I alone. Circular dichroism clearly 
demonstrated the higher binding affinity of TPP with respect to PPi for the chitosan chains. 
This may be ascribed to the presence of an extra negative charge in the case of TPP. 
Indeed, at the pH values here investigated, TPP and PPi should bear almost three and two 
negative charges, respectively, one on each monophosphate unit. 
To get further insights into the behavior of chitosan upon binding with both anions, 1H-
NMR measurements were performed. A molar ratio (r) of 0.184 was chosen for 
comparison purposes.  
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Figure 18. 1H resonances in the 4 - 2.8 ppm spectrum region for chitosan (black solid line), 
chitosan + PPi (red solid line) and chitosan + TPP (blue solid line) with cross-linker/chitosan 
monomeric unit ratio (r) of 0.16 in 0.2 M CH3COOH solution (pH = 2.6). The assignments for 
glucosamine and N-acetylglucosamine protons (labelled as A) according to literature are 
reported.(194) Inset: the low field 13C satellite of AcOH-Ac in the same order as the main figure. 
 
In the presence of either TPP or PPi, the signal of the methyl group of acetate-acetic acid 
experienced a slight shift (by about 0.005 ppm) to lower frequencies owing to the increase 
of the amount of acetate caused by the base addition. In the inset of Figure 18 was reported 
the low field carbon satellite of the acetate-acetic acid pair. On the contrary, glucosamine 
H2 proton, which is sensitive to pH changes,(132) is unaffected by the small base addition 
in line with the lower acidity of chitosan with respect to acetic acid. These results rule out 
deprotonation as origin of the conformational changes detected by CD, which therefore 
should be attributed to chitosan interaction with multivalent anions. Rather, the presence of 
TPP and PPi affects the pattern of the envelope of the overlapped resonances of most 
protons of chitosan monomeric units, between 3.9 and 3.5 ppm (Figure 18), in agreement 
with the occurrence of conformational changes. Hence, a probable explanation to light 
scattering, CD and 1H-NMR observations seemed to point to a gradual neutralization of 
chitosan charge when strong interactions with polyphosphate anions occurred, as already 
demonstrated by means of Z-potential measurements,(170) bringing about a 
conformational reconfiguration.  
In the previous chapter it was already demonstrated to fine control the ionotropic gelation 
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of confined chitosan by tuning polymer, TPP and NaCl concentrations to obtain 
macroscopic hydrogels. The work presented in this section aimed at exploring on the 
ability of PPi to form tridimensional matrices by exploiting slow ion diffusion technique 
and, consequently, to study the different mechanical behavior or resulting matrices. In 
order to achieve this purpose, chitosan concentration was kept constant (3% w/v) in the 
vessel and different cross-linker concentrations were selected so as to vary r. It is 
noteworthy that the aforementioned molar ratio was calculated taking into account the 
concentration of cross-linker at the beginning of the dialysis so as to exclude diffusion 
phenomena. For both anions, no hydrogel formation occurred for r < 3.1. Upon exceeding 
this limit, the formation of wall-to-wall systems by both cross-linkers took place. These 
results represent a very interesting finding in the case of PPi as a promising strategy to 
develop tridimensional matrices by the use of this anion.  
When the dialysis starts, TPP or PPi migrate through the semipermeable membrane and 
bind to positive chitosan: the ionotropic gelation takes place and the confined viscous 
chitosan solution tends to gradually become opaque. This phenomenon is due to the 
cooperative self-assembly process between chitosan and cross-linkers, as already discussed 
above, which proceeds through a two-step process: (i) the formation of small primary 
nanoparticles and (ii) their aggregation into larger, higher-order colloids.(195),(189) 
Nevertheless, in this system an additional step has to be considered, the aggregation of 
higher-order colloids, so simply named microgels, until to obtain a macroscopic network 
(Figure 19). The slow diffusion of both TPP and PPi through dialysis membranes, assisted 
by the screening effect of the supporting salt NaCl and by hydrophobic interactions 
between polymer’s chains, enables to fine control the self-assembling of microgels until an 
opaque wall-to-wall system was obtained. 
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Figure 19. Wall-to-wall hydrogel chitosan-based obtained by slow ion diffusion technique. The 
inset represents the hypothetical disposition of junctions within the hydrogel where polymer chains 
(yellow ribbons) bind either TPP or PPi by electrostatic interactions. Cross-linkers are represented 
as reddish dots where each one may be considered as a single phosphate unite or a single negative 
charge. 
 
In order to investigate the different mechanical behavior of resulting hydrogels, rheological 
measurements were performed. Frequency sweep analyses were carried out to record 
mechanical spectra of hydrogels undergone to a constant shear stress (Figure 20). 
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Figure 20. G' (full symbols) and G'' (open symbols) for chitosan-TPP (A) and chitosan-PPi (B) 
hydrogels at different cross-linker/glucosamine unite molar ratios (r) of 3.8 (blue squares), 5.2 (red 
circles) and 7.0 (black triangles); solid lines represent the best fitting by means of Maxwell model. 
Dependence of the shear modulus (±SD), black solid line, and Ge (±SD), red solid line, versus 
different r for chitosan-TPP (C) and chitosan-PPi (D) hydrogels. 
 
Experimental measurements were fitted by means of Maxwell model described 
elsewhere.(172) The number of Maxwell elements (sketched by a sequence of elastic 
springs, of constant Gi, and viscous dashpot elements) was selected through a statistical 
procedure to minimize the product 𝜒!  𝑛, where 𝜒! is the sum of the squared errors between 
experimental and model fitting values while n is the number of fitting parameters. 
Mechanical spectra in Figure 20A-B point out that both storage (G') and loss moduli (G'') 
differ of approximately one order of magnitude for almost two decades of frequency, thus 
indicating the strong nature of TPP-PPi hydrogels. By means of Maxwell model the shear 
modulus (G) can be easily calculated according to equation (3) reported in previous 
chapter. 
Shear modulus is a pivotal parameter to assess the stiffness of a material. In general terms, 
it has been found that shear moduli of TPP-containing hydrogels were higher than those 
prepared using PPi. Specifically, in the case of TPP hydrogels the shear modulus at r = 3.8 
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was higher than those with r = 7.0 (Figure 20C). The best mechanical response to the shear 
stress was observed for hydrogels with r = 5.2. The shear modulus trend for present TPP 
hydrogels was in line with that already demonstrated for systems obtained with a different 
TPP powder (technical grade 85%) as described in the previous chapter. Moreover, a 
similar behavior was identified for the purely elastic constant Ge. In the case of PPi 
hydrogels, shear modulus was found to increase with the increasing of (r) as pointed out in 
Figure 20D. Furthermore, the higher experimental error for PPi hydrogels (due to a less 
fitting by Maxwell model) suggests a partial inhomogeneity of such networks, albeit wall-
to-wall matrices were obtained. In any case, shear moduli of TPP hydrogels (except for r = 
7.0) were higher than those of PPi hydrogels, thus indicating higher stiffness for the first. 
Moles of point-like junctions (polymeric network crosslink density, 𝜌) between chitosan 
chains per hydrogel unit volume can be calculated by exploiting the Flory’s theory in 
agreement to the equation  
 𝜌 =    𝐺𝑅𝑇       (4) 
 
where R is the universal gas constant, T is the temperature and G is the shear 
modulus.(172) By assuming the parameter 𝜉 as the diameter of the collection of spheres 
that composes an ideal network with a regular mesh, cross-link density enables to easily 
calculate the average network mesh size as  
 
𝜉 =    6𝜋𝜌𝑁!!       (5) 
 
where Na is the Avogadro number.(172) Outcomes for both TPP and PPi hydrogels with 
different amount of cross-linker are reported in Table 5. The average network mesh size 
was found to be smaller for TPP systems with respect to PPi ones, except for r = 7.0. For 
instance, the average network mesh size was assessed to be ~ 11 nm for TPP systems and ~  22 nm for PPi ones in the case of r = 3.8. These results indicate the better reticulation of 
meshes for TPP hydrogels, as confirmed by the higher moles of point-like junctions for 
different molar ratios explored. This is consistent with those observed in CD measurements 
previously described. In fact, the different affinity of both cross-linkers, due to the diverse 
net charge contribution, affects the gelation rate so as to provide hydrogels with variable 
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homogeneity which responding in a different manner under a constant stress. 
 
  PPi   TPP  
r 3.8 5.2 7.0 3.8 5.2 7.0 
G (kPa) 1.04 ± 0.19 2.39 ± 0.40 2.48 ± 0.28 5.95 ± 0.22 6.87 ± 0.45 2.87 ± 0.42 𝜌 x 10-6 
(mol cm-3) 
0.29 ± 0.03 0.97 ± 0.16 1.00 ± 0.11 2.40 ± 0.09 2.77 ± 0.18 1.16 ± 0.17 𝜉 (nm) 22.3 ± 0.9 14.9 ± 0.8 14.7 ± 0.8 11.0 ± 0.1 10.5 ± 0.2 14.0 ± 0.7 
 
Table 5. Physical-chemical parameters for TPP/PPi-containing hydrogels. r represents the molar 
ratio between the cross-linker and the glucosamine unite of chitosan. Shear modulus (G), polymeric 
network crosslink density (𝜌) and average network mesh size (𝜉) were calculated by means of 
Maxwell model and Flory’s theory. 
 
Intriguing information about the polymer meshes distribution within hydrogels may be also 
pointed out by means of TEM analyses. By comparing TPP-hydrogels to PPi-ones (Figure 
21A and B, respectively) the different cross-linking density is shown. At a glance, 
networks composed of entangled polymer (dark ribbons) and not-contrasted zones (grey 
spaces) random distributed were observed. TEM image of TPP-hydrogels (Figure 21A) 
displays a homogeneous distribution of chitosan both with a wide range of pore sizes and 
with generally lack of aggregates. Conversely to the latter, PPi-hydrogels looked with a 
heterogeneous network characterized by a reduction of point-by-point connectivity. The 
outcomes clearly demonstrated that, albeit no discrepancies at the macroscopic level may 
be identified, the different reticulation throughout the network strictly affects the 
mechanical behavior of hydrogels.  
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Figure 21. Chitosan meshes distribution in TPP (A) and PPi (B) hydrogel cross-sections with 
cross-linker/chitosan monomeric unit molar ratio of 3.8. The polymer was contrasted by means of 
UO2(CH3COO)2 0.2% w/v. TEM images were acquired at a constant accelerating voltage of 100 
kV. 
 
To get further insights about mechanical response by hydrogels, the distribution of 
chitosan within wall-to-wall systems was studied. By considering the very thin thickness of 
hydrogels fabricated with the standard method reported in the paragraph 3.2.2.5., a slight 
modification of protocol was thought in order to increase the cross-section surface. To this 
purpose, a dialysis tube of 25 mm as diameter was used for the gelation process and the 
same r of 3.8 was maintained. Resulting hydrogels were cut along the gelation axis and 
ratio between dry/wet weights of slices was calculated. Results are pointed out in Figure 
22.  
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Figure 22. Polymer distribution profile along chitosan-TPP (black solid line) and chitosan-PPi (red 
solid line) hydrogel cross-section expressed as dry/wet weight ratios of slices (numbered 1-5). 
Cross-linker/chitosan monomeric unit molar ratio (r) was set to 3.8 with comparison purposes to 
TEM analyses. Data are expressed as mean (± SD) with n = 2 and n = 3 for TPP and PPi hydrogels, 
respectively.  
 
Polymer distribution within TPP hydrogels demonstrated to be approximately constant 
along cylinder axis, albeit with higher experimental error to the boundary. At variance, PPi 
hydrogels showed a not homogeneous profile of chitosan concentration. More in detail, the 
concentration of polymer was higher at the boundary compared to that of the core, 
although continuous matrices were obtained at macroscopic scale. This condition can be 
ascribed to a partial inhomogeneity occurred during the ionotropic gelation, due to the 
milder ability of PPi to bind chitosan leading to the formation of a more liquid-like core. 
As a consequence, mechanical properties of hydrogels reticulated with the same amount of 
either TPP or PPi are essentially dissimilar as reported in Table 5 with higher shear moduli 
for the former.  
 
3.2.4. Main conclusions 
• Turbidimetry, circular dichroism and 1H-NMR suggested the higher ability of TPP 
with respect to PPi to interact with chitosan thus inducing chain reconfiguration; 
• The ability of PPi giving rise to the formation of wall-to-wall hydrogels with 
tunable mechanical properties was demonstrated; 
• Different mechanical response of TPP/PPi-hydrogels is affected by the distribution 
of the polysaccharide network within hydrogels. 
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CHAPTER III 
 
Fabrication and biological properties of chitosan/chitlac-AgNPs 
membranes for wound healing applications 
 
3.3.1. Aim of work 
This section is aimed at exploiting the slow ion diffusion technique discussed in the 
chapter I for the preparation of macroscopic chitosan hydrogels to obtain soft pliable 
membranes which include antimicrobial silver nanoparticles (AgNPs) stabilized by a 
lactose-modified chitosan (chitlac). The rationale of this approach is to enhance the 
antibacterial properties of chitosan membranes by means of silver nanoparticles without 
impairing the viability of eukaryotic cells. 
 
3.3.2. Materials and methods 
3.3.2.1. Materials. Highly deacetylated chitosan (fraction of N-acetyl-glucosamine units - 
Fa - of 0.16 as determined by means of 1H-NMR), was purchased from Sigma-Aldrich 
(Chemical Co.). The relative molar mass (“molecular weight”, Mw) of chitosan determined 
by intrinsic viscosity measurements was found to be around 690 kDa.(162) Chitlac 
(lactose-modified chitosan, CAS registry number 85941-43-1) was prepared according to 
the procedure reported elsewhere starting from highly deacetylated chitosan.(162) The 
composition of chitlac was determined by means of 1H-NMR and resulted to be: 
glucosamine residue 20%, N-acetylglucosamine 18% and 2-(lactit-1-yl)-glucosamine 62%. 
The relative Mw of chitlac is around 1.5 x 106. Pentasodium tripolyphosphate (TPP), 
sodium chloride (NaCl), glycerol (ReagentPlus® ≥ 99.0%), silver nitrate (AgNO3), ascorbic 
acid (C6H8O6), MTT formazan powder [1-(4,5-Dimethylthiazol-2-yl)-3,5-
diphenylformazan], phenazine methosulfate (PMS) powder and phosphate buffered saline 
(PBS) were all purchased from Sigma-Aldrich (Chemical Co.). Luria Bertani (LB) broth, 
LB Agar and Brain Heart Infusion (BHI) broth were from Sigma-Aldrich (Chemical Co.). 
All other chemicals and reagents were of the highest purity grade commercially available. 
 
3.3.2.2. Chitlac-silver nanoparticles preparation (chitlac-nAg). Although chitlac is able 
to directly reduce silver ions,(196) it was resorted to obtain silver nanoparticles (AgNPs) 
by reducing Ag+ ions by means of ascorbic acid in chitlac solution according to the 
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protocol described elsewhere.(62) Briefly, freeze-dried chitlac was dissolved in deionized 
water to obtain a solution with final concentration 4 g L-1. Chitlac solution was then mixed 
with AgNO3 solution to achieve a final silver nitrate concentration of 4 mM. Ascorbic acid 
(reducing agent) solution was added at final concentration of 2 mM. Resulting mixture was 
held for 4 h at room temperature in dark condition and subsequently stored at 4 °C.   
 
3.3.2.3. Membrane preparation. Membranes were produced by exploiting a controlled 
freeze-dried process starting from wall-to-wall hydrogels obtained by a slow diffusion 
technique already described in paragraph 3.1.2.3 with slight modifications. Briefly, a 
solution composed by chitosan (2% w/v), chitlac-nAg (1.5 g L-1 and 1.5 mM as chitlac and 
silver final concentration, respectively) and glycerol (5% v/v) - “chitlac-nAg gelling 
solution” - was casted into the same mold described previously. Mixture composed of 
chitosan (2% w/v), chitlac (1.5 g L-1) and glycerol (5% v/v) was employed for the 
preparation of membranes without AgNPs. The system was hermetically sealed and 
immersed into a TPP (1.5% w/v) - NaCl (150 mM) - glycerol (5% v/v) solution (Figure 
24B). Ions diffusion proceeded for 24 h under moderate stirring at room temperature 
allowing hydrogel formation. At the end of dialysis, hydrogels were washed twice in 
deionized water (1 h for each washing) in order to remove all residual traces of unbound 
TPP. Thereafter hydrogels were cooled by immersion in a liquid cryostat (circulating bath 
28L, VWR, Radnor, PA, U.S.A). Ethylene Glycol in water (3:1) was used as refrigerant 
fluid. Temperature was decreased from 20 to -20 °C by 5 °C steps with 20 minutes 
intervals. Samples were then freeze-dried for 24 h. For convenience, resulting membranes 
are named in overall chapter as M (without AgNPs) and M-Ag (with AgNPs). 
 
3.3.2.4. UV-Vis Spectroscopy. UV-Visible spectroscopy measurements were performed 
on diluted (1:20) chitlac-nAg gelling solution by means of Cary 400 spectrophotometer. 
Acetic acid (0.2 M) was used as blank solution and subsequently subtracted to all spectra 
recorded. The following setup was used throughout the measurements: data interval 1 nm, 
scan speed 600 nm min-1. 
 
3.3.2.5. Transmission electron microscopy (TEM). TEM images were acquired by a 
PHILIPS EM 208 Microscope. Diluted (1:50) chitlac-nAg gelling solution was deposited 
onto Nickel grids coated with a carbon film and dried overnight. Images were recorded at 
different magnification. Statistical analysis was performed upon 140 silver nanoparticles 
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randomly selected at 89 kX magnification. The diameter of silver nanoparticles was 
calculated by ImageJ software.  
 
3.3.2.6. Morphological analyses. Morphological analyses of hydrogels embedding silver 
nanoparticles and of M-Ag membranes were performed by scanning electron microscopy 
(Quanta250 SEM, FEI, Oregon, U.S.A) in the same experimental conditions already 
described in the paragraph 3.1.2.4. In this case the accelerating voltage was kept constant 
at 30 kV. 
 
3.3.2.7. Swelling studies. Swelling studies of M-Ag membranes were carried out placing 
samples in 10 mL of PBS (pH 7.4) up to 3 days at 37 °C. At different time intervals (t = 0, 
2, 4, 6, 8, 24, 48 and 72 h) membranes were removed from the medium and weighed after 
blotting the excess of water using filter paper. The swelling ratio was calculated as the 
percentage of water uptake with respect to the initial weight in agreement with the 
following formula: 
 𝑊𝑎𝑡𝑒𝑟  𝑢𝑝𝑡𝑎𝑘𝑒 =   𝑊! −   𝑊!𝑊!   ×  100 
 
where Wt is the weight of samples at different time intervals and W0 the dry weight of 
membranes at t = 0. All measurements were performed in triplicate. 
 
3.3.2.8. Antimicrobial tests. The antibacterial activity of both M and M-Ag membranes 
was evaluated using strains of Escherichia coli (ATCC® 25922™), Staphylococcus 
epidermidis (ATCC® 12228™), Staphylococcus aureus (ATCC® 25923™) and 
Pseudomonas aeruginosa (ATCC® 27853™). 
 
3.3.2.8.1. Growth inhibition assay. Membranes were sterilized (30 minutes of UV-
irradiation for each side of sample) and incubated in sterilized PBS for 72 h at 37 °C under 
shaking condition in order to re-swell the system. Bacterial suspensions were prepared by 
adding 20 µL of bacteria, preserved in glycerol, to 5 mL of LB broth. The obtained 
suspensions were incubated overnight at 37 °C. After 24 h, 500 µL of bacterial suspension 
was diluted in 10 mL of broth and grown up for 90 min at 37 °C in order to restore an 
exponential growth phase. Bacterial concentration was measured by means of optical 
 65 
density (O.D.) at 600 nm. The bacterial suspension was then diluted in 10% (v/v) LB broth 
in PBS to obtain a final concentration of 5 x 106 bacteria mL-1. After re-swelling, PBS was 
removed from membranes and 2 mL of bacterial suspension was added to each one. All 
bacteria strains were then incubated at 37 °C for 4 h. Tests were carried out in shaking 
condition (140 rpm) to optimize the contact between bacteria and membranes. At the end 
of incubation, bacterial suspension was collected and membranes were washed with 2 mL 
of PBS by vortexing for defined time so as to recover all bacteria. The washing solution 
was then added to the bacterial suspension previously transferred into a tube. The total 
collected bacterial solution was serially diluted in PBS (from 10-1 to 10-5) and 25 µL of 
each suspension were plated on LB agar. After overnight incubation at 37 °C, the colony 
forming units (CFUs) were counted. Outcomes were compared with a suspension of 
bacteria grown in liquid medium as control. Data are pointed out as the mean of three 
independent determinations with comparable results. 
 
3.3.2.8.2. Biofilm formation. Bacterial suspensions of S. aureus and P. aeruginosa were 
prepared by adding 20 µL of bacteria, preserved in glycerol, to 5 mL of BHI broth plus 3% 
w/v sucrose. The obtained suspensions were incubated overnight at 37 °C. After 24 h, 
bacteria were diluted 1:100 in the same broth and plated (300 µL/well) into 24-well plates. 
For confocal laser scanning microscopy analyses, bacteria were plated on sterile 13 mm 
tissue culture coverslips (Sarstedt, U.S.A.) previously laid down on the bottom of culture 
plate wells. Plates were incubated at 37 °C for 24 h allowing biofilm formation After 24 h, 
broth was removed and formed biofilm was carefully rinsed twice with 100 µL of sterile 
PBS in order to remove non-adherent cells. 300 µL of PBS were then added to each well 
and circular specimens of swollen membranes were deposited on the bacterial layer. 
Biofilms treated with membranes were then incubated at 37 °C and MTT assay was 
performed according to the following protocol after 4 and 24 h of incubation.  
 
3.3.2.8.3. Viable biomass assessment. The test was performed according to the protocol 
described elsewhere.(197) Briefly, MTT stock solution was prepared by dissolving 5 mg 
mL-1 of MTT powder in sterile PBS. PMS stock solution was prepared by dissolving 0.3 
mg mL-1 of relative powder in sterile PBS. Solutions were further filtered (0.22 µm filters, 
Biosigma, Italy) and stored at 2 °C in light-proof vials until the day of the experiment, 
when a fresh measurement solution (FMS) was prepared by mixing 0.5 mL of MTT stock 
solution, 0.5 mL of PMS stock solution, and 4 mL of sterile PBS. DMSO was used as 
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lysing solution (LS). After the biofilm incubation period, membranes and PBS were gently 
removed from the plates and each well was carefully rinsed three times with 100 µL of 
sterile PBS in order to remove non-adherent cells. 200 µL of FMS solution were placed 
into each well and the plates were incubated for 3 h under light-proof conditions at 37 °C. 
The FMS solution was then gently removed and formazan crystals were dissolved by 
adding 200 µL of LS to each well. Plates were stored for an additional 1 h under light-
proof conditions at room temperature and then 80 µL of the solution were transferred into 
the wells of 96-well plates. The absorbance of the solution was measured using a 
spectrophotometer (Infinite M200 PRO NanoQuant, Tecan) at a wavelength of 550 nm. 
Outcomes were expressed as optical density (O.D.) units and are the mean of three 
independent experiments. 
  
3.3.2.9. Confocal laser scanning microscopy (LSCM). LSCM studies were addressed at 
detecting viability/death of bacteria grown in the biofilm community. FilmTracer 
Live/Dead biofilm viability kit (Invitrogen™) was used. Dead cells were stained by 
propidium iodide, (red fluorescence - λex 514 nm; λem 590 nm) whereas live cells by 
SYTO® 9 (green fluorescence - λex 488 nm; λem 515 nm). Staining was performed on 
biofilms grown on coverslips as described above, according to the manufacture’s protocol. 
Images were acquired on a Nikon Eclipse C1si confocal laser scanning microscope with a 
Nikon Plan Fluor 20X as objective. Resulting stacks of images were analyzed using 
ImageJ software. 
 
3.3.2.10. Cell culture. Mouse fibroblast-like NIH-3T3 (ATCC® CRL1658) and 
immortalized human keratinocyte HaCaT (kindly gifted by Dr. Chiara Florio, University of 
Trieste) cell lines were used for the in vitro experiments. Both cell lines were cultured in 
Dulbecco’s Modified Eagle’s Medium high glucose (EuroClone, Italy), 10% heat-
inactivated fetal bovine serum (Sigma Aldrich, Chemical Co. U.S.A), 100 U mL-1 
penicillin, 100 µg mL-1 streptomycin and 2 mM L-glutamine in a humidified atmosphere 
of 5% CO2 at 37 °C. 
 
3.3.2.11. Cytotoxicity evaluation and fluorescence microscopy. In vitro cytotoxicity of 
membranes was evaluated by using MTT assay on both NIH-3T3 and HaCaT cells. UV-
sterilized samples of approximately 20 mm in diameter and 1.5 mm in width were placed 
in Dulbecco’s modified Eagle’s medium, inactivated fetal bovine serum 10%, penicillin 
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100 U mL-1, streptomycin 100 µg mL-1 and L-glutamine 2 mM for 72 h at 37 °C and 5% 
pCO2. After 72 h of incubation, the cytotoxicity test was performed by direct contact of the 
cells with the swollen membranes. 200 000 cells were plated on 6-well plates and, after 
complete adhesion, culture medium was changed with 2 mL of fresh medium. Tested 
materials were directly deposited on the cell layer. After 24 and 72 h, MTT assay was 
performed according to the manufacture’s protocol. As a positive control material, 
poly(urethane) films containing 0.25% zinc dibuthyldithiocarbamate (ZDBC) (20 mm 
disks) were used. As negative control material, plastic poly(styrene) sheets (20 mm disks) 
were used. Each material test was performed in triplicate. Cytotoxicity was expressed as 
percentage of viability by normalizing the O.D.570 nm of samples to the O.D.570 nm of the 
negative control. Data are pointed out as the mean of three independent determinations 
with comparable results.  
For fluorescence microscopy analyses, cells were fixed by 4% paraformaldehyde in PBS, 
permeabilized with 0.1% v/v Triton X-100 and blocked with 1% BSA (15 min at 37 °C). 
Finally, cells were stained 1 h at 37 °C with Phalloidin-FITC 50 µg mL-1 and 1 min with 
DAPI 0.1 µg mL-1 (Sigma-Aldrich, Chemical Co. U.S.A). Photographs were taken with a 
Nikon Eclipse E600 microscope equipped with a Nikon Coolpix995 digital camera. 
 
3.3.2.12. Statistical analyses. Data are expressed as means and standard deviations (SD). 
Statistical analyses were performed using Student's t test, and a p value of < 0.05 was 
considered statistically significant. 
 
3.3.3. Results and discussion 
The main goal of this work traced back to the idea of exploiting the ability of two 
polysaccharides, namely chitosan and chitlac, to form antibacterial and non-cytotoxic 
hydrophilic membranes to be used as dressing in the treatment of non-healing wounds. In 
another contribution, the higher ability of chitlac to coordinate and stabilize silver 
nanoparticles compared to chitosan was demonstrated.(62) In chapter I, the novel process 
that exploits the capability of chitosan to undergo ionotropic gelation in the presence of 
TPP anions was discussed. Given these premises, the main purpose was to create a 
chitosan-chitlac-nAg blend capable of gelling in the presence of TPP without affecting the 
stability and the antibacterial activity of silver nanoparticles. 
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UV-Vis spectroscopy and TEM investigations were performed to evaluate shape, 
distribution and dimensions of the nanoparticles. Figure 23A shows the UV-Vis spectra of 
a diluted chitosan-chitlac-nAg gelling solution pointing out the plasmon resonance band at 
about 400 nm due to the presence of the AgNPs. The symmetrical shape of this narrow 
band suggests that nanoparticles are well dispersed and stabilized in the mixture. No 
significant differences in the UV-Vis spectra were observed after five months of storage at 
room temperature, indicating a good stability over time.   
In order to evaluate nanoparticles shape and dimensions, TEM analyses were carried out. 
Figures 23B and C display images of nanoparticles in diluted gelling solution at different 
magnifications, showing good dispersion, lack of aggregates and spherical shape 
morphology for the majority of nanoparticles. TEM images have been analyzed to evaluate 
the dimensional distribution of the nanoparticles. The histogram in Figure 23D points out a 
narrow size distribution scattered with maximum frequency at around 20 nm and a mean 
diameter of 20.1 ± 8.4 nm. 
 
 
 
Figure 23. (A) UV-Vis spectra of silver nanoparticles in diluted 1:20 gelling solution (chitosan, 
chitlac-nAg, glycerol) after one day (solid line) and after five months storage (dashed line). (B-C) 
TEM images of silver nanoparticles dispersed in diluted 1:50 gelling solution at different 
magnifications. (D) Silver nanoparticles size distribution based on TEM images and calculated by 
means of ImageJ software. 
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Chitlac-nAg was mixed with chitosan (and glycerol) and a homogeneous solution was 
obtained. A sketch of the interpenetrated polymer network preparation is depicted in 
Figure 24A, where chitlac and chitosan are represented as worm-like structures whereas 
silver nanoparticles as red dots. When the chitlac-nAg colloidal dispersion and chitosan 
solution were mixed at investigated concentrations, no aggregates or precipitates were 
observed, thus suggesting the completely miscibility of the two polysaccharides. TEM 
analyses demonstrated the presence of small, round-shaped and mono-dispersed 
nanoparticles (Figures 23B, C). This result was supported by UV-Vis measurements where 
the presence of very narrow and symmetrical bands confirmed the good dispersion of 
nanoparticles. This finding clearly suggests that the presence of chitosan-glycerol did not 
negatively affect the stability of silver nanoparticles coordinated by chitlac.  
 
 
 
Figure 24. (A) Entangled distribution of chitosan (black ribbons), chitlac (yellow ribbons) and 
AgNPs (red dots) in gelling solution. (B) Slow ion diffusion technique: a vessel containing the 
viscous gelling solution is placed into an outer solution [TPP (1.5% w/v) - NaCl (150 mM) - 
glycerol (5% v/v)] under stirring. When the dialysis starts, TPP ions diffuse through the 
semipermeable walls (membranes) of the vessel so as to favor a controlled ionotropic gelation. 
 
The mixture was then confined in dialysis membranes by means of a custom-made vessel 
immersed in a TPP solution (Figure 24B). This technique enabled to turn the chitlac-nAg 
gelling solution into a macroscopic homogenous hydrogel, exploiting the slow TPP 
diffusion through the dialysis membranes. Chitlac-nAg did not prove to hamper the 
ionotropic gelation of chitosan, which resulted in homogeneous hydrogels and membranes 
as confirmed by SEM investigation (Figures 25A-F). Indeed, E-SEM images pointed out 
the continuous polymeric network both at the surface and at the cross-section of the 
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hydrogel (Figure 25B,C). Since the primary purpose of the present work was to produce 
dried pliable membranes, nanocomposite hydrogels were freeze-dried according to a 
procedure previously described. Resulting membranes (Figure 25D) were analyzed by 
SEM analyses that revealed the compact polymeric mesh of the material (Figure 25E,F). 
 
 
 
Figure 25. Upper row: hydrogel embedding AgNPs. (A) Top view, (B) E-SEM micrograph of the 
hydrogel surface, (C) E-SEM micrograph of the hydrogel cross-section. Lower row: dried 
membrane derived from the hydrogel depicted in (A) by freeze-drying. (D) Top view, (E) SEM 
micrograph of the membrane surface, (F) SEM micrograph of the membrane cross-section. 
 
An ideal wound dressing should offer protection from infections, should remove wound 
exudates (maintaining at the same time a moist environment) and should demonstrate lack 
of cytotoxicity towards eukaryotic cells to not interfere with tissue regeneration.(123) 
According to these requirements, several studies were aimed at assessing the antibacterial 
properties of membranes, their swelling behavior and the biocompatibility towards 
eukaryotic cells. Antibacterial features of membranes were evaluated towards both Gram- 
and Gram+ bacteria strains. Anti-bacterial tests were carried out on E. coli, a typical 
bacterium employed in laboratory to assess the efficacy of antimicrobial agents and 
antibiotics, S. epidermidis which belongs to microbiota of the skin and finally P. 
aeruginosa and S. aureus because of their ability to produce biofilm in chronic 
wounds.(29)  
 71 
Experiments were addressed to assess the bacterial growth inhibition and biofilm 
eradication activities of the membranes with AgNPs (M-Ag) in comparison with the 
membranes without AgNPs (M). Figures 26A,B show the results obtained by a growth 
inhibition assay with E. coli and S. aureus. For both strains, a significant drop of CFU (p < 
0.001) was identified for both M- and M-Ag-treated samples in comparison with control 
(suspension of bacteria grown in medium).  
 
 
 
Figure 26. Growth inhibition rate expressed as Log CFU mL-1 of E. coli (A), S. aureus (B) and P. 
aeruginosa (C) following 4 h of treatment with M-Ag (with AgNPs) and M (without AgNPs) 
membranes. Growth inhibition rate of S. epidermidis (D) following 20 h of treatment with the same 
membranes. Statistical differences were determined by means of Student’s t test. *p < 0.05; **p < 
0.01; ***p < 0.001. E. coli colonies on LB agar: not diluted (E) and diluted 10-1 (F) M-Ag-treated 
sample; not diluted (G) and diluted 10-1 (H) M-treated sample; not diluted (I) and diluted 10-1 (J) 
control sample. 
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M membranes exert mainly a bacteriostatic effect which can be ascribed to the presence of 
chitosan. Indeed, the number of bacteria after four hours remains basically constant when 
compared with the amount of bacteria seeded at time zero (5 x 106 bacteria mL-1). At 
variance, M-Ag membranes showed a marked antibacterial activity in comparison with M 
ones (p < 0.001) owing to the presence of embedded AgNPs. This finding is confirmed by 
visual observations as reported in Figures 26E-J that show the growth of E. coli colonies 
on LB agar for treated and untreated samples. A similar trend was observed for P. 
aeruginosa (Figure 26C) where a drop of around 5 Log was found for M-Ag-treated 
samples. Also in this case, the presence of AgNPs in M-Ag membranes enables to 
significantly increase (p < 0.05) the antibacterial properties of such membranes with 
respect to M ones. In the case of S. epidermidis, no significant differences were revealed 
between M and M-Ag after 4 h of treatment, although a marked antibacterial activity (3 
Log CFU drop) was detected for both of them compared with the control (not shown). In 
order to spot significant differences between M and M-Ag membranes with this strain, 
time of incubation was increased up to 20 h so as to extend the exposure time of bacteria to 
membranes. In these conditions, the Log CFU mL-1 calculated for M-Ag and M 
membranes were 1.9 ± 0.2 and 3.3 ± 0.6, respectively (p < 0.05, n = 3), thus indicating an 
enhanced activity in the presence of AgNPs (Figure 26D).  
After demonstrating that M-Ag membranes possess the capability to significantly impair 
the growth of different bacteria strains, the following step was to verify the activity of such 
membranes upon mature biofilms. Figures 27A,B pointed out the results obtained after 4 
and 24 h of treatment for S. aureus and P. aeruginosa biofilms, respectively. In the case of 
the Gram+ strain, it was revealed that M-Ag membranes were effective in breaking apart 
the biofilm, as revealed by MTT colorimetric assay where samples treated with membranes 
embedding AgNPs showed a reduction of ~ 75% of O.D. after only 4 h with respect to 
control (Figure 27A). Conversely, M membranes did not impair biofilm viability in the 
same timeframe. At longer time (24 h of treatment), M membranes displayed an 
antibacterial activity towards S. aureus biofilm, in any case milder than in the presence of 
AgNPs (M-Ag). These results were confirmed by analysis of the biofilms with confocal 
laser scanning microscopy (Figure 27C-E). In Figure 27E S. aureus biofilm appears as a 
green fluorescent layer, which indicates the good bacteria viability in the case of the 
growth control. Conversely, cells treated for 24 h with M-Ag membranes pointed out 
mainly red fluorescent bacteria and only a few green cells, thus suggesting cell membrane 
damage and the consequent entry of propidium iodide into dead cells (Figure 27D). 
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Moreover, the bacteria layer appeared non-homogeneous and broken apart. Biofilms 
treated with M membranes showed a partial disaggregation of the bacteria layer after 24 h 
of treatment, as pointed out by sagittal YZ projection, albeit a higher number of viable 
cells with respect to M-Ag-treated biofilm was detected (Figure 27C). These findings are 
in agreement with what measured in the viable biomass experiments above discussed. 
Viable biomass assessment was also carried out on P. aeruginosa as shown in Figure 27B. 
In this case, by comparing M and M-Ag membranes no statistical differences were 
observed at investigated times, even if a O.D. decrease was measured for both in 
comparison with the control group. 
 
 
 
Figure 27. Viable biomass MTT assay expressed as O.D. at 550 nm of S. aureus (A) and P. 
aeruginosa (B) following 4 and 24 h of treatment with M-Ag (with AgNPs) and M (without 
AgNPs) membranes. Statistical differences were determined by means of Student’s t test. NS: no 
statistical differences versus M; **p < 0.01 versus M. LSCM images of S. aureus biofilm: M-
treated sample after 24 h (C), M-Ag 24 h-treated sample (D) and control (E). For all images green 
fluorescence indicates live cells whereas red fluorescence refers to dead ones. Horizontal sagittal 
sections: XZ projections; vertical sagittal sections: YZ projections. 
 
Considering that chitlac is devoid of antibacterial properties,(56) the synergistic effect on 
bacteria killing of AgNPs when combined with chitosan after already 4 h of contact was 
proved. In the case of S. epidermidis, statistical differences between M-Ag and M 
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membranes started to be evident only after longer times (20 h). The higher resistance of 
this strain in presence of silver nanoparticles is consistent with another work.(77) The 
studies on mature biofilms pointed out that both membranes are able to break apart S. 
aureus biofilm after 24 h of treatment, as demonstrated by LSCM analyses (Figures 
27C,D). While M membranes are supposed to exert antibacterial activity owing to the 
properties of chitosan (electrostatic, hydrophobic and chelating effects(148)), M-Ag 
membranes also exploit the presence of silver nanoparticles to boost the bactericidal 
efficacy. This is confirmed by the rapid O.D. reduction already after 4 h of treatment in the 
case of S. aureus (Figure 27A). It is very important to notice that LSCM images were 
acquired after removing membranes from the bacteria biofilm. Indeed, given that AgNPs 
have previously proved to exert their antibacterial activity by interaction with bacterial 
membranes,(62),(67) in the present system AgNPs grafted on the surface of M-Ag 
membranes are supposed to interact with bacteria cells in correspondence to molecular 
target, e.g. thiol groups (-SH) of proteins, causing membrane damage.(67),(68) The 
bactericidal effect of silver in this system can be also ascribed to the small dimensions of 
the nanoparticles (20.1 ± 8.4 nm), which ensures a high surface area of contact with 
bacteria membranes.(66) 
Tridimensional systems based on polysaccharide networks can prevent nanoparticles from 
being available for eukaryotic cellular uptake but, at the same time, preserve their 
antimicrobial activity allowing the direct interaction of the nanoparticles with the proteins 
localized on the bacterial surface.(62) In fact, in bacteria the thiol groups (-SH) of 
membrane proteins, main molecular targets of the silver antibacterial activity, are exposed 
to the extracellular portion of the membrane as discussed above. Conversely to prokaryotic 
cells, eukaryotic cells do not have exterior (-SH) groups at membrane level.(56) As a 
result, AgNPs are unable to interact with them except if internalized. Indeed, recently Lee 
et al. proved that AgNPs were potentially cytotoxic towards NIH-3T3 cells when they 
were taken up, thus favoring changes of morphology, oxidative stress, induction of reactive 
oxygen species, up-regulation of Heme oxygenase 1 expression, apoptosis and 
autophagy.(72)  
In order to assess the biocompatibility of M-Ag membranes for dermatological 
applications, MTT assay was performed on keratinocytes (HaCaT) and fibroblasts (NIH-
3T3) cell lines and results are pointed out in Figure 28. HaCaT and NIH-3T3 cell lines 
were chosen because they are cellular components of skin and because of their large use as 
model to evaluate the response of biological systems towards biopolymer networks.(198) 
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M membranes were tested as chitosan-based control without AgNPs. The plot in Figure 
28A shows that the viability of treated HaCaT cells was not influenced when membranes 
are in direct contact with cells. No statistical differences were identified for M-Ag samples 
compared to the negative control at time investigated, thus suggesting lack of cytotoxicity 
of the material. This outcome is consistent with what observed by optical microscopy 
(Figure 28C), where cells showed a normal keratinocyte-like morphology, good spreading, 
and absence of suffering signals such as cytoplasmic vacuoles, chromatin aggregation, or 
formation of cellular debris. Fluorescence microscopy (Figure 28D) confirmed the viability 
of treated cells showing an optimal distribution of cytoskeleton (Phalloidin-FITC staining) 
and intact nuclei (DAPI staining). Similar results were obtained with NIH-3T3 cell line as 
shown in Figure 28B. Also in this case the MTT assay did not point out any significant 
difference between treated samples versus negative control and optical/fluorescence 
microscopy confirmed the viability of cells (Figures 28E,F). 
 
 
 
Figure 28. Percentage of viability of keratinocytes HaCaT (A) and fibroblast NIH-3T3 (B) cells 
measured using MTT assay. M-Ag (with AgNPs) and M (without AgNPs) membranes were kept in 
touch with cells and test was performed after 24 and 72 h of treatment. Poly(urethane) sheets 
containing 0.25% zinc dibuthyldithiocarbamate were used as contact positive control (C+) whereas 
plastic poly(styrene) sheets were used as contact negative control (C-). Statistical differences were 
determined by means of Student’s t test NS: no statistical differences between C- and M-Ag both at 
24 and 72 h of treatment. Optical microscopy of HaCaT (C) and NIH-3T3 (E) cell lines after 72 h 
of treatment with M-Ag membrane. Fluorescence microscopy of HaCaT (D) and NIH-3T3 (F) cell 
lines: cytoskeleton was stained by means of Phalloidin-FITC (P-FITC) whereas nuclei by DAPI. 
Images were acquired after 72 h of contact with M-Ag membranes. 
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Thanks to lack of morphological alterations and cellular debris in this model, as pointed 
out by optical and fluorescence microscopy, a massive cellular uptake of silver 
nanoparticles may be excluded, thus concluding AgNPs are firmly grafted and 
immobilized in the chitlac/chitosan polymeric network and therefore do not diffuse into the 
surrounding environment.  
Finally, water uptake is particularly important for an ideal wound dressing because it 
enables to eliminate exudates from an infected lesion thus hampering bacteria spread. To 
study the hydrophilicity of membranes, swelling studies were carried out and results are 
shown in Figure 29.  
 
 
 
Figure 29. Water uptake (%) versus time (h) of M-Ag membranes immersed in PBS buffer (pH 
7.4) at 37 °C. The data are expressed as mean (±SD, n = 3). 
 
Membranes demonstrated a complete swelling state in PBS buffer at 37 °C after 72 h of 
soaking. The plot displays a slow, albeit constant, water uptake by membranes that took 
place in the first 4 h. Furthermore, the water uptake increased from 34.1 ± 5.6 to 191.7 ± 
29.8% after 48 h of soaking because of diffusion of water molecules into the hydrophilic 
polymeric network. As a result, membranes reached the equilibrium and the swelling rate 
did not vary significantly after 72 h (193.6 ± 28.8% as final water uptake). What observed 
is in agreement with Silva et al. that demonstrated a similar water uptake in the case of 
tridimensional constructs based on chitosan.(199)  
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3.3.4. Main conclusions 
• A silver-containing antimicrobial membrane was successfully fabricated; 
• The stability of chitlac-coordinated AgNPs was not affected by mixture with 
chitosan and glycerol; 
• This nanocomposite material was proved to possess antimicrobial activity towards 
bacteria suspensions and mature biofilms and lack of cytotoxicity.  
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CHAPTER IV 
 
Chitosan-hyaluronan nanoparticles (complexes) 
 
3.4.1. Aim of work 
The work presented in this chapter was primarily aimed at verifying the anti-inflammatory 
properties of butyrate upon two inflammatory cell models. Macrophages and neutrophils 
were considered because of their different involvement in the inflammation phase. The 
effect of butyrate on cytokine production by macrophages and on neutrophils respiratory 
burst was studied. As the anti-inflammatory activity of butyrate versus human neutrophils 
was demonstrated to be time-dependent, chitosan (CH)/hyaluronan (HA)-based 
nanoparticles (complexes) able to host butyrate (B-NPs) as payload were fabricated.  The 
goal was to provide over time to the cells a constant supply of cargo.  
The final target of this investigation is addressed: (i) to load B-NPs within the chitosan 
membranes described in the previous chapters for non-healing wounds applications, (ii) to 
use B-NPs alone for the treatment of inflammatory bowel diseases exploiting their 
mucoadhesive properties. 
 
3.4.2. Materials and methods 
3.4.2.1. Materials. The characteristics of the hydrochloride chitosans (kindly gifted by 
Prof. Kjell Morten Vårum, NTNU, Trondheim, Norway) used in this study are presented in 
Table 6.  
 
Chitosan (Fa) 𝜂   mL g-1 Mw (kDa) Mn (kDa) PI (Mw/Mn) 
< 0.008 480 183 65 2.82 
0.64 300 112 61 1.84 
 
Table 6. Features of chitosans used in the study. The intrinsic viscosity [η] was calculated by 
means of viscosimetry. The molecular weights (Mw, Mn) and polydispersity index (PI) were 
analyzed by SEC-MALLS. The fraction of acetylated units (Fa) was determined by 1H-NMR. 
 
The acetylation degree (Fa) was determined by means of 1H-NMR whereas the 
polydispersity index (PI) and molecular weights (Mw and Mn) were analyzed by size-
exclusion chromatography with a multiangle laser light scattering detector (SEC-MALLS). 
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The intrinsic viscosity was determined by viscosimetry analyses. Sodium Hyaluronate (Mw 
180 kDa) was kindly provided by Sigea Srl, Padriciano (Trieste). Sodium tripolyphosphate 
pentabasic - Na5P3O10 - (TPP ≥ 98%), sodium butyrate (NaBut 98%), Percoll, bovine 
serum albumin (BSA, ≥ 96% cell culture-tested), cytochrome c (type VI from horse heart), 
phorbol 12-myristate 13-acetate (PMA), N-formyl-L-methionyl-L-leucyl-L-phenylalanine 
(fMLP), xanthine/xanthine oxidase (from bovine milk), superoxide dismutase (SOD, from 
bovine erythrocytes) and lipopolysaccharides (LPS, from E. coli, suitable for cell culture) 
were purchased from Sigma-Aldrich Co. (St. Louis, MO). Fibronectin (FN), from human 
plasma, was from Roche Diagnostics GmbH (Penzberg, Germany). Human recombinant 
tumor necrosis factor-α (TNF-α, from yeast) was obtained from MiltenyiBiotec GmbH 
(BergischGladbach, Germany). High-purity Trypan Blue (TB, Color Index 23850) was 
obtained from Merck KgaA (Darmstadt, Germany), dissolved in distilled water at 5 mg 
mL-1 and filtered through a Millipore filter to remove non-solubilized material. All other 
reagents and chemicals were of the highest purity grade available. All solutions were made 
in endotoxin-free water or physiologic saline (0.9% NaCl) for clinical use. 
 
3.4.2.2. U937: cell culture, differentiation, and induction of cytokine release. U937 
human monocytic cells (Sigma) were cultured in RPMI 1640 medium with stable L-
glutamine (2 mmol L-1) (EuroClone, MI, Italy), supplemented with penicillin (100 U mL-
1), streptomycin (100 U mL-1) and 10% fetal bovine serum. Cells were maintained under 
humidified atmosphere with 5% CO2 at 37 °C. Differentiation of U937 cells into adherent 
macrophages was induced with PMA. Briefly, cell suspensions were centrifuged, 
resuspended in fresh complete medium and cell viability (> 95%) was assessed by trypan-
blue dye exclusion. 1.5 x 105 cells were then seeded into each well of a 24-well plate in 0.5 
mL as final volume of complete RPMI. Cells were cultured in the presence of 15 ng mL-1 
PMA for 72 h and further grown for 24 h in fresh complete medium to allow cell recovery. 
Cells were then incubated for 24 h with butyrate in fresh complete medium before LPS 
stimulation (1 ng mL-1 as final concentration). Cell-free supernatants were collected and 
stored at -20 °C until measurements of cytokines. TNF-α, IL-1β and IL-6  in the culture 
supernatants were measured using commercially available ELISA kits (InvitrogenTM, Life 
Technologies, Thermo Fisher Scientifics). 
 
3.4.2.3. Neutrophil isolation. Institutional ethics committee approval was obtained and 
written informed consent was signed by healthy volunteers from which venous blood was 
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withdrawn. Neutrophils were isolated by a discontinuous Percoll gradient centrifugation, as 
described previously in (200) and suspended in Ca2+- and Mg2+-free PBS solution, pH 7.4, 
containing 5 mM glucose and 0.2% w/v BSA. 
 
3.4.2.4. Preparation of FN-coated surfaces. Flat-bottom poly(styrene) wells (F16 
MaxiSorp Nunc-ImmunoTM Modules, ThermoFisher Scientific Inc., Waltham, MA) or 
Falcon culture slides (8 chamber poly(styrene) vessel tissue culture treated glass slide, 
Becton Dickinson and Co., Franklin Lakes, NJ) were coated with FN as described 
elsewhere.(201) Briefly, 50 or 150 µL of FN solution (20 µg mL-1 in PBS) were put in 
each well or chamber, and the plate or the slide was left at 37 °C for 1-2 h in a humidified 
chamber. Just before use, the wells or slides were rinsed three times with PBS. 
 
3.4.2.5. Assay of O2− production. O2− production was measured by the SOD-inhibitable 
cytochrome c reduction assay, as previously described.(202) Briefly, freshly isolated 
neutrophils were suspended at 3.75 x 106 cells mL-1 in PBS-BSA and prewarmed for 30 
min at 37 °C in a shaking water bath to restore basal conditions. Five to ten minutes before 
starting the assay, the cell suspension was supplemented with 1 mM of CaCl2 and 1 mM of 
MgCl2. Aliquots (20 µL) were then added to FN-coated wells containing cytochrome c 
(0.12 mM as final concentration) and butyrate in a total volume of 0.16 mL PBS-BSA 
supplemented with 1 mM CaCl2 and 1 mM MgCl2 (Ca2+/Mg2+ PBS-BSA). Immediately 
after the addition of the cells, 20 µL of TNF (10 ng mL-1 final concentration) or fMLP (5 
µM final concentration) were pipetted in each well. The plate was then transferred in a 
thermostated microplate reader (MultiskanMCC/340; LabsystemOy, Helsinki, Finland) 
and readings were taken at intervals of 2.5 minutes for one hour. The amount of reduced 
cytochrome c was calculated from the absorbance difference between 550 nm and 540 nm, 
using an absorbance of 0.037 optical density (OD) units for 1 nmol reduced cytochrome c 
as a standard. 
 
3.4.2.6. Measurement of adhesion. The number of neutrophils adherent to FN was 
assessed in the same wells in which O2- release had been measured as described 
elsewhere.(200) At the end of incubation, wells were filled with PBS, sealed with 8-cap 
strips and centrifuged upside-down for 5 min at 200 × g to remove non-adherent cells. The 
wells were then flicked empty and the adherent cells were quantified by measuring 
myeloperoxidase activity. Standards with known cell numbers were run in parallel for a 
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quantitative determination of adherent cells. 
 
3.4.2.7. Preparation of blank nanoparticles (NPs) and butyrate-loaded nanoparticles 
(B-NPs). CH-HA-nanoparticles were fabricated by exploiting the protocol reported in 
(203) with slight modifications. Chitosan (0.6 mg mL-1) and hyaluronan (1.25 mg mL-1) 
solutions were prepared by solubilizing the polymers in deionized water. After the 
complete dissolution, both solutions were filtered (0.22 µm filters, Biosigma, Italy) and 
stored at room temperature prior the use. Plain NPs were fabricated from the addition of 
100 µL of TPP solution (0.5 mg mL-1 dispersed in deionized water) to 2 mL of filtered HA 
mixture under stirring condition. Resulting solution (0.5 mL) was then gently added 
dropwise to 0.5, 1 and 2 mL of CS solution, respectively, in order to vary the HA/CH 
weight ratio. The formation of NPs occurred within 10 min of stirring. Resulting mixtures 
were then held at room temperature for 30 min so as allowing their stabilization. For the 
preparation of B-NPs, sodium butyrate was solubilized in deionized water so as to obtain 
three solutions with different concentrations (135, 13.5 and 1.35 mM). 80, 120, 200 µL of 
each butyrate solution were mixed with 0.5, 1 and 2 mL of CS solution, respectively, under 
stirring. The formation of B-NPs occurred in the same experimental conditions above 
discussed. The final butyrate concentration in B-NPs solutions was of 10, 1 and 0.1 mM. 
 
3.4.2.8. Physical-chemical characterization of NPs and B-NPs. The size of both NPs 
and B-NPs was determined using Dynamic Light Scattering (DLS) on a Zetasizer Nano ZS 
(Malvern Instruments). Measurements were performed in deionized water at a temperature 
of 25 °C. The size is expressed as the Z-average hydrodynamic diameter obtained by a 
cumulative analysis of the correlation function using the viscosity and refractive index of 
water in the calculations. ζ-potential values were obtained by using the technique of laser 
doppler velocimetry. All the samples were diluted with deionized water (1:10) to adequate 
scattering intensity prior to the measurements. 
Images of NPs were acquired by TEM. NPs were contrasted for ten minutes using 
UO2(CH3COO)2 1% w/v, diluted 1:10 in deionized water and gently deposited onto copper 
grids. Visual analysis and image record were performed using a PHILIPS EM 
Transmission Electron Microscope. 
 
3.4.2.9. Fluorescent labelling of HA. Sodium hyaluronate was labeled using 
Fluoresceinamine isomer I - green fluorescence (Sigma Aldrich, Chemical Co.) by 
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exploiting the NHS-EDC reaction. HA was solubilized in MES buffer (50 mM, pH 5.5) 
with a final concentration of 3 mg mL-1. Ethanol absolute 3.33 mL, NHS (43.3 mg) and 
EDC (71.6 mg) were progressively added into the HA mixture (30 mL) under stirring. 
Finally, 346 µL of fluoresceinamine solution (5 mg mL-1 ethanol as solvent) was added 
dropwise to HA mixture and the reaction was let occur in dark condition and room 
temperature overnight. By using this procedure 1 out of 50 repetitive units were labeled. 
The resulting solution was sealed in a dialysis bag (cutoff 12 kDa) and extensively 
dialyzed against NaHCO3 50 mM firstly and deionized water afterwards. The complete 
lack of free dye was confirmed by means of fluorescence spectroscopy. The pH of the 
resulting dialyzed mixture has been adjusted in the range 6.8 - 7.4. The labeled-polymer 
was finally freeze-dried and stored at 4 °C. 
 
3.4.2.10. Evaluation of B-NPs stability. The stability of B-NPs was assessed in deionized 
water and in PBS buffer (pH 7.4 and physiological ionic strength). The formulations were 
diluted 1:10 either in deionized water or in PBS and stored at 37 °C. The stability was 
determined by evaluating the dimensions of nanoparticles over time up to three days. At 
time investigated, B-NPs were analyzed by dynamic light scattering (DLS) in the same 
experimental conditions above reported. 
 
3.4.2.11. Encapsulation efficiency. To evaluate the encapsulation efficiency of butyrate, 
B-NPs were centrifuged (3000 × g; 10 min; 20 °C) and the un-encapsulated butyrate was 
recovered from the supernatant. Encapsulation efficiency was calculated as ((A x B) - (C x 
D) / (A x B)) x 100 where A and C are the concentrations of butyrate before and after the 
centrifugation, respectively, whereas B and D are the total suspension volume before 
centrifugation and the supernatant volume recovered after centrifugation, respectively. 
Butyrate supernatants were analyzed by means of mass spectrometry in ESI-mode on a 
Waters XevoTQ-S instrument coupled to an I-Class UPLC in SIR (single ion recording). 
The SIR ion was set to m/z 87.0972. UPLC was run isocratic using 30% water + 0.025 mM 
NH3OH as mobile phase A and 70% ACN + 0.025 mM NH3OH as mobile phase B on a 
Waters BEH HILIC 1.7 µm x 2.0 µm 100 mm column. A mixture of 10% ACN/90% water 
+ 0.1% FA was used as wash and purge solvent. Flow rate was set to 0.150 mL min-1 and 
column temperature to 40 °C. Injection volume was in the range 2-10 µL. Total run time 
2.5 min per sample. Capillary voltage was set to 2.5 kV, desolvation temperature 500 °C, 
desolvation gas flow 1000 L hr-1 and cone voltage 20 kV. Dwell time set to 0.15 s, adjusted 
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to get a minimum of 15 data points across the peak. Standard curves (R2 > 0.99) were 
performed with known amount of butyrate and run in parallel.  
 
3.4.2.12. Cell interaction and internalization of NPs. The interaction of NPs with 
neutrophils and their cell internalization was verified by means of flow cytometry. Flow 
cytometric analysis of neutrophils incubated with fluorescence-labeled NPs was conducted 
according to the method described by Busetto et al. with slight modifications.(204) 
Neutrophils, suspended at 2.5 × 106 mL-1 in Ca2+/Mg2+ PBS - 0.05% BSA, were incubated 
at 37 °C in a shaking water bath with fluoresceinamine-isomer I-labeled NPs, in the 
presence of 10 ng mL-1 of TNF. At selected times, 250 µL (aliquots of the incubation 
mixtures) were withdrawn into the tubes used for flow cytometry analysis and put on ice. 
Some samples were washed twice with Ca2+/Mg2+ PBS - 0.05% BSA (centrifugation at 
1000 × g for 5 minutes) and resuspended in 250 µL of the same medium prior to the 
cooling step. Immediately before the analysis, samples were diluted with an equal volume 
of TB (75 µg mL-1) dissolved in ice-cold 0.1 M citrate buffer, pH 4. After 1 min of 
incubation on ice, the samples were analyzed. Flow cytometry was performed with a 
FACScalibur (Becton Dickinson) equipped with an air-cooled 15-mW Argon-ion laser, 
operating at 488 nm. Fluoresceinamine green fluorescence (FL1) was collected using a 530 
± 30 band pass filter; red fluorescence emitted from TB bound to fluoresceinamine-isomer 
1-labeled NP (FL3) was collected by using a 650 ± 13 bandpass filter. The data were 
collected using linear amplification for FSC and SSC, and logarithmic amplification for 
FL1 and FL3. For each sample 10 000 events were collected and analyzed by using 
CellQuest software from Becton Dickinson. Neutrophil population was identified by 
combined measurement of FSC and SSC and gated in R1 region. The percentage 
distribution of neutrophil subsets was calculated from dot plot analysis (FL-1 vs. FL-3) of 
R1-gated events. 
 
3.4.2.13. Evaluation of O2− scavenging activity of NPs. The scavenging effect of NPs 
was investigated using the xanthine/xanthine oxidase system. Superoxide generation by the 
xanthine/xanthine oxidase system was measured by a cytochrome c reduction assay as 
previously described with slight modifications.(205) Xanthine (0.05 mM final 
concentration), cytochrome c (0.02 mM final concentration) and, when needed, NPs, 
chitosan, HA or butyrate were added to microplate wells and the reaction was started by 
the addition of xanthine oxidase (0.0025 U mL-1 as final concentration) to reach the final 
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volume of 200 µL of PBS. Final concentration of SOD, added as positive control, was 2.5 
µg mL-1. The plate was incubated at 37 °C in a thermostated microplate reader and 
readings were taken at 550 nm and 540 nm at the selected times. 
 
3.4.2.14. In vitro release studies. The leakage of butyrate from B-NPs was studied in PBS 
buffer at 37 °C in order to mimic a physiological milieu. 0.1 mL of PBS 10X was added to 
0.9 mL of B-NPs suspension in order to equilibrate the physiological ionic strength. 
Resulting dispersions were sealed in a dialysis tube (Sigma Aldrich, cutoff 12 kDa) and 
flooded in 2 mL of PBS dialysis solution under both dynamic (140 rpm) and static 
conditions. The PBS dialysis solution was replaced with fresh medium at time investigated 
in order to simulate infinite sink conditions. The amount of released butyrate was assessed 
by mass spectrometry in ESI-mode. In order to eliminate the salts from the buffer, butyrate 
samples were derivatized using the ortho-benzylhydroxylamine (o-BHA) and N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDAC) protocol reported 
elsewhere(206) with slight modifications. The solvent for o-BHA and EDAC was prepared 
mixing 675 µL of HCl (12 M), 1.1 mL of pyridine and 11 mL of deionized water. 160 mg 
mL-1 o-BHA and 196 mg mL-1 EDAC were dissolved yielding a 1 M solution. 
Derivatization reagents have been made fresh for each analysis. Once the derivatization 
reagent was ready, UPLC analyses were performed: 20 µL of the samples/standards were 
added to a 1 mL tube, 50 µL of the o-BHA solution and then 50 µL of the EDAC solution 
were added to each tube and kept at room temperature for 45 minutes. 300 µL of Ethyl 
Acetate were added and subsequently vortexed for roughly 5 seconds. 100 µL of the top 
layer were removed and transferred to an HPLC vial, which was speedvaced for 20 
minutes at 45 °C in order to remove the ethyl acetate. Resulting solution was re-dissolved 
in 400 µL of MetOH/water (1/1) directly in HPLC vial and 5 µL were then injected into 
the UPLC-MS. The leakage of the fatty acid from B-NPs was monitored up to three days 
and results are reported as the percentage of the cumulative release on time. 
 
3.4.2.15. Biocompatibility studies. AlamarBlue assay was performed on NIH-3T3 cells in 
order to evaluate the effects of the nanoparticles on proliferation. All reagents for the 
preparation of nanoparticles were solubilized using sterile deionized water and resulting 
solutions were then filtered by 0.22 µm filters. All steps were performed in sterile 
conditions. 100 µL of cell suspension (2500 cells/well) were plated in a 96-well plates. 
Plates were finally incubated at 37 °C for 24 h allowing the attachment of cells. After that, 
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cells were rinsed with PBS 1X and treated with B-NPs with a final concentration of 0.5 mg 
mL-1 and 0.1 mg mL-1. Untreated cells were considered as control. At selected times, the 
medium was removed and 130 µL of Alamar Blue (1:10 in the same medium) added and 
the plate incubated. After 4 hours of incubation at 37 °C, 100 µL of the Alamar Blue 
medium were transferred into a black multiwell plate; a blank constituted of only the 
Alamar Blue medium was included. Fluorescence (λex 544 nm; λem 590 nm) was measured 
using FLUOStar Omega-BMG Labtech spectrofluorometer. Results are normalized with 
respect to Day 0. 
 
3.4.2.16. NPs uptake in chitosan membrane. Chitosan membranes were fabricated as 
described in the Chapter I (see 3.1.2.3. paragraph). At the end of freeze-drying process, 
resulting membranes were cut in three pieces, weighed and incubated with a final volume 
of 1 mL containing fluorescence-labeled NPs (0.4 mL NPs suspension + 0.6 mL deionized 
water). Incubation proceeded for 24 h at room temperature and in dark conditions. At the 
end of incubation, membrane pieces were removed from the medium and the fluorescence 
was measured (λex 485 nm; λem 520 nm) on the same medium. The percentage of NPs 
uptake has been calculated according to: 
 𝑈𝑝𝑡𝑎𝑘𝑒   % =   𝑉!    𝐹! −   𝑉!  𝐹!𝑉!  𝐹!   ×  100 
 
where V0 and Vf are the starting and final volume, respectively, whereas F0 and Ff 
represents the fluorescence of the incubation medium at time zero and at the end of 
incubation. Percentage of uptake was therefore normalized for the weight of dried 
membranes and data expressed as µg of NPs vs. mg of dried membrane. 
 
3.4.2.17. Evaluation of NPs mucoadhesiveness . In vitro mucoadhesive properties have 
been evaluated by assessing the interaction between NPs and mucin from porcine stomach 
(type III, bound sialic acid 0.5 - 1.5%, stored at 4 °C, Sigma Aldrich). Mucin was purified 
prior the use by dialysis against deionized water. The solution was thereafter filtered 
through 8 µm Millipore filters and then freeze-dried. Freeze-dried mucin was solubilized in 
deionized water at final concentration of 2 mg mL-1. NPs (0.82 mg mL-1 as final 
concentration) and mucin were mixed at different concentration ratios and resulting 
mixtures have been analyzed by DLS measurements. The change of NPs size distribution 
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was used as parameter to evaluate adhesive phenomena. 
 
3.4.2.18. Statistical analysis. Data are expressed as means and standard deviations (SD). 
Statistical analysis was performed using Student’s t test, and a p value of < 0.05 was 
considered statistically significant. 
 
3.4.3. Results and discussion 
The first part of this chapter is addressed to describe the study of the anti-inflammatory 
properties of butyrate. Two cell models were used: human macrophages and neutrophils. 
These cells intervene at different time frame during wound healing process as described in 
the introduction of the thesis, thus is worth investigating upon biological properties of 
butyrate among both. Human monocytes are able to cross the membrane vessels and 
consequently migrate to inflamed site. Herein cells face numerous stimuli thus turning 
their phenotype into active macrophages able to tackle inflammation. To mimic such 
condition, monocytes have been differentiated into macrophages by PMA and afterwards 
stimulated by LPS, a potent pro-inflammatory endotoxin residing in the outer membrane of 
Gram- bacteria. Different concentrations of butyrate were explored to check the reduction 
of pro-inflammatory cytokines production by macrophages and results are pointed out in 
Figure 30. The take home message of this early investigation is that butyrate dampens the 
production of all cytokines in a dose-response manner with the highest activity at the 
concentration 0.5 mM. Interestingly, this activity was proved only when butyrate was pre-
incubated with cells for 24 h prior stimulation with LPS. Conversely, if cells were treated 
with butyrate and LPS simultaneously, any anti-inflammatory evidence was not detected. It 
is well known that butyrate plays its biological activity mainly by two distinct pathways: a 
“quick” pathway through membrane-associated G-coupled proteins and a “slow” pathway 
through the inhibition of histone deacetylase (HDAC) causing histones 
hyperacetylation.(82) Given these considerations, it is reasonable to hypothesize that 
butyrate acts via HDAC pathway on the present cell model by modulating transcriptional 
regulation owing to HDAC inhibition. However, further analyses are needed to validate 
this supposition. 
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Figure 30. Effect of butyrate on the production of pro-inflammatory cytokines by LPS-stimulated 
macrophages: (A) TNF-α, (B) IL-6, (C) IL-1β. Control group represents non-stimulated cells. 
Cytokines are expressed as pg mL-1 and have been quantified by means of ELISA assays. 
 
Concerning neutrophils, preliminarily it was observed that the degree of inhibition of 
superoxide production was strongly dependent on the length of preincubation with butyrate 
before the addition of TNF as pro-inflammatory stimulus. If cells were pretreated for 15 
min with butyrate, superoxide production was reduced to a much lesser extent than cells 
encountering butyrate and TNF simultaneously. The inhibitory effect was unnoticeable if 
pretreatement with butyrate was extended to 30 - 60 minutes. As a consequence, 
experiments were performed by exposing neutrophils to butyrate immediately before 
addition of the stimulus. Figure 31A shows the dose-response curve of TNF-stimulated 
neutrophils residing on fibronectin (FN). Butyrate exerted its highest inhibitory activity at 
1 mM, a concentration far lower than those generally reported in the literature.(84),(89) 
Such a discrepancy might be well justified by considering that (i) published results are 
obtained mostly with cells in suspension, which may behave much differently from 
neutrophils in adherent conditions, and (ii) preincubation of cells with butyrate before 
addition of agonist is a common procedure that could however limit butyrate efficacy in a 
manner similar to that discussed above, warranting the use of high concentrations to 
achieve a significant effect. In this regard, it is noteworthy that at concentrations equal or 
higher than 2.5 mM the effect of butyrate in the investigated model was comparable with 
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that of equimolar solutions of NaCl or sodium gluconate. This implies that at high butyrate 
concentrations the observed inhibition of the respiratory response is ascribable to the 
increased toxicity of the medium rather than to a specific effect of butyrate. It is well 
known, in fact, that neutrophils functions, especially in adherent conditions, are extremely 
susceptible even to slight hypertonic changes.(207) Since the metabolic activation of 
neutrophils in response to TNF is strictly adhesion-dependent, the interference with cell 
attachment and/or spreading was studied afterwards. The results reported in Figure 31B 
prove that neutrophil adhesion to FN was unaffected by the presence of butyrate. 
 
 
 
Figure 31. Biological properties of butyrate towards human neutrophils. (A) Percentage of 
inhibition with respect to control group of superoxide anion production by butyrate at different 
concentrations. (B) Effect on neutrophils adhesion on fibronectin by butyrate at 1 mM. (C) Time-
dependency anti-inflammatory activity of 1 mM butyrate. (D) Elucidation on the possible 
mechanism of action of butyrate: cells were treated with pertussis toxin (G-coupled protein 
inhibitor) and stimulated either with fMLP or TNF. Statistical differences were determined by 
means of Student’s t test. NS: no statistical differences; **p < 0.01; ***p < 0.01. 
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Herein it has to be stressed that the effectiveness of butyrate in reducing O2- production 
appeared to be time-dependent: superoxide inhibition was maximal at about 20 min of 
incubation with TNF, then tended to decline with time (Figure 31C). A possible 
explanation for this trend comes from the experiments performed with pertussin toxin 
(PTX). As a G-protein inhibitor, PTX hinders the signaling pathway of the G-protein 
coupled receptor 43 (GPR43), which recognizes butyrate and is highly expressed on 
neutrophils. As shown in Figure 31D, the inhibitory effect of butyrate on TNF-induced 
superoxide production is abolished in the presence of PTX, indicating that butyrate activity 
is exerted mainly by interaction of extracellular butyrate with GPR43. Since butyrate 
uptake by neutrophils is likely rapid, as evidenced for other cell types as colonocytes, it 
can be hypothesized that the observed short-term inhibitory effect follows the actual 
butyrate concentration in the incubation medium, which is expected to diminish with time 
thus limiting butyrate binding to GPR43. This is supported also by preliminary observation 
above mentioned on the drastic reduction in butyrate effect when neutrophils are 
preincubated with the fatty acid prior to TNF exposure. 
As described before, butyrate is a molecule able to manifest an anti-inflammatory activity 
by likely two different pathways in human macrophages and neutrophils. In spite of this, 
the activity of such molecule is reduced over time if neutrophil cells are considered. In 
order to prolong its biological properties, the idea was to produce a reservoir suitable to 
host and to fine control the leakage of butyrate thus providing a constant payload to the 
cells. Biopolymer nanoparticles (complexes) based on CH and HA were fabricated with 
the aim to encapsulate butyrate. The synthesis of nanoparticles take place in a step-by-step 
process depicted in Figure 32A.  
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Figure 32. (A) Experimental setup to fabricate butyrate-loaded nanoparticles (B-NPs): the butyrate 
was first mixed with a chitosan solution under stirring; thereafter a solution of HA/TPP was added 
dropwise in order to favor the electrostatic/hydrophobic interactions between polysaccharides. The 
final construct is a nanoparticle containing butyrate. (B-C) TEM investigation at different 
magnification of NPs made of chitosan with Fa < 0.008 and HA/CH weight ratio of 2:1 
demonstrated the presence of nanoparticles with a round-shape morphology and with a core-shell 
structure. (D) Size distribution of the previous formulation pointed out as percentage of DLS 
intensity. 
 
Butyrate was first mixed with CH, wherein an electrostatic interaction between the 
carboxylic group of such molecule and the positive amino groups of polymer occurred. 
When the HA-TPP solution was dropped into the CH-butyrate mixture, resulting solution 
became progressively turbid so as to indicate the formation of nanoparticles. Herein, the 
opposite charge of both polysaccharides, the ability of chitosan to undergo a liquid-gel 
transition in the presence of TPP and the interchain interactions are considered the driving 
forces for the development of such nanoparticles.(208) The HA/CH weight ratio was 
varied so as to obtain several formulations. Dynamic Light Scattering and ζ-potential 
analyses were performed to investigate dimensions, surface charge and polydispersity and 
the outcomes are reported Table 7. Both chitosans demonstrated to foster the formation of 
NPs with different properties. This represented a very interesting finding in the case of the 
highly acetylated chitosan (Fa = 0.64) considering its very poor availability of positive 
charges to make the formation of NPs possible. TEM analyses at different magnification 
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(Figure 32B-C) in dried state confirmed the presence of nanoparticles with a round-shape 
morphology and with approximately similar dimensions to those calculated by means of 
DLS measurements. By comparing the butyrate-free formulations, interesting differences 
can be traced. NPs made of chitosan with Fa < 0.008 were found to gradually diminish 
their dimensions by increasing the HA/CH weight ratio. This phenomenon may be easily 
explained considering the porous nature of such NPs. Indeed, when HA is added to CH, the 
polyanion tends to penetrate along the chitosan network, which can accommodate the 
anionic polysaccharide in its internal structure leading to a more cross-linked and therefore 
shrunken core, as already described by Almalik et al.(209) The increasing of HA mass 
affects even the surface charge of NPs, by varying from ~ 52 to -25 mV when the HA/CH 
mass ratio was tuned from 1:2 to 2:1. The excess of HA is supposed to form a coating 
(Figure 32C), which cover the cross-linked core of CH and HA according to the core-shell 
model already proposed for either chitosan and alginate or chitosan and dextran 
complexes.(210),(211)  
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Nanoparticles Chitosan (Fa) Butyrate (mM) 
HA:CH 
weight 
ratio 
Particles size 
(nm) 
𝜉- potential 
(mV) 
PDI 
NPs < 0.008 0 1:2 771 ± 20 51.7 ± 0.7 0.33 ± 0.05 
   1:1 206 ± 3 34.0 ± 0.2 0.18 ± 0.01 
   2:1 190 ± 1 - 24.8 ± 0.5 0.10 ± 0.01 
       
B-NPs  0.1 1:2 905 ± 14 47.2 ± 2.0 0.28 ± 0.12 
   1:1 201 ± 2 32.5 ± 0.6 0.24 ± 0.01 
   2:1 212 ± 1 - 26.1 ± 0.4 0.15 ± 0.02 
       
  1 1:2 300 ± 5 40.4 ± 0.5 0.32 ± 0.06 
   1:1 175 ± 4 31.1 ± 0.4 0.11 ± 0.03 
   2:1 232 ± 1 - 27.1 ± 0.2 0.16 ± 0.02 
       
  10 1:2 189 ± 2 28.2 ± 0.6 0.12 ± 0.03 
   1:1 422 ± 8 23.9 ± 0.9 0.06 ± 0.04 
   2:1 317 ± 4 - 34.3 ± 1.0 0.20 ± 0.05 
       
NPs 0.64 0 1:2 196 ± 2 20.7 ± 0.2 0.15 ± 0.02 
   1:1 255 ± 2 - 22.6 ± 0.5 0.21 ± 0.01 
   2:1 230 ± 4 - 25.3 ± 0.3 0.33 ± 0.04 
       
B-NPs  0.1 1:2 465 ± 46 13.0 ± 0.3 0.09 ± 0.10 
   1:1 268 ± 1 - 24.8 ± 0.4 0.21 ± 0.06 
   2:1 434 ± 2 -30.0 ± 0.3 0.44 ± 0.11 
       
  1 1:2 824 ± 4 13.7 ± 0.3 0.26 ± 0.04 
   1:1 287 ± 1 - 23.1 ± 0.1 0.18 ± 0.04 
   2:1 456 ± 9 - 27.6 ± 2.1 0.53 ± 0.41 
       
  10 1:2 687 ± 23 - 3.9 ± 0.7 0.42 ± 0.07 
   1:1 821 ± 109 - 23.3 ± 3.5 0.60 ± 0.06 
   2:1 994 ± 116 -31.9 ± 0.3 0.66 ± 0.39 
 
Table 7. Plain (NPs) and butyrate-loaded (B-NPs) nanoparticles were fabricated by using chitosans 
with different acetylation degree (Fa) by varying the butyrate concentration and the polymer’s 
weight ratio. The particles size distribution, the ξ-potential and the polydispersity index were 
determined by Dynamic Light Scattering analyses. All results are the mean (± SD, n = 3). 
 
The abundance of HA with respect to CH was found also to positively reduce the size 
distribution of NPs as demonstrated by the decrease of PDI (Table 7). In the case of NPs 
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produced with chitosan with Fa 0.64, the increasing amount of HA was not found to 
significantly influence the dimension of NPs (from ~ 196 to 230 nm when the HA/CH 
mass ratio was changed from 1:2 to 2:1). This is probably ascribed to the low availability 
of positive amino groups able to interact with HA, as proved by lower ζ-potential values. 
Conversely to the NPs made of CH with Fa < 0.008, the PDI progressively increased by 
augmenting the amount of HA for the NPs made of CH with Fa 0.64, a condition due to 
minor interactions between the two polysaccharides and consequently broadening of size 
distributions. 
When butyrate was added at different concentrations to both chitosan solutions and the 
formation of B-NPs took place, some differences were identified with respect to NPs 
(Table 7). The presence of such molecule within the core of nanoparticles affects the 
hydrodynamic diameter, the surface charge and the particle size distribution. More in 
detail, the higher is the concentration of butyrate the lower is the ζ-potential for all 
formulations investigated, thus suggesting electrostatic interactions between the fatty acid 
and the chitosan. Nevertheless, hydrophobic interactions between the butyrate and the 
biopolymer’s chains that successfully contribute to the encapsulation of the molecule can 
not be neglected.  
The colloidal stability of B-NPs is a pivotal feature for such nano-systems. Opposite 
charged polyelectrolyte complexes are in fact strongly affected by the presence of salts 
(because of screening effects between charges) and by the pH.(212),(210) For instance it 
has been already demonstrated that the stability of CH/HA-based nanoparticles is 
influenced when they were moved from deionized water to PBS buffer.(213) This could 
represent the major issue for their potential use both in in vitro and in vivo models. Most 
recently Wu et al. demonstrated that CH/HA-polyelectrolyte complexes can be easily 
stabilized in physiological salts and pH conditions by the addition of metallic Zn+2,(214) 
but biocompatibility analyses are necessary for such system prior its use for biomedical 
applications. In the present study the time stability of B-NPs in both deionized water and 
PBS buffer was evaluated. The latter was conveniently selected because of its adequate 
ionic strength (~ 150 mM) and pH (7.4), which mimics a physiological milieu and the 
results are shown in Figure 33.  
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Figure 33. Evaluation of B-NPs stability in deionized water (empty columns) and in PBS buffer 
(filled columns) at 37 °C. The stability was studied by evaluating the particle size distribution up to 
three days by means of DLS analyses. (A,B,C) formulations made of chitosan with a Fa < 0.008. 
The weight ratios HA/CH were 1:2, 1:1 and 2:1, respectively. (D,E,F) formulations made of 
chitosan with a Fa = 0.64. The weight ratios HA/CH were 1:2, 1:1 and 2:1, respectively. All 
formulations studied were fabricated with a final butyrate concentration of 1 mM. 
 
B-NPs made of chitosan with Fa < 0.008 and HA/CH of 1:2 are firmly affected by the 
change of medium: B-NPs rapidly increased their dimensions when dispersed in PBS until 
to reaching roughly 1.8 µm as hydrodynamic radius average (Figure 33A). B-NPs 
demonstrated to be stable in the first two days while again increased their dimensions in 
such conditions. Conversely, B-NPs in deionized water retained their size distribution in 
the same timeframe. A probable explanation is that the deprotonation of chitosan -NH3+ 
groups (due to the increase of pH), the ionic strength and the presence of phosphates in 
such buffer led to the destabilization of B-NPs causing aggregation phenomena. This 
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aspect was evident by the presence of a flocculated suspension after 24 h. Some attempts 
were performed by modulating pH and/or the ionic strength to understand which 
mechanism governs the aggregation. We observed that when 0.9% w/v of NaCl were 
added to B-NPs dispersed in deionized water and DLS analyses were carried out, particle 
size distribution increased in the same way, thus ruling out phosphates as probable cross-
linkers between nanoparticles. On the contrary, no aggregation phenomena occurred when 
the pH was tuned in the range 7.0 - 7.4, so as to attribute to the ionic strength the origin of 
aggregation. By increasing the HA/CH weight ratio, the aggregation can be limited and 
resulting B-NPs in PBS are weakly larger with respect to those in deionized water at time 
zero (Figure 33B,C). Nevertheless, aggregation progressively occurred thereafter and 
dimensions were found similar to those described above. On the other hand, the size 
distribution of B-NPs made of chitosan with Fa 0.64 and dispersed in both media was 
almost comparable (Figure 33D,E,F). More in detail, no apparently aggregation 
phenomena were identified for formulations with 1 mM of butyrate and different HA/CH 
weight ratio. This can be ascribed to the highly acetylation degree of CH, resulting in a 
lower net positive charge. In these conditions, the increasing of pH and screening effects 
by the presence of salts did not allow aggregation phenomena since the stability was 
mostly ensured by hydrophobic interactions between the polysaccharides. The dimensions 
of such nanoparticles did not excessively increased (if compared to B-NPs made of 
chitosan with Fa < 0.008), albeit the size distribution was variable during the three days of 
incubation due to swelling phenomena. The possibility to avoid the aggregation (and 
following flocculation) of B-NPs in PBS buffer simply using a more acetylated chitosan 
represents a noteworthy result. 
Some conclusions can be drawn: the behavior of B-NPs in physiological conditions varies 
on which CH is used and on the polysaccharide/butyrate concentration and their stability is 
sufficiently ensured only for a narrow range of formulations investigated. Another 
parameter to take into account is the role of HA as coating for B-NPs. Indeed, the presence 
of HA guarantees some advantages as well as a net negative surface charge allowing shield 
against the adsorption of proteins, protection versus macrophage uptake,(215) and 
feasibility to bind HA receptors as CD44 both on inflammatory and tumor cells enabling a 
selective targeting.(216),(203) Considering the parameters reported in Table 7 together 
with stability analyses above discussed and preliminary biological studies, the following 
best formulation was chosen for further analyses: 
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Chitosan with Fa = 0.64; butyrate 1 mM; HA/CH 1:1 
 
The encapsulation efficiency was calculated and was assessed at 77%.  
HA and CH are well known to possess the ability to react with ROS.(217) To investigate 
about scavenging properties of the resulting plain carrier, an acellular model based on the 
xanthine - xanthine oxidase system was used (Figure 34).  
 
 
 
Figure 34. Evaluation of the NPs scavenging properties by means of the xanthine-xanthine oxidase 
model. NPs, butyrate and free polysaccharides were incubated at indicated concentrations and the 
kinetics was followed up to 20 minutes. Superoxide dismutase (SOD) was used as positive control. 
 
HA and CH at the same concentrations as that in the best NP formulation induced a 
decrease in cytocrome c reduction up to 22%, while cytocrome c reduction induced by NPs 
was equal to 42%, thus demonstrating a significant sum scavenger effect.  
Subsequently, the association and/or internalization of NPs in neutrophils were studied by 
means of cytometric analyses and the outcomes are pointed out in Figure 35. 
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Figure 35. The association and the internalization of NPs versus human neutrophils was verified 
by means of flow cytometry. TNF-stimulated neutrophils were incubated at 37 °C with 
fluoresceinamine-isomer I-labeled NPs (except for control group) and analyzed at selected times 
(from t = 0 to 180 min). At the end of the experiment, neutrophils were centrifuged, resuspended 
and subsequently analyzed (washed panel). Green fluorescence due to fluoresceinamine-isomer I 
was collected using a 530 ± 30 band pass filter whereas red fluorescence emitted from trypan blue 
(75 µg mL-1 as final concentration) bound to fluoresceinamine-isomer 1 was collected by using a 
650 ± 13 bandpass filter. For each sample 10 000 events were considered. 
 
Control group shows the majority of the cells in the down left quadrant with the presence 
of only a small quenched fluorescence due to the presence of the TB. As soon as the NPs 
were added to the cells (t = 0 min) a significant red-shift occurred, ascribed to a quick 
association of the NPs with the cells. By increasing the time of exposure to t = 180 min, a 
progressively higher percentage of cells was found to be positive for both membrane 
binding (up left and right quadrant) and internalization (up and down right quadrant). By 
considering the percentage of cells who internalized NPs (0.33%) as well as the percentage 
of the cells which both internalized and associated NPs (0.59%), an internalization of ~ 1% 
and a binding efficacy of ~ 41% after 3 hours of incubation can be estimated. A further 
control was carried out in order to validate the presence of NPs at the membrane level. 
Human neutrophils were centrifuged at the end of incubation in order to favor the 
detachment of nanoparticles from the cells. The panel in Figure 35 shows that after 
centrifugation the quenched fluorescence reverted to the down left quadrant thereby 
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indicating that NPs were detached from cells and consequently eliminated when 
neutrophils were centrifuged and thereafter resuspended. By these evidences, it can be 
concluded that the association of the NPs with the neutrophils is weak (likely ascribed to 
the interaction between the HA and CD44 receptor of PMN)(209) whilst only a small 
amount of cells was effectively positive to the internalization. The percentage of uptake is 
lower compared to other models in which CH/HA-nanoparticles have been used. For 
instance, the overexpression of CD44 and a different experimental setup led to an 
internalization of ~ 80% in a breast cancer cell model.(203) This represents an advantage 
for the system presented in this chapter, considering that the anti-inflammatory activity of 
butyrate is probably exerted mainly via GPR43 receptor towards neutrophils.  
Considering the time-dependence of the anti-inflammatory activity of butyrate, one of the 
main purposes for this work was to provide a smart tool able to guarantee the right amount 
of payload at the right time to neutrophils. To investigate this aspect, release studies of 
butyrate from B-NPs were performed in PBS buffer. As shown in Figure 36, the leakage 
profile of butyrate from B-NPs was almost constant in the first twenty minutes with 
approximately 45% of butyrate leaked from nanoparticles in such time frame. Further, the 
leakage tends to slow down and progressively to reach a plateau. The cumulative release 
reached ~ 87% up to 4 h of incubation. It is noteworthy mention that the cumulative release 
of butyrate from B-NPs did not significantly vary up to 72 h (not shown) never reaching 
100%. Overall, chitosan-hyaluronan nanoparticles have proved behaving as break for the 
butyrate leakage, taking into account that preliminary experiments demonstrated that the 
release of free butyrate in the same experimental conditions reached 100% only after 2 
hours of incubation. As a consequence, B-NPs may be considered as a controlled release 
system for the short chain fatty acid. However, by comparing such nanoparticles with 
similar ones reported in literature, a faster leakage was found, probably due to the different 
nature of the cargo and polysaccharide’s features.(203) 
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Figure 36. In vitro cumulative release of butyrate leaked from B-NPs (black solid line) with 
HA/CH of 1:1 and chitosan Fa 0.64 in the first 4 h of incubation. The experiments (n = 3) were 
performed in PBS buffer at 37 °C to mimic a physiological milieu. 
 
To evaluate the lack of cytotoxicity of NPs, AlamarBlue assay was performed on murine 
fibroblast-like NIH-3T3 cells and results are reported in Figure 37. 
 
 
 
Figure 37. Proliferation rate of NIH-3T3 cells treated with NPs at different concentrations. Control 
group represents untreated cells. Proliferation was measured by means of AlamarBlue assay and 
data are normalized with respect to day 0 and expressed as mean (± SD, n = 6). 
 
Figure 37 shows that NPs at different concentrations did not prove any effect on the 
proliferation of NIH-3T3 cells up to three days of incubation thereby suggesting lack of 
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toxicity of such constructs. 
The further aim was to study the mucoadhesive properties of NPs for potential applications 
in inflammatory bowel disease treatments. Polysaccharide-based complexes can be 
extensively studied in terms of muco-adhesive properties by adopting several approaches. 
The most commons deal with the use of mucin as in vitro model of gastric mucus and with 
the use of portion of animal stomachs/intestines for ex vivo analyses. A very useful 
technique to verify mucoadhesive properties is to follow variations of dimension and 
distribution of aggregates by means of DLS measurements upon NPs and mucin mixing. 
This approach was followed in this work and results are pointed out in Figure 38. While 
the NPs show a typical unimodal size distribution with very low PDI (indicating the 
presence of a homogeneous dispersion of complexes in solution), mucin at concentration 1 
mg mL-1 shows a bimodal distribution with the presence of two peaks at 642.7 and 54.7 
nm. This mucin distribution is in agreement with other works. For instance, Sogias et al. 
demonstrated a bimodal distribution and similar range of dimensions for mucin at the same 
concentration.(218) By mixing NPs and mucin at different concentration ratios (r), a 
progressive increase of the Z-average was noticed by increasing the amount of mucin. 
More in detail, the Z-average was found to scale linearly with the concentration of mucin 
as pointed out in the plot of Figure 38 thereby indicating aggregation phenomena. At the 
same time, the peak 2 of mucin at ~ 50 nm disappeared by merging into a unique one when 
NPs were added, thus indicating the presence of a more uniform distribution, as even 
confirmed by reduced values of PDI. However, PDI tends to gradually increase by 
augmenting the amount of mucin so as suggesting the onset of more unstable colloidal 
systems. Sogias et al. concluded their work claiming that electrostatic interactions, 
hydrogen bonding and hydrophobic effects cooperate to favor mucoadhesive interactions 
between chitosan and mucin. Electrostatic interactions may be easily ruled out for the NPs 
presented in this chapter as contribution for mucoadhesion considering their negative 𝜉-
potential (~ -20 mV) as well as the negative charge of mucin for the pH investigated (~ -18 
mV).(218) Conversely, both hydrogen bonding and hydrophobic effects might be with no 
doubt considered the root of mucoadhesive interactions. 
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Z-average 
(nm) 
PDI 
Peak 1 mean 
intensity (nm) 
Peak 2 mean 
intensity (nm) 
Peak 1 area 
intensity (%) 
Peak 2 area 
intensity (%) 
NPs 286.8 0.101 323.3 0 100 0 
r: 0 281.6 1.000 642.7 54.7 84.4 15.6 
r: 4.10 298.3 0.149 350.1 0 100 0 
r: 0.82 340.1 0.240 439.8 0 100 0 
r: 0.41 379.2 0.294 501.6 0 100 0 
 
 
Figure 38. DLS analyses to elucidate the muco-adhesive properties of NPs. In the table are 
reported the hydrodynamic diameter (Z-average), the polydispersity index (PI), the percentages of 
intensities related to the dimensions and the area under the curves of size-distribution profiles. NPs 
(0.82 mg mL-1) were added to mucin (0.1, 0.5 and 1 mg mL-1 as final concentrations) with 1:1 v/v. 
r value is the concentration ratio between NPs and mucin. Final pH after mixing was ~ 5.5. In the 
plot is pointed out the trend of Z-average of complexes versus amount of mucin. The dashed line 
represents the linear fitting among experimental points (R2 > 0.99). 
 
The last part of present work was addressed to load nanoparticles within the chitosan 
membranes described in the previous chapters of this thesis. As a proof of concept, plain 
carriers were considered. The basic idea was to load the NPs by exploiting the ability of 
membranes to uptake water and consequently to swell as already demonstrated beforehand. 
NPs present in the soaking medium are supposed to be internalized in the membranes by 
diffusion phenomena. As expected, when membranes were incubated for 24 h with NPs, 
the decrease of fluorescence in the incubation medium was evidenced, thus suggesting the 
incorporation of NPs within membranes. Considering the amount of water diffused during 
this time frame, the amount of NPs up taken was assessed being 4.86 ± 0.65 µg per mg of 
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dried membrane. Further studies are needed to evaluate the leakage of such constructs from 
chitosan matrices and, consequently, the release of the payload. 
 
3.4.4. Main conclusions 
• Butyrate demonstrated dose- and time-dependent anti-inflammatory activities on 
two immune cell models; 
• The production of chitosan-hyaluronan nanoparticles (complexes) to host butyrate 
was addressed; 
• The stability of the nanoparticles in a physiological medium was found being 
strongly affected by the acetylation degree of chitosans;  
• Plain complexes demonstrated to behave as radical scavenger and to display lack of 
cytotoxicity and mucoadhesive properties;  
• Complexes loaded with butyrate constitute a potential controlled release system for 
the delivery of the short chain fatty acid. 
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CHAPTER V 
 
Biological properties of a silver/lipoate hyaluronan derivative 
 
3.5.1 Aim of work 
In this chapter, a novel complex of sodium hyaluronate-lipoate with silver ions (termed 
SHLS12) is described. It has been studied in terms of biological properties of a biomaterial 
usable for the treatment of non-healing wounds. The present contribution is part of a more 
extent work carried out in collaboration with Sigea Srl company, Trieste (Italy). 
 
3.5.2. Materials and methods 
3.5.2.1. Materials. Sodium hyaluronate (Phylcare Sodium Hyaluronate extra LW) 
employed in this study was purchased from Biophil Italia Spa (Mw ~ 100 - 400 kDa). 
Sodium hyaluronate-lipoate (SHL, see Figure 39), prepared as previously reported,(219) 
had a degree of substitution of 0.3 as determined by NMR analysis with a corresponding 
molar mass of the repeating unit equal to 457.5 g mol-1. Neutral Red, Thiazolyl Blue 
Tetrazolium Bromide (MTT), phenazine methosulfate (PMS), bovine serum albumin 
(BSA) powders, fetal bovine serum, Luria-Bertani (LB) broth, LB Agar, Brain Heart 
Infusion (BHI) broth, silver acetate (≥ 99.0%) and phosphate buffered saline (PBS) were 
all purchased from Sigma-Aldrich (Chemical Co.). Dulbecco’s Modified Eagle’s Medium, 
fetal bovine serum, penicillin, streptomycin and glutamine solutions were purchased from 
EuroClone, Italy. All chemicals and reagents were of the highest purity grade 
commercially available.  
 
 
 
Figure 39. SHL structure. 
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3.5.2.2 Antibacterial tests. The antibacterial activity of SHLS12 was evaluated using 
strains of Escherichia coli (ATCC® 25922TM), Staphylococcus epidermidis (ATCC® 
12228TM), Staphylococcus aureus (ATCC® 25923TM) and Pseudomonas aeruginosa 
(ATCC® 27853TM). 
 
3.5.2.2.1 Growth inhibition assay. Growth inhibition assay was performed according to 
the protocol described in (220) with slight modifications. SHLS12 solution (0.2% w/v) was 
prepared by adding SHLS12 in LB broth and vigorously vortexed for 30 seconds in order 
to obtain a clear and homogeneous dispersion of the polymer in such medium. Bacterial 
suspensions were prepared by adding 20 µL of bacteria, preserved in glycerol, to 5 mL of 
LB broth. The obtained suspensions were incubated overnight at 37 °C. After 24 h, 500 µL 
of bacterial suspension was diluted in 10 mL of broth and grown up for 90 min at 37 °C in 
order to restore an exponential growth phase. Bacterial concentration was measured by 
means of optical density (OD) at 600 nm. After centrifugation (3500 rpm, 5 min), 
supernatants were removed and bacteria were resuspended with either SHLS12 solution in 
LB broth or LB broth to obtain a final concentration of 5 x 106 bacteria mL-1. In the case of 
evaluation of the BSA influence on SHLS12 activity, bacteria were resuspended in LB 
broth added with either BSA (40 g L-1) or BSA and SHLS12 (40 g L-1 and 0.2% w/v, 
respectively). All bacteria strains were then incubated at 37 °C for 4 h in shaking 
conditions (140 rpm). At the end of incubation, bacterial suspension was serially diluted in 
PBS buffer (from 10-1 to 10-5) and 25 µL of each suspension were plated on LB agar. After 
overnight incubation at 37 °C, the colony forming units (CFUs) were counted. Outcomes 
were compared with the suspension of bacteria grown in liquid medium as control. 
 
3.5.2.2.2 Biofilm formation. Bacterial suspensions of S. aureus and P. aeruginosa were 
prepared by adding 20 µL of bacteria, preserved in glycerol, to 5 mL of BHI broth plus 3% 
w/v sucrose. The obtained suspensions were incubated overnight at 37 °C. After 24 h, 
bacteria were diluted 1:100 in the same broth and plated (300 µL/well) into 24-well plates. 
For confocal laser scanning microscopy analyses, bacteria were plated on sterile 13 mm 
tissue culture coverslips (Sarstedt, USA) laid down on the bottom of the culture plate 
wells. Plates were incubated at 37 °C for 24 h to allow biofilm formation. After 24 h, broth 
was removed and formed biofilm was carefully rinsed twice with 100 µL of sterile PBS in 
order to remove planktonic cells. 300 µL of PBS containing 0.2% w/v of SHLS12 were 
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deposited on the bacterial layer. Biofilms were then incubated at 37 °C and MTT assay was 
performed according to the following protocol after 4 and 24 h of incubation. 
 
3.5.2.2.3. Viable biomass assessment. The test was performed according to the protocol 
described elsewhere.(197) Briefly, MTT stock solution was prepared by dissolving 5 mg 
mL-1 of MTT powder in sterile PBS. PMS stock solution (0.3 mg mL-1) was prepared by 
dissolving PMS powder in sterile PBS. Solutions were further filtered (0.22 µm filters, 
BioSigma, Italy) and stored at 2 °C in light-proof vials until the day of the experiment, 
when a fresh measurement solution (FMS) was prepared by mixing 0.5 mL of MTT stock 
solution, 0.5 mL of PMS stock solution, and 4 mL of sterile PBS. DMSO was used as 
lysing solution (LS). After the biofilm incubation period, SHLS12 and PBS were gently 
removed from the plates and each well was carefully rinsed three times with 100 µL of 
sterile PBS in order to remove non-adherent cells. 200 µL of FMS solution were placed 
into each well and the plates were incubated for 3 h under light-proof conditions at 37 °C. 
The FMS solution was then gently removed and formazan crystals were dissolved by 
adding 200 µL of LS to each well. Plates were additionally stored for 1 h under light-proof 
conditions at room temperature and then 100 µL of the solution were transferred into the 
wells of 96-well plates. The absorbance of the solution was measured using a 
spectrophotometer (FLUOStar Omega-BMG Labtech) at a wavelength of 550 nm. 
Outcomes were expressed as OD units. 
 
3.5.2.3. Confocal laser scanning microscopy (LSCM). LSCM analyses were addressed at 
detecting viability of bacteria in the biofilm mass. FilmTracer Live/Dead biofilm viability 
kit (Invitrogen™) was used (see paragraph 3.3.2.9.). 
 
3.5.2.4 Cell culture. Mouse fibroblast-like NIH-3T3 and immortalized human keratinocyte 
HaCaT cell lines were used for the in vitro experiments (see paragraph 3.3.2.10.). 
 
3.5.2.5 Biocompatibility studies. In vitro cytotoxicity of SHLS12 was evaluated by using 
Neutral Red assay on both NIH-3T3 and HaCaT cells. 20 000 cells were plated on 24-well 
plates and, after complete adhesion, culture medium was changed with 300 µL of fresh 
medium. The cytotoxicity test was performed by direct contact of the cells with SHLS12 
(50 µL of a solution 0.2% w/v) laid down on filter papers, (16 mm2 as surface) placed in 
the middle of each well. As a positive control material, poly(urethane) films containing 
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0.25% zinc dibuthyldithiocarbamate (ZDBC) were used. As negative control material, 
plastic poly(styrene) sheets were used. Untreated cells (without any contact-material) were 
also considered as additional control. After 24 and 72 h, Neutral Red assay was performed 
according to the manufacture’s protocol. Each material test was performed in triplicate. 
Cytotoxicity was expressed as percentage of viability by normalizing the OD540 nm of 
treated cells to the OD540 nm of the untreated cells. 
 
3.5.2.6 Statistical analysis. Data are expressed as means and standard deviations (SD). 
Statistical analysis was performed using Student’s t test, and a p value of < 0.05 was 
considered statistically significant. 
 
3.5.3. Results and discussion 
The main purpose for the present work was to use a hyaluronan-lipoate derivative (named 
Lipohyal)(219) to synthesize a silver complex with antibacterial properties and lack of 
toxicity towards eukaryotic cells. There are very few papers concerning the ability of HA 
to favor the binding and stabilization of silver in different chemical forms with respect to 
other biopolymers, e.g. chitosan or alginate.(221),(222) For instance, Abdel-Mohsen et al. 
developed HA fibers via wet-spinning method, which were formed and to stabilized silver 
nanoparticles.(223) Chudobova et al. demonstrated the formation of hyaluronate-silver 
complexes after the addition of silver nitrate to a solution of HA.(224) 
The main characteristic of silver-containing biomaterials refers to their antibacterial 
properties against different bacteria strains without hindering the viability of mammalian 
cells. In this section, the ability of SHLS12 to influence the growth and viability of bacteria 
both in a planktonic and in an organized community state (biofilm) is reported. E. coli, S. 
aureus, P. aeruginosa and S. epidermidis strains were selected for such a purpose. Figure 
40 points out the results obtained by growth inhibition assays. A small amount of SHLS12 
(0.2% w/v) showed a marked antibacterial activity owing to the presence of silver ions. For 
all strains investigated, a significant drop of CFU (at least p < 0.01) was spotted for 
SHLS12-treated samples with respect to the control. This result is validated by visual 
observations as reported in Figure 40 E-H, which shows the growth of S. aureus colonies 
on LB agar for treated and untreated samples. 
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Figure 40. Growth inhibition rate expressed as Log CFU mL-1 of S. aureus (A), S. epidermidis (B), 
E. coli (C) and P. aeruginosa (D) following 4 h of treatment with SHLS12. Statistical differences 
were determined by means of Student’s t test. **p < 0.01; ***p < 0.001. S. aureus colonies on LB 
agar: diluted 10-4 (E) and diluted 10-5 (F) SHLS12-treated sample; diluted 10-4 (G) and diluted 10-5 
(H) control sample. 
  
The inactivation of silver by serum proteins can be a concern for in vivo applications of 
SHLS12. In particular, serum albumin has been shown to have specific binding sites for 
metal ions entering the bloodstream.(225),(226),(227) They are best characterized for 
human serum albumin (HSA) and for bovine serum albumin (BSA), which is often used as 
a model protein for HSA.(228) Zhao et al. proved the formation of complexes between 
Ag+ and BSA by spectroscopic investigation.(229) Ostermeyer et al. demonstrated that 
BSA dampened the toxicity of citrate silver nanoparticles by chelating silver ions leaked 
from silver nanoparticles (AgNPs) and by binding to AgNPs surface thereby preventing 
NH3-dependent dissolution from occurring.(230) This aspect has also been investigated in 
another study where serum proteins reduced the antibacterial features of a colloidal 
solution of chitlac-nAg.(75) It should be reminded that at physiological pH the overall 
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charge of albumin is predominantly negative, thus electrostatic interactions with the chitlac 
polycation may be at the root of such an adverse effect. BSA at a concentration of 40 g L-1 
was selected to verify its influence on the antibacterial properties of SHLS12. As shown in 
Figure 41, a significant drop of S. aureus and P. aeruginosa CFUs was spotted after 4 h of 
treatment with both SHLS12 and SHLS12 + BSA with respect to the control. By 
comparing SHLS12 with SHLS12 + BSA treated samples, no statistical differences were 
identified for S. aureus. Concerning P. aeruginosa, a significant but small difference was 
identified (p < 0.05), thus evidencing only a partial and minimal inhibitory effect of serum 
albumin towards SHLS12 antibacterial activity.  
 
 
 
Figure 41. Growth inhibition rate in the presence/absence of BSA expressed as Log CFU mL-1 of 
S. aureus (A) and P. aeruginosa (B) following 4 h of treatment with SHLS12. Statistical 
differences were determined by means of Student’s t test. NS no statistical differences between 
SHLS12 and SHLS12 + BSA-treated samples; *p < 0.05 between SHLS12 and SHLS12 + BSA-
treated samples. 
 
Another pivotal parameter that has been considered in this section is the capability of 
silver-complex to exert antibacterial activity towards organized-community of bacteria, so 
termed biofilms. Biofilms are characterized by an extracellular polymeric substance (EPS) 
that surrounds bacterial cells making them one thousand times more resistant to antibiotics 
and drugs than planktonic ones.(38) S. aureus and P. aeruginosa were selected for these 
studies because of their ability to form biofilms.(220),(231) Figure 42 A-B points out the 
outcomes obtained after 4 and 24 h of treatment of S. aureus and P. aeruginosa biofilms, 
respectively. In both cases, SHLS12 broke apart biofilm, as revealed by MTT colorimetric 
assay. The optical density (OD) of S. aureus treated with SHLS12 showed a reduction of ~ 
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30% after 24 h of treatment compared to the control, whereas no statistical differences 
were observed after 4 h of treatment. At a variance, in the case of P. aeruginosa a marked 
OD reduction was spotted already after 4 h of treatment. It may be argued that P. 
aeruginosa is more susceptible than S. aureus strain to Ag+ ions, likely because of their 
thinner cell wall, which enables silver ions to penetrate into the bacterial cell more 
easily.(232) These results were confirmed by differential biofilm staining for dead (red) 
and alive (green) cells and visualization with confocal laser scanning microscopy after 
treatment with SHLS12. In Figure 42 C-F P. aeruginosa and S. aureus biofilms show a 
green fluorescent layer indicating the good viability of bacteria in the case of control. 
Conversely, treated cells for 24 h with SHLS12 pointed out the presence of a non-
homogeneous layer of bacteria with few viable green cells and a lot of reddish/yellow 
bacteria, so as to suggest cell suffering and biofilm disaggregation. These outcomes are in 
agreement with what evidenced in the viable biomass experiments reported above. Overall, 
growth inhibition assays and viable biomass assessment clearly proved antibacterial 
properties of SHLS12 thanks to the presence of silver ions which, as reported in literature, 
exert their activity (i) by interacting with thiol/phosphorus-groups of the cell wall and the 
plasma membrane proteins of bacteria,(38),(56) causing membrane damage or (ii) by 
binding DNA of microbes leading to cell division alterations.(67)  
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Figure 42. Viable biomass MTT assay expressed as O.D. at 550 nm of S. aureus (A) and P. 
aeruginosa (B) following 4 (empty columns) and 24 h (filled columns) of treatment with SHLS12. 
Statistical differences were determined by means of Student’s t test. NS no statistical differences 
versus control; *p < 0.05 versus control; **p < 0.01 versus control. LSCM images of P. aeruginosa 
biofilm: control group (C) and SHLS12-treated sample (D). LSCM images of S. aureus biofilm: 
control group (E) and SHLS12-treated sample (F). Biofilms were grown on tissue culture 
coverslips in BHI broth plus 3% w/v sucrose and following treated with SHLS12 for 24 hours. For 
cell staining, FilmTracer Live/Dead biofilm viability kit (Invitrogen™) was used. Green 
fluorescence indicates live cells whereas red and yellow fluorescence refers to dead and suffering 
ones, respectively. Scale bar was 50 µm for all images. 
 
One of the most important challenge for silver-containing biomaterials concerns their 
ability to exert antibacterial activity without hindering the viability of eukaryotic cells. The 
toxicity of silver for mammalian cells is proportional to the amount of metal present in 
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environment, thus causing cellular damages if internalized.(72) A key strategy to dampen 
the toxicity of silver resides then in the fabrication of systems capable to avoid - or at least 
reduce - the leakage of silver, but at the same time, preserve its antimicrobial activity 
allowing for the direct interaction of the metal ions with the proteins localized on the 
bacterial surface. Polysaccharide-based materials loaded with silver nanoparticles have 
been already described to prevent an excess of silver release and thus not to affect the 
viability of mammalian cells.(220),(62),(77) In this view, it is reasonable that the amount 
of released metal is under the lethal dose threshold resulting not cytotoxic. To assess the 
biocompatibility of SHLS12, a Neutral Red cytotoxicity assay was carried out. As pointed 
out in Figure 43, SHLS12 did not exert any cytotoxic effect on the cell lines used. Indeed, 
there was no significant difference in Neutral Red signal between the SHLS12-treated and 
untreated cells after 24 and 72 h. The results of the positive control group on NIH-3T3 
cells showed an apparently inexplicable result, namely a similar percentage of viability as 
the negative control after 4 h of treatment. However, this is likely ascribed to the slow 
cytotoxic activity of zinc dibuthyldithiocarbamate in poly(urethane) films towards such 
cell line. At 72 h the cytotoxicity of positive control was evident in all cases. The 
combination of results proves that SHLS12, besides providing a good antibacterial activity 
against biofilm-forming bacteria strains, is not dangerous for eukaryotic cells likely 
because silver ions are firmly coordinated and immobilized by the lipoate groups and 
therefore do not diffuse into the surrounding environment. 
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Figure 43. Percentage of viability of fibroblast NIH-3T3 (A) and ketatinocytes HaCaT (B) cells 
measured using Neutral Red assay. SHLS12 was kept in touch with cells and testing was performed 
after 24 (empty columns) and 72 h (filled columns) of treatment. Poly(urethane) sheets containing 
0.25% zinc dibuthyldithiocarbamate were used as contact positive control (C+) whereas plastic 
poly(styrene) sheets were used as contact negative control (C-). Statistical differences were 
determined by means of Student’s t test. 
 
3.5.4. Main conclusions 
• SHLS12 proved straightforward antibacterial properties towards different bacteria 
strains grown both in planktonic and sessile conditions; 
• Such activity was mostly not affected by the presence of physiological amounts of 
serum proteins;  
• The lack of cytotoxicity towards eukaryotic cells was demonstrated. 
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4. CONCLUDING REMARKS 
 
Despite several medical resources are available for the treatment of lesions, non-healing 
wounds still represent a concern and challenge healthcare worldwide. Various non-surgical 
approaches have been investigated together with the use of numerous drugs to help the 
recovery of such wounds. Innovative polymer-based biomaterials are by far the most 
studied tools to entrap active molecules capable to face the multiplicity of negative aspects 
at damaged sites. In this context, the present thesis work wants to provide additional 
paradigms to tackle chronic wounds following an unambiguous thread starting from 
biomaterial fabrication to characterization. 
 
Specifically, the main goals reached by the research activity presented in this thesis are 
summarized below.  
 
• Homogeneous hydrogels and membranes based on chitosan and TPP were 
developed by exploiting an innovative approach through the ionotropic gelation 
process. A diffusion technique was selected in order to avoid the local saturation of 
chitosan binding sites, thus obtaining a macroscopic uniform hydrogel structure. 
The influence of chitosans with different Fa and Mw, concentrations of polymer, 
TPP and NaCl were studied in order to fabricate wall-to-wall systems and to tune 
the homogeneity of gelation. In addition, it was revealed that not only TPP but also 
PPi contributes to the gelation of chitosan. Soft and pliable biocompatible 
membranes have been finally prepared through a temperature-controlled freeze-
drying procedure. 
 
• Additional insights about the ionotropic gelation of chitosan-TPP-PPi system have 
been provided. Light scattering (turbidimetry), CD and 1H-NMR demonstrated the 
higher ability of the former to interact with biopolymer and to induce chain 
reconfiguration by both. The demonstrated ability of not-traditional cross-linker PPi 
giving rise to the formation, by means of three-step process, of wall-to-wall 
hydrogels with tunable mechanical properties represents an innovation with great 
potential in biomedical field. 
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• A silver-containing antimicrobial membrane was successfully obtained. This 
nanocomposite material was proved to possess antimicrobial activity towards 
bacteria suspensions and mature biofilms. The stability of chitlac-coordinated 
AgNPs was not affected by mixture with chitosan and glycerol, enabling to prepare 
homogeneous macroscopic nanocomposite hydrogels and pliable membranes. 
Overall, the ability of AgNPs to enhance the antibacterial properties of chitosan, 
combined with the lack of cytotoxicity towards eukaryotic cell lines and the 
hydrophilic behavior of the construct, allow to consider this membrane as a 
promising biomaterial for the treatment of non-healing wounds. 
 
• The ability of butyrate to dampen both pro-inflammatory cytokines production by 
stimulated macrophages and the respiratory burst of human neutrophils in a dose-
manner is reported. The anti-inflammatory behavior of such molecule was also 
found to be time-dependent for the latter. As a consequence, the fabrication of 
smart reservoirs for butyrate was addressed. The stability in PBS medium of B-NPs 
with different composition was found being strongly affected mainly by the 
acetylation degree of chitosans. The stability, together with the surface charge, 
polydispersity and preliminary biological studies enabled to identify the most 
promising formulation (size: 287 ± 2 nm; surface charge: -23.0 ± 0.1 mV; 
polydispersity index: 0.18 ± 0.04). Related plain carrier demonstrated to behave as 
a radical scavenger and as a controlled release system. Considering all these 
aspects, together with the lack of cytotoxicity and mucoadhesive properties, 
complexes based on chitosan and hyaluronan may be considered as promising 
vehicles for the delivery of the anti-inflammatory butyrate molecule to inflamed 
tissues in vivo. 
 
• SHLS12  proved straightforward antibacterial properties towards different bacteria 
strains grown both in planktonic and sessile conditions. Moreover, such activity 
was mostly not affected by the presence of physiological amounts of serum 
proteins. The lack of cytotoxicity towards eukaryotic cells was demonstrated with 
respect to two eukaryotic cell lines. The overall outcomes allow considering 
SHLS12 a promising biomaterial for further in vivo applications. 
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